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The objective of this three-manuscript dissertation is to examine how lymphology is 
integrated into the field of physical therapy, including professional Doctor of Physical Therapy 
(DPT) education and Post-Professional Physical Therapy practice.  The overarching aim of this 
dissertation is to advance lymphology aptitudes among faculty, post-professional educators and 
clinicians, and students.  Understanding current lymphology curriculum standards, clinical use of 
manual lymphatic drainage techniques (MLdT), and use of outcome measures related to breast 
cancer related lymphedema brings into focus the physical therapy profession attentiveness, or 
lack thereof, of a major body system, the lymphatic system, that effectuates fluid homeostasis 
and immunity. 
 Three independent studies embody the aim of this dissertation.  The status of lymphology 
education in professional DPT programs was investigated in the first study with the aims to 1) 
describe current, typical lymphology content within professional DPT programs; and 2) identify 
whether lymphology content is perceived as entry-level material amongst professional DPT 
faculty who were responsible for teaching lymphology content and professional DPT faculty 
who did not teach lymphology content.  The second study comprises a systematic review that 
investigated whether MLdT, in addition to conventional rehabilitation, for conditions affecting 
the musculoskeletal system, can decrease edema, and improve ROM, patient-reported outcomes, 
and healthcare utilization.  The third study examined 1) OMs used by CLTs on BCS with BCRL 
and their differences between professions; 2) unique characteristic predictors for use of OMs; 
and 3) facilitators and barriers which influence CLTs use of OMs and their differences between 
professions.     
 Chapter one consists of the background for the aim of this dissertation and frames the 
purpose of the following individual studies contained in chapters II-IV.  Each study contains a 
background/introduction, methods, results, and discussion sections.  The final chapter (V) 
synthesizes the previous four chapters as a final discussion. 
 
 




The American Physical Therapy Association (APTA) vision statement, “Transforming 
society by optimizing movement to improve the human experience” 1 affirms the purpose of the 
physical therapy profession and physical therapists (PTs) alike.  Identity, collaboration, and 
quality are guiding principles to accomplish the APTA vision statement.1  Physical therapists 
uphold this quality by “embrac[ing] best practice standards in examination, 
diagnosis/classification, intervention and outcome measurement.”1  They collaborate with 
“Interprofessional research approaches [that] ensure[s] evidence translates to practice and is 
consumer-centered.” These principles coalesce to form an identity in which the physical therapy 
profession promotes the movement system, described as “the integration of body systems that 
generate and maintain movement at all levels of bodily function.”1    
Integration of body systems in the physical therapy profession would consist of major 
body systems including cardiovascular, metabolic, gastrointestinal, endocrine, integumentary, 
musculoskeletal, neurological, genital and reproductive, renal and urologic, pulmonary, and 
lymphatic systems.2(p.26, 7C)  The lymphatic system interrelates the immune system and the 
circulatory system, but stands independently as a unique major body system.3,4  As a vital 
component of microcirculation, the lymphatic system maintains fluid homeostasis, and is 
responsible for the resolution of edema.4,5  The management of edema contributes to the APTA 
vision statement of transforming society through optimizing the movement system of humans 
which may be affected by many conditions affected by edema, albeit, integument, 
musculoskeletal, or neurological pathogenesis.  The study and practice of lymphology concepts 
enhances the guiding principles of the APTA vision by integrating body systems, participating in 
interprofessional collaboration, and embracing evidence-based examination, 
diagnosis/classification, interventions, and outcome measurements.  Physical therapists that 
engage lymphology concepts into their discipline are able to optimize human movement through 
edema management and thereby transform society by decreasing the continuum of disease and 
injury comorbidities related to the imbalance of interstitial fluid homeostasis.  
Society is greatly affected by lymphedema whose prevalence worldwide is not fully 
known, but is estimated to affect 140-250 million people, and is a common disease in America, 
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affecting 1 in every 1,000 persons.6  Of these persons, secondary lymphedema affects 
approximately 99%.6  The most common cause of secondary lymphedema is lymphatic filariasis 
(a parasitic disease) which affects 120 million people in 80 countries, and is consider to be the 
second leading cause of permanent and long-term disability worldwide.7  Primary lymphedema 
is less common, affecting approximately 1 in every 100,000 persons of the American 
population.6  The incidence rate of breast cancer-related lymphedema (BCRL) ranges greatly but 
is approximately one in five breast cancer survivors.6,8,9  Lower extremity lymphedema makes up 
approximately 90% of patients with lymphedema worldwide due to filariasis, inguinal 
lymphadenectomy and/or radiation, obesity, primary lymphedema, or progressive end-stage 
chronic venous insufficiency.6,10  Approximately 50% of head and neck cancer survivors may 
develop lymphedema resulting from treatment for cancer.11  A study conducted in the United 
Kingdom revealed that chronic edema resulted in >80% of sick leave affecting 9% of 
employment status.12  Prospectively, crude prevalence of chronic edema in the United Kingdom 
over a 10 year period ranged from 1.33/1000 to 3.93/1000.12,13  While chronic edema was 
notably higher in men than women, only 3% was related to cancer or cancer treatment.13 
Lymphology is the study of the lymphatic system, including its anatomy, physiology and 
pathology.14  The need for education pertaining to the lymphatic system and lymphedema is 
evident within the collective medical fields including, but not limited to, general practitioners, 
physical therapists, occupational therapists, speech-language pathologists, nurses, and 
surgeons.15  The American Lymphedema Framework Project (ALFP) identified the deficiency of 
education pertaining to the anatomy, physiology, and pathophysiology of the lymphatic system 
across medical disciplines, and the education of legislative and healthcare reform policy 
stakeholders.16  In 2017, Stanley Rockson, MD, professor of lymphatic research and medicine at 
Stanford University, poignantly stated in an editorial, that a deplorable lymphatic ignorance has 
arisen in the medical community.17  The physician notes that, “health care providers are ill-
equipped to provide the care and solace that they [primary lymphedema patients] seek.”17  The 
International Lymphedema Framework suggests a lack of awareness about lymphedema and 
related disorders is unacceptable especially considering the decades of research that has occurred 
in the field of lymphology.18 
Physical therapists provide interventions for limitations in movement and the pain that 
may occur from inflammatory processes or various profiles of edema (i.e. effusion, pitting 
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edema), while being guided by the chronological characterizations of tissue healing (e.g. acute, 
subacute, and chronic).19,20  Knowledge of the fundamentals of lymphology is important for 
physical therapists to provide safe and effective care to patients with various causes and 
classifications of edema. Professional DPT students should be knowledgeable about different 
edematous diseases, chronological edema modifications, and lymphatic classifications (i.e. 
dynamic insufficiency, mechanical insufficiency, combined insufficiency) in order to make 
appropriate differential diagnoses.  This foundational knowledge would be considered an 
important component of a PT’s clinical reasoning21,22 for proper edema treatment and 
rehabilitation choices (e.g. ice, elevation, manual lymph drainage, compression, exercise).  Amid 
the vast spectrum of PT curriculums within the United States, a concern exists for adequate 
education pertaining to the lymphatic system.23  To prepare professional DPT graduates in 
becoming effective clinical and scholarly practitioners, the Commission on Accreditation in 
Physical Therapy Education (CAPTE) requires that lymphology curriculum content should 
include examination, evaluation, diagnosis, and interventions of circulation (arterial, venous, 
lymphatic) and integumentary integrity.2(pp.28-29;7D19, 7D27)   Since 2018, the national physical 
therapy examination (NPTE) informs students of the importance of “movement analysis as 
related to the lymphatic system”, and the “interpretation of knowledge about diseases/conditions 
of the lymphatic system.”24  Current trends of lymphology education in professional Doctorate of 
Physical Therapy programs is vital to the future profession as this field engages in the discipline 
of primary care.  Investigating what is currently being taught and what is currently considered 
entry-level knowledge of lymphology for the primary care physical therapist may encapsulate the 
breadth and/or depth needed for clinical reasoning in patient-centered care.  Therefore, the first 
study investigated the status of lymphology education in professional DPT programs with the 
aims to 1) describe current, typical lymphology content within professional DPT programs; and 
2) identify whether lymphology content is perceived as entry-level material amongst professional 
DPT faculty who were responsible for teaching lymphology content and professional DPT 
faculty who did not teach lymphology content.   
  The examination blueprint descriptions of the NPTE, includes the importance of entry-
level knowledge of adverse effects or complications on the lymphatic system, as a result of 
physical interventions upon the lymphatic system, or other systems.24  While the term 
lymphedema appears to be unique and perhaps an isolated lymphatic morphology, sources have 
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argued that chronic edema better encapsulates the broad spectrum of edema and associated 
disorders as they relate to the “adverse effects” and “complications” of the lymphatic system.18  
Edema emerges when lymphatic drainage capacity is overwhelmed by capillary filtration.18  In 
fact, in recent interpretations of the Starling’s model of human fluid homeostasis, there is 
evidence that capillary venous reabsorption is non-existent and that the lymphatic system may be 
solely responsible for macromolecule and fluid reabsorption of the interstitial spaces.25  PRICE 
(protection, rest, ice/cryotherapy, compression, elevation) is a practical and intuitive theorem 
used to treat pain and inflammation on conditions affecting the musculoskeletal system.  
However, the evidence of effectiveness for such a construct is lacking.26  Two of constituents of 
PRICE, ice and compression, have recently been examined to have limited clinical benefits.  A 
meta-analysis reported that compression bandaging did not attain statistically significant 
differences (p > 0.05) in pain, swelling and range of motion.27  Similarly, in a Cochrane 
systematic review, cryotherapy was noted to have very low quality evidence in improving pain 
(Mean Difference (MD)) = -1.32 points on a 10 point scale, 95%CI, -2.37 – -0.27) and knee 
range of motion (MD = +11.39 degrees of flexion, 95%CI 4.13 – 19.66), but had no significant 
benefit for swelling following total knee replacement.28  Considering the role of the lymphatics 
with regards to the revised Starling’s model and aligning cryotherapy with the physiology of 
lymph transportation, intrinsic contractility of lymphatic vessels are adversely affected by 
cooling temperatures of 4-8 degrees Celsius and are unable to adapt to their optimal temperature 
contractility.29  Even at a one-degree change from baseline tissue temperature, there was a 
decrease in contraction frequency (-2.08 cycles/minute) of the lymphatic vessels.29  Being 
cognizant of the aforementioned warrants a systematic review examining the effects of manual 
lymph drainage techniques (MLdT) on conditions affecting the musculoskeletal system, which 
often are the recipient of PRICE interventions.  Therefore, the second study, a systematic review, 
investigated whether MLdT, in addition to conventional rehabilitation, for conditions affecting 
the musculoskeletal system, can decrease edema, and improve ROM, patient-reported outcomes, 
and healthcare utilization.  Examining these effects lends to the need for a core set of outcome 
measures for use in both the clinical setting and in research for a homogenous effect in the 
multidisciplinary field of physical therapy. 
In the Guide for Physical Therapist Practice 3.0, the APTA describes skillsets that are a 
part of professional PT practices including examination, evaluation, and selection of 
 - 5 - 
interventions pertaining to the lymphatic system.30  Examination and re-examination of the 
peripheral circulation, including lymphedema, are considered minimum required skill sets per 
the APTA – Board of Directors (BOD).31  In 2006, the APTA Section on Research developed the 
Evaluation Database to Guide Effectiveness (EDGE) Task Force, commissioned to promote 
standardization of outcome measures (OMs) by identifying best OMs  that were reliable, valid, 
and had good clinical utility for each practice area.32  Quantifiable OMs are an essential 
component of evidence-based practice (EBP) and are often incorporated in the examination of a 
disorder and the outcome assessment of interventions for related impairments and limitations.33,34  
The results of these measures provide a foundation for clinical reasoning in the diagnosis, 
prognosis, and establishment of interventions and/or management of a health condition.35  
Standardized OMs are a key component to patient-centered care, value-based healthcare, and 
current value-based reimbursement models, especially in complex long-term conditions.36  
Value-based healthcare and reimbursement models seek to provide improved health-related 
outcomes relative to the cost of healthcare and is pivotal for the profession of PT aspiring to 
EBP.  Through consistent use of examinations with standardized OMs and evidence-based 
interventions recommended in clinical practice guidelines, physical therapists achieve value-
based outcomes that add value for their patient’s health and improves the therapist-patient 
relationship.36,37     
Generally, physical therapists hold positive attitudes about EBP and believe that OMs 
enhance patient-provider and provider-payer communication, enhance examination 
thoroughness, and improve directing and focusing a plan of care.34,38  However, only 48% of 
physical therapists reported using OMs.38  Investigating a multidisciplinary healthcare provider 
population, Burton et al.39 assessed the use of OMs in stroke rehabilitation and found that 77% of 
nurses and 60% of physician used one OM weekly, compared to only 33% of physiotherapists, 
33% of speech and language therapists, and 35% of occupational therapists at the same 
interval.39  Use of OMs within specialty groups may demonstrate favorable trends as noted in a 
study investigating hand therapists, which reported that 92% had used patient-reported OMs.40  
These authors reported that hand specialist respondents that used more than one OM determined 
that they were able to better establish functional and physical limitations for their patients.  
Certified lymphedema therapists (CLT) are specialists who have completed 135 hours of 
education consisting of both 1/3 theoretical instruction and 2/3 practical training to examine, 
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evaluate, and select interventions pertaining to the lymphatic pathologies and associated 
impairments.41  Various medical professionals may be a CLT, including nurse (RN), 
occupational therapist (OT), certified occupational therapist assistant (COTA), physical therapist 
(PT), physical therapist assistant (PTA), physician (MD or DO), chiropractor (DC), massage 
therapist (MT), and certified athletic trainer (ATC). 41  The comorbidities related to lymphatic 
pathologies include various musculoskeletal changes limiting range of motion and strength, 
difficulty reaching, increased fatigue and tissue volume, sensory impairments, pain, integument 
changes, and low self-esteem and quality of life perceptions.6,8,42–45  Identifying OMs with good 
psychometric properties for the examination on BCS with BCRL, including the associated 
comorbidities, benefits the physical therapist – CLT in application of an evidence-based 
approach addressing the impairments and limitations identified in the evaluation of the 
examination findings and in concert with the patient goals.  While OMs have been recommended 
by the EDGE task force, the extent to which CLTs are using them is unknown.  Furthermore, 
there is a lack of knowledge of the barriers and facilitators to the use of OMs by CLTs.  An 
investigation addressing this gap of knowledge fosters further understanding of the physical 
therapist post-professional CLT and their continuum of lymphology exposure.  Therefore, the 
third study examined 1) OMs used by CLTs on BCS with BCRL and their differences between 
professions; 2) unique characteristic predictors for use of OMs; and 3) facilitators and barriers 
which influence CLTs use of OMs and their differences between professions. 
In summary, this three-manuscript dissertation takes the scholar, both lymphology naïve 
and experienced, on a journey investigating the breadth and depth of lymphology education and 
practice in the field of physical therapy.  It is a journey that weaves from entry-level to post-
professional knowledge and applications of lymphology, while being framed by the mission, 
vision, and guiding principles of the APTA.  Use of MLdT in disciplines beyond oncology and 
wound care is still in its infancy in physical therapy but recent research is evidencing its use in 
orthopedics.46,47  However, the intervention of MLdT as a catch-all tool for edema is not sound in 
its theory and practice.  In addition, employing MLdT without foundational lymphology 
knowledge diminishes the guidance in a physical therapist’s clinical reasoning.  Knowing when, 
why, and how to use MLdT requires standardized OMs to assess edema and its related 
comorbidities associated with body functions and structures, and a patient’s limitations in 
activities and societal participation.  Quality evidence for lymphology education and practice in 
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professional Doctor of Physical Therapy programs is presented in this dissertation.  Closing 
remarks of the primary investigator in Chapter V reflects on what needed to be known, what has 
become evident, and what continues to be available to be explored. 
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ABSTRACT 
 
Background and Purpose: The lymphatic system is vital for fluid homeostasis, waste removal, 
immunity, and tissue healing.  It can be impacted by multiple diseases and traumatic processes 
seen by physical therapists across practice settings; hence, lymphology education in professional 
(entry-level) Doctor of Physical Therapy (DPT) programs is needed.  Information about 
professional DPT lymphology education has not been conducted for 20 years.  The purposes of 
this study were to 1) describe current, typical lymphology content within professional DPT 
programs; and 2) identify whether lymphology content is perceived as entry-level material 
amongst professional DPT faculty who were responsible for teaching lymphology content (TL) 
and professional DPT faculty who did not teach lymphology content (NTL).  Subjects: 
Professional DPT faculty (n=43) in the US who taught or did not teach lymphology curriculum.  
Methods: Cross-sectional online survey research design.  Descriptive data was gathered on 
lymphology content, hours, and curriculum standings.  Chi-square test assessed relationships 
between faculty status and entry-level lymphology curriculum status.  Spearman rank correlation 
coefficient assessed relationships between teaching hours and entry-level status.  Results: 
Variability exists across curricula in range of hours devoted to didactic (0.4-14.1 hours) and 
laboratory (0-10 hours) instruction pertaining to lymphology.  Individual curriculum contents 
were predominantly considered entry-level material.  Limitations: Response rate was limited.  
Conclusion:  Consistent lymphology curriculum content and format are lacking within the 
professional DPT programs that participated in the survey, indicating opportunities for 
advancements in entry-level lymphology education and investigation into best educational 
practices for teaching this content.    
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INTRODUCTION 
Lymphology is the study of the lymphatic system, including its anatomy, physiology and 
pathology.1  The lymphatic system is part of the immune system and the circulatory system, but 
stands independently as a unique system of the body.2,3  The lymphatic system transports 
lymphatic loads (i.e. water, protein, long chain fatty acids, hyaluronan, and cell fragments) to the 
venous system.2,4–6  As a vital component of microcirculation, the lymphatic system maintains 
fluid homeostasis, and is responsible for the management of edema.3,7  In 2018, the blue print of 
the National Physical Therapy Examination (NPTE) changed by partitioning the lymphatic 
system from the cardiovascular and pulmonary systems as a separate body system, essential for 
clinical application of knowledge required of professional PT practitioners.8,9  Knowledge of the 
fundamentals of lymphology is important for physical therapists to provide safe and effective 
care to patients with various causes and classifications of edema.  
The most recent survey research on lymphedema management content in physical 
therapy programs was conducted in 1998.  The authors reported that designated curricular 
content about lymphatics (89%) and lymphedema (73%) was being taught in physical therapy 
programs, but that far less content on the specifics of anatomy and physiology (42%) , and 
innovative treatment techniques (48%) were included.10 Currently, there is a need to have a more 
contemporary understanding of what is being taught in professional (entry-level) DPT 
lymphology curricula. 
The professional DPT curriculum content includes clinical sciences pertaining to the 
major systems of the body.11  These systems include the cardiovascular, metabolic, 
gastrointestinal, endocrine, integumentary, musculoskeletal, neurological, genital and 
reproductive, renal and urologic, pulmonary, and lymphatic systems.11(p.26, 7C)  To prepare 
professional DPT graduates in becoming effective clinical and scholarly practitioners, the 
Commission on Accreditation in Physical Therapy Education (CAPTE) mandates that there 
should be content and learning experiences related to these systems, coupled with “system 
interactions, differential diagnosis, and the medical and surgical conditions across the lifespan 
commonly seen in physical therapy practice”.11(p.26,7C)  CAPTE requires that lymphology 
curriculum content should include examination, evaluation, diagnosis, and interventions of 
circulation (arterial, venous, lymphatic) and integumentary integrity.11(pp.28-29;7D19, 7D27)  In the 
Guide for Physical Therapist Practice 3.0, the American Physical Therapy Association (APTA) 
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describes skillsets that are a part of professional PT practices including examination, evaluation, 
and selection of interventions pertaining to the lymphatic system.12  Examination and re-
examination of the peripheral circulation, including lymphedema, are considered minimum 
required skill sets per the APTA – Board of Directors (BOD).13  According to the APTA Section 
of Women’s Health, professional PT graduates addressing the integument system should have a 
mastery level of lymphatic anatomy, proficiency level of lymphatic physiology, and a familiar 
level of lymphatic pathophysiology and management.14   
The 2018 NPTE content outline, provided by the Federation of State Boards of Physical 
Therapy (FSBPT), indicates that the lymphatic system comprises up to eight test items out of a 
possible 191 body systems items pertaining to examination, intervention, and foundations for 
evaluation, differential diagnosis, and prognosis.8,9  The NPTE content outline informs faculty 
and students of the importance of “movement analysis as related to the lymphatic system”, and 
the “interpretation of knowledge about diseases/conditions of the lymphatic system.”8  The 
examination blueprint descriptions of the NPTE, includes the importance of entry-level 
knowledge of adverse effects or complications on the lymphatic system, as a result of physical 
interventions upon the lymphatic system, or other systems.8  Lymphedema affects one in every 
thousand Americans,15 and while lymphology is not a large portion of the body systems items on 
the NPTE, the incidence of varied clinical presentations in physical therapy appears to 
substantiate its curricular distinction. 
Physical therapists provide interventions for limitations in movement, and the pain that 
may occur from inflammatory processes or various profiles of edema (i.e. effusion, pitting 
edema), while being guided by the chronological characterizations of tissue healing (e.g. acute, 
subacute, and chronic).16,17  Professional DPT students should be knowledgeable about different 
edematous diseases, chronological edema modifications, and lymphatic classifications (i.e. 
dynamic insufficiency, mechanical insufficiency, combined insufficiency) in order to make 
appropriate differential diagnoses.  This foundational knowledge would be considered an 
important component of a PT’s clinical reasoning18,19 for proper edema treatment and 
rehabilitation choices (e.g. ice, elevation, manual lymph drainage, compression, exercise).  In 
addition, best evidence physical therapy intervention for the lymphatic system, are to be 
understood under the premise of anatomy and physiology for rehabilitation, health promotion, 
and physical performance.9  Preparing professional DPT students for clinical reasoning strategies 
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should include evidenced-based, entry-level skill sets for the intervention of various kinds of 
edema within the various stages of healing, which might consist of manual lymphatic techniques 
and compression bandaging.20–26  Providing best-practice treatment methods for the type of 
edema and prevailing physiological conditions, has been reported to be safe, effective, and 
improves quality of life outcomes.27–29   
According to Sander and Perdomo,30  there has been a lack of literature investigating 
curriculum models that integrate management into the professional DPT curriculum.  These 
authors investigated two models developed to integrate edema management into the professional 
PT curriculum.  According to Sander and Perdomo,30 The Northwestern University Department 
of Physical Therapy and Human Movement Science (DPTHMS), and the University of Southern 
California (USC) have demonstrated higher rankings than other programs on the FSBPT 
examination in the areas of cardiovascular and pulmonary, and lymphatic systems.  Northwestern 
University DPTHMS administers a separate forty-hour course combining lymphatic and 
integumentary dysfunctions, twenty of which are spent in examination and intervention skills for 
edema/lymphedema.  USC administers 29 hours in edema management integrated throughout 
several courses in the program’s three-year curriculum.  In both curriculum styles, didactic 
anatomy, physiology and pathology information is enhanced through training in skill sets 
pertaining to examination and intervention (including manual lymph drainage and short stretch 
compression bandaging) which required approximately 10-13 class hours.30  While this case 
study outlines distinguishable perspectives on content and instructional guidelines for edema and 
lymphedema management, there exists gaps of what content is currently taught or expected to be 
taught, who teaches the content, and across which disciplines. 
The purposes of this study were to 1) describe the current lymphology content within 
professional DPT programs; and 2) identify whether lymphology content is perceived as entry-
level material amongst professional DPT faculty who were responsible for teaching lymphology 
content (TL) and professional DPT faculty who did not teach lymphology content (NTL).     
METHODS 
 Email addresses of program directors from accredited professional DPT programs in the 
US were retrieved from the CAPTE website.  Survey links were emailed to program directors of 
221 professional DPT programs (October 2017 – December 2017), who in turn were requested to 
disseminate the survey link through email to all of their faculty.  Two follow-up emails were 
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disseminated during this time interval.  Survey responses were separated into two groups: TL 
and NTL.  The inclusion of NTL subjects was determined to offer non-biased interdisciplinary 
opinions about entry-level curriculum content status on lymphology, whose physiological affect 
crosses disciplines in professional DPT curricula.  A total of 53 surveys were returned (24% 
response rate).  Participants could choose to not to answer survey questions, which resulted in 
missing data.  Ten surveys were incomplete, leaving 43 surveys with complete data sets for 
analysis.  Thirty-five separate universities were represented.  Descriptive data are presented in 
Table II.1.  The areas of acquired specialty certifications and the primary practice patterns that 
respondents taught were partitioned into TL and NTL respondents (Table II.2).   
A cross-sectional survey research design was implemented. Using a 37-item online 
Faculty Survey on Lymphology through Qualtrics® software, Version 2018 (Qualtrics, LLC, 
Provo, Utah) (Appendix II.A), information was gathered about the current status of lymphology 
education in the respondent’s professional DPT program and overall curriculum content in 
programs in the U.S. education.  Questions concerning the characteristics of the survey 
respondents, professional DPT lymphology curriculum content, format, and hours of instruction 
were included in the survey.  Face validity of the survey was attested by the primary investigator 
and a collaborative colleague via its design based on similar studies.10,31  Consultation with 
colleagues in the field of survey research (n = 3), lymphology (n = 4), and generalist (n = 2) 
resulted in questionnaire modifications.  An agreement amongst these colleagues (n = 6) on the 
final survey instrument conferred the content validity of the survey instrument.  The 
questionnaire was pilot tested by four professional DPT faculty, two of which had teaching 
experience with lymphology, as well as two certified lymphedema therapists.  Feedback on the 
pilot testing promoted modifications to the final survey. The study was approved by the Health 
Sciences and Behavioral Sciences Institutional Review Board of the University of Michigan - 
Flint.   
Data were analyzed using SPSS® version 24 (Armonk, NY).  Descriptive statistics are 
presented as means + standard deviations (SD), frequencies (%), and where appropriate, 
interquartile ranges.   The Chi-square test of independence was used to determine if there were 
significant relationships between faculty status (TL and NTL) and perceptions on entry-level 
status of curriculum topics.  Across all analyses, the alpha level of significance was set at 0.05. 
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RESULTS 
 Information collected on content taught on lymphology within professional DPT 
programs was obtained from TL.   Ninety-two percent (n = 35) of respondents reported that 
lymphatics anatomy and physiology was taught at their professional DPT program.   Lymphatics 
anatomy and physiology was taught in four courses including, anatomy (52.6%, n = 20), 
integumentary (47.4%, n = 18), pathophysiology (44.7%, n = 17), and cardiopulmonary (34.2%, 
n = 13).  Ninety-two percent (n = 35) of respondents reported that their programs taught 
lymphatic pathophysiology and that it was taught in one of three courses including 
integumentary (44.7%, n = 17), pathophysiology (47.4%, n = 18), and cardiopulmonary (26.3%, 
n = 10).  Table II.3 presents the descriptive data related to the hours spent teaching anatomy, 
physiology, and pathophysiology of the lymphatic system, as well as lecture hours and lab hours 
taught on examination.  Types of edema most frequently taught were mechanical insufficiency 
(86.8%, n = 33), dynamic insufficiency (73.7%, n = 28), combined insufficiency (68.4%, n = 
26), and lipedema (57.9%, n = 22); while chronic venous insufficiency (CVI) was less frequently 
taught (39.5%, n = 15).  Ninety percent (n = 34) of respondents reported that their professional 
DPT programs taught on examination pertaining to lymphatics.  Examination including 
circumferential measurements, special tests, volumetric measurement, and integument was 
taught in the integumentary course (44.7%, n = 17), followed by cardiopulmonary (28.9%, n = 
11), and musculoskeletal (21.1%, n = 8); while an assortment of other courses (39.5%, n = 15) 
were also mentioned.  Ninety-five percent (n = 36) of the TL respondents reported teaching 
interventions pertaining to lymphology in the integumentary (47.4%, n = 18), and 
cardiopulmonary (31.6%, n = 12) courses; while other courses (34.2%, n = 13) were also stated.  
Types and frequency of interventions taught included compression devices (84.2%, n = 32), 
multi-layer compression bandaging (78.9%, n = 30), skin care (78.9%, n = 30), therapeutic 
exercises (78.9%, n = 30), manual lymphatic techniques (68.4%, n = 26), and sequential 
compression pumps (65.8%, n = 25).  Table II.4 presents the descriptive data related to the hours 
spent teaching various interventions related to the topic of lymphology.   
Respondents somewhat agreed to strongly agreed that the subject matters of anatomy and 
physiology (88.4%, n = 38), pathophysiology (90.7%, n = 39) of the lymphatic system, and 
examination of the lymphatic system (81.4%, n = 35) was entry-level material.  Figure II.1 
presents frequencies of additional specific didactic content that was further analyzed for entry-
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level content.  Opinions from all respondents (TL and NTL) regarding if interventions should be 
included in professional DPT programs varied.  Pertaining to didactic education of manual 
lymphatic techniques and multi-layer compression bandaging, 58.1% (n = 25) and 58.1% (n = 
25), respectively of the respondents somewhat to strongly agreed that the content material was 
entry-level.  More specific intervention frequencies are presented in Figure II.2.  Perceptions 
about the entry-level status of discrete curriculum topics (e.g. anatomy, pathophysiology, 
examinations, compression bandaging, and manual lymph drainage) were not significantly 
different between TL and NTL. 
Insert figures II.1 and II.2 here 
 Respondents similarly reported four main challenges in integrating lymphology into 
professional DPT programs, those being lack of time (62.8%, n = 27), lack of expertise (44.2%, n 
= 19), content undervalued by students (37.2%, n = 16), and content undervalued by faculty 
(37.2%, n = 16).  Thirty percent of the respondents (n = 13) also reported that lymphology 
material was beyond entry-level knowledge.  Observed strategies to integrate the subject matter 
of lymphatics into professional DPT programs included 1) Consultation with credentialed 
therapist (s) about the subject matter (65.1%, n = 28), 2) Credentialed liaison/adjunct instructor 
to teach the subject (60.5%, n = 26), and 3) offered supervised clinical education experiences 
with either lymphedema clinics or clinics that have a certified lymphedema therapist (32.6%, n = 
14). 
DISCUSSION AND CONCLUSIONS 
Survey results from this study identified current lymphology content within professional 
DPT programs, and indicate that programs most frequently teach on lymphology intervention, 
followed by anatomy, physiology, pathophysiology, and to a lesser extent examination content.  
Peripheral circulation examination and reexamination (including lymphedema) are considered a 
minimum required skill set by the APTA – BOD.13  CAPTE11 emphasizes the knowledge base of 
examination, evaluation, and diagnosis of the lymphatics; whereas, the NPTE8 may include 
topics related to examination, differential diagnosis, prognosis, and interventions.  Lymphology 
content is taught mostly in the integument course, followed by pathophysiology, and 
cardiopulmonary courses.  While lymphatics are present in the integument system and most 
tissues of the body, its independent significance is evident and recognized by the FSBPT.9  
Additional lymphology content within the respondent’s professional DPT programs focused on 
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teaching about mechanical insufficiency of the lymphatic system, but less about dynamic 
insufficiency and combined insufficiency.  Lipedema and CVI which involve lymphatic 
insufficiency classifications were taught in only a few programs.   
  The current study offers evidence that there has been an increase (76.3%) in curricular 
content devoted to contemporary intervention techniques (manual lymph drainage, skin care, 
exercise, and compression bandaging) since the survey results (48%) from 1998.  As this study 
reports, the frequency of teaching about compression devices (garments and bandage 
alternatives) took precedence to other interventions.  These compression devices are typically 
considered for patient use in self-management, rather than a source of intervention during the 
more intensive decongestive PT treatments.  
Survey results from this study identified entry-level status of lymphology content within 
professional DPT programs.  Across most didactic lymphology curriculum topics, respondents 
have a unified perception of what constitutes entry-level lymphology material (Figure II.1).  
Those topics that varied in opinion lend more to uncertainty than to non-entry-level status.  
Respondents in this survey labeled most of the didactic curriculum as being entry-level including 
anatomy (suprafascial and subfascial), physiology, and lymphedema pathophysiology (including 
its comorbidities).  Lipedema and micro-circulation were considered entry-level; albeit, the 
frequency taught was less than other topics.  Pathophysiology of CVI was considered entry-level; 
however, not all programs taught CVI content.  A majority of respondents perceived that didactic 
education on Kinmonth classifications15 of primary lymphedema were either not entry-level 
material or unsure of the entry-level status.  For the purposes of clinical reasoning and 
differential diagnosis, understanding various diseases of the lymphatic system, and having the 
skillsets of lymphatic examination, evaluation, and diagnosis would align with their importance 
as indicated  by CAPTE11 and the APTA – BOD.13  Professional DPT students may benefit from 
the knowledge of Kinmonth primary lymphedema classifications since it provides a framework 
for differential diagnoses and clinical reasoning for proper intervention or referral.  For example, 
in the case of adolescent onset primary lymphedema (i.e. praecox), the manifested edema is often 
attributed to other causes (e.g. trauma) and dismissed by professionals,32 which may lead to 
advancement of the disease without proper intervention or referral.    
This survey provided evidence that respondents varied in opinion as to whether the 
intervention of complete decongestive therapy (CDT) was entry-level education, but trended 
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toward non-entry-level status.  However, individual components of CDT (i.e. manual lymphatic 
techniques, compression bandaging, compression garments) trended toward entry-level status 
(Figure II.2).  Compression garment and device interventions were largely considered entry-level 
content.  Despite evidence for its guarded and adjunct use for the treatment of lymphedema,33–35 
sequential pneumatic compression pumps were considered entry-level status.  Consideration 
should be taken of where (cardiovascular versus lymphatic system), and how this education is 
best delivered, since sequential pneumatic compression pumps are indicated for DVT prevention 
and post-thrombotic syndrome, despite lack of dosage protocols and treatment strategies.36 
The extent to which professional DPT curricula are currently meeting lymphology 
educational requisites is determined by the individual programs.  However, inconsistency of the 
didactic and laboratory hours are noted in this study.  While it is expected that individual 
curricula would have variability in educational hours, the range (didactic = 0.40-14.10 hours and 
laboratory = 0.00-10.00 hours) is broad (Table II.3 and II.4).    
Similar to the cardiovascular system, the physiological importance that the lymphatic 
system provides to the integument, muscles, nerves, joints, periosteum, and central nervous 
system warrants consideration of both its placement and timetable in a curriculum.  The breadth 
of lymphology topics indicates that lymphology curricula could extend across practice patterns, 
but this may prove to be a difficult task for professional DPT programs.  Augustine, et al.10 
reported that the main challenges for faculty with integrating lymphology into professional DPT 
programs included lack of time, expertise, and that the content was undervalued, which this 
current study reaffirms in reporting four main challenges in integrating lymphology into 
professional DPT program.  Sander and Perdomo30 also seem to echo a similar viewpoint, stating 
that a key to successful delivery of edema and lymphedema management material was the 
availability of faculty members trained in the management of lymphedema.  Affording 
professional DPT students specialized clinical rotation opportunities with certified lymphedema 
clinicians may fill the gap in scenarios in which these trained faculty members are unavailable or 
to augment the current lymphology education.  
This study had limitations in methodology and response rate.  First, recruitment of faculty 
who were involved in the lymphology curriculum allowed for more than one faculty member per 
university to respond to the survey.  This may have resulted in a duplication of quantitative data 
for these university’s curricula; however, consideration should be given that their summative 
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individual responses may have also been an accurate representation of the curriculum.  Second, 
FSBPT data on the NPTE scores pertaining to lymphology content are combined with 
cardiopulmonary scores and does not afford the ability to assess the national outcome averages 
pertaining to the lymphatic content alone.  Third, web-based surveys yield less response than 
other modes of survey delivery, and on average, yield an expected 35% response rate, or 
approximately a third of the surveys administered.37–39  Therefore, using a 35% response rate, we 
initially expected a sample size of approximately 80 representatives from a larger pool of 
accredited professional DPT programs in the United States, assuming that all these programs 
deliver a lymphology curriculum.  Despite reminder email notifications to the program directors 
to enhance participation, the response rate (24%) was marginal.  Unfortunately, this low response 
rate and limited geographical representation would not allow us to generalize the outcomes.  
Regardless of the inclusivity efforts imbedded in the survey instructions and email reminders, a 
significant disproportion of TL to NTL respondents (Table II.2) occurred.  
This survey investigation concerning lymphology content in professional DPT programs 
establishes a foundation in which future studies are warranted.  To ensure safe and effective 
entry-level physical therapy practice, future studies may consider investigating DPT programs 
that offer specialist certifications and those that offer lymphology education without certification.  
Interviews with individual faculty members may clarify the reasons for the variability of hours 
devoted to lecture and lab, and towards anatomy, physiology, pathophysiology, examination and 
intervention content.  As FSBPT data emerges beyond 2018, future research may consider 
analyzing survey curriculum data with national outcome data. In addition, a future study may 
consider repeating this study in other health care professions curricula including physical 
therapist assistant and occupational therapy.  Methodology of a similar survey should attempt to 
improve response rates of national surveys that isolate a specific field of study within a particular 
discipline of medicine.  The opportunity for discussions about appropriate curriculum placement 
and content on lymphology exists across practice patterns.  The International Lymphedema 
Framework has developed the Lymphoedema Education Benchmark Statements, which were 
developed as a reference and guideline to, “foster global consistency and governance in relation 
to lymphoedema education.”40  These statements may prove to be a foundational resource for 
future deliberations amongst professional DPT programs to establish consistency and governance 
of curricula that can align with international standards.  Pre-existing guidelines from the 
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Lymphology Association of North America (LANA®), pertaining to the number of hours that is 
expected for examination candidacy have been established since 1998.  LANA® recommends 
that certified lymphedema therapist candidates have 135-classroom hours with 1/3 theoretical 
instruction and 2/3 practical lab work,41 which could be considered beyond entry-level 
lymphology education, but could serve as a foundation for future deliberations to establish 
commonality in time and content across professional DPT curricula.  While specialty 
certifications may not be expected for professional DPT students, a thorough comprehension of 
the lymphatic system, lymphedema, and chronic edema42 management may need to be 
explicated.  A structured process (e.g. modified Delphi) could be used among experts to make 
recommendations on professional DPT lymphology education content and practices. 
In conclusion, according to the analyses of these survey responses, consistent content, 
and format (didactic and laboratory hours) is lacking with regards to lymphatic system 
examination skills, and intervention techniques within the professional DPT programs.  The 
variability of hours was significant, with one program’s cumulative hourly investment in 
lymphology content to be two hours, while another school’s cumulative hours were forty (Figure 
II.3).  The rationale for this unexpected variability was not investigated in this study.  The 
cumulative hours for professional DPT lymphology curriculum content may depend on the 
overall objective.  If a curriculum’s lymphology content is focused upon the disease of 
lymphedema, with the expectation that an entry-level PT can confidently employ patient referral 
or pursue CDT specialization later, then fewer hours consisting mainly of didactic education may 
be sufficient.  Whereas, if the premise is that the lymphatic system is involved in all types of 
edema (e.g. dynamic, static, and combined lymphatic insufficiencies), in all stages of healing 
(e.g. acute, subacute, chronic), affecting multiple tissues (e.g. integument, musculoskeletal, and 
neurological), and seen across all patient populations and practice settings, then a greater number 
of education hours may be expected.  Although NPTE lymphatic system results are unavailable 
for analysis, inconsistencies in curriculum topics and hours of didactic and lab hours may result 
in educational gaps.  There is evidence for opportunities in developing optimal and congruous 
professional entry-level lymphology education in order to provide patient centered evidence-
based lymphatic examinations and interventions.  Mixed method research might allow further 
exploration of the variability of hours and further description of professional DPT education 
practice as it relates to lymphology.        
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Figure II.1. Frequency of Respondents (n = 43) Rating Didactic Material as Non-Entry-Level, 
Not Sure, and Entry-Level.  
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Figure II.2. Frequency of Respondents (N = 43) Rating Intervention Material as Non Entry-
Level, Not Sure, and Entry-Level.  
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Table II.1.  Characteristics of Faculty Survey Respondents. 
Age – (years) [N = 42*] n (%) 
  31-40 3 (7.0) 
  41-50 18 (41.9) 
  51-60 12 (27.9) 
  61 or older 9 (20.9) 
  
Gender [N = 42*] n (%) 
  Female 32 (74.5) 
  Male 9 (20.9) 
  Preferred not to answer 1 (2.3) 
  
Location of Teaching Institution [N =43] n (%) 
  West 8 (18.6) 
  Midwest 14 (32.6) 
  South 12 (27.9) 
  Northeast 9 (20.9) 
  
Type of Teaching Institution [N = 42*] n (%) 
  Private 17 (39.5) 
  Public 25 (58.2) 
  
Employment Status [N = 42*] n (%) 
  Full Time 40 (93.1) 
  Part Time 1 (2.3) 
  Occasional 1 (2.3) 
  
Job Position** n (%) 
  Adjunct/Liaison 3 (7.0) 
  Assistant Professor 14 (32.6) 
  Associate Professor 15 (34.9) 
  Clinical Professor/Director 3 (7.0) 
  Curriculum Coordinator 2 (4.7) 
  Director of professional DPT Program 6 (14.0) 
  Professor 7 (16.3) 
   Other 3 (7.0) 
  
Currently in Clinical Practice [N = 43] n (%) 
  Yes 30 (69.8) 
  No 13 (30.2) 
*One survey did not complete demographic information (2.3%) 
**Respondents may have more than one job position 
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Table II.2. Characteristics of Respondents Responsible and Not Responsible for Teaching Lymphatic 
Content Within a Professional DPT Program 
Faculty Teaching  
Lymphatic Content (TL)* n=38 
Faculty Not Teaching Lymphatic 
Content (NTL)* n=5 
Specialty n (%) Specialty n (%) 
  Cardiovascular and Pulmonary 5 (13.2)   None 3 (60) 
  Lymphedema 16 (42.1)   Orthopedics 1 (20) 
  Women’s Health 2 (5.3)   Neurology 1 (20) 
  Wound Care 6 (13.5)   
  None 4 (10.5)   
  Orthopedics 6 (15.8)   
  Geriatrics 4 (10.5)   
  Neurology 2 (5.3)   
  Other 3 (7.9)   
    
Primary Area of Practice of 
Faculty Teaching Lymphatic 
Content* 
n (%) 
Primary Area of Practice of Faculty 
Not Teaching Lymphatic Content* n (%) 
  Cardiovascular/Pulmonary 13 (34.2)   Cardiovascular/Pulmonary 1 (20) 
  Integumentary 22 (57.9)   Musculoskeletal 2 (40) 
  Musculoskeletal 12 (31.6)   Neuromuscular 3 (60) 
  Neuromuscular 10 (26.3)   Geriatrics 1 (20) 
  Pediatrics 3 (7.9)   Other 1 (20) 
  Women’s Health 5 (13.2)   
  Geriatrics 8 (21.1)   
  Other 10 (26.3)   
*Respondents were allowed to choose more than one option. 





Table II.3. Hours of Lecture and Lab Education Devoted to Anatomy and Physiology, 
Pathophysiology and Examination  













Mean 2.8 2.5 1.6 2.0 
Median 2.0 1.7 1.0 1.0 
SD 2.8 2.7 1.4 2.1 
Minimum 0.5 0.4 0.5 0.5 
Maximum 14.0 14.1 6.1 8.1 
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Appendix II.A. Survey on Lymphology Education in Professional Doctor of Physical Therapy 
Programs. 
 
1. Do you teach ANY of the following lymphatic content within an entry-level PT program?   
 Anatomy and physiology  Pathophysiology  Examination  Interventions   
o Yes    
o No    
 
 
2. Which of the following lymphatic content are you responsible for teaching within the institution's entry-
level PT program?  Select all that apply. 
o Anatomy of the lymphatic system (e.g. capillary, pre-collector, collector, lymphangion, nodes, 
watersheds, etc.)   
o Physiology of the lymphatic system (e.g. lymphangiomotoricity, insufficiencies, etc.)    
o Pathophysiology of the lymphatic system (e.g. lymphedema, lipolymphedema, Stage 3 chronic venous 
insufficiency, etc.)   
o Examination of the lymphatic system (e.g. circumferential measurements, special tests, volumetric 
measurements, integument, etc.)   
o Interventions of the lymphatic system (e.g. manual lymphatic techniques, bandaging, pneumatic 
pumps, etc.)   
 
3. Is the subject matter of anatomy and physiology of the lymphatic system taught at this institution's entry-
level PT program? 
o Yes   
o No   
o Unsure   
 
4. What course (s) is this material taught in?  Select all that apply. 
o Anatomy   
o Cardiopulmonary   
o Integumentary   
o Neuromuscular   
o Musculoskeletal   
o Pathophysiology   
o Physiology   
o Other, describe:  ________________________________________________ 
 
5. Approximately, how many hours are spent in lecture on the topic of lymphatic system anatomy and 
physiology? 
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6. Is the subject matter of pathophysiology of the lymphatic system taught at this institution's entry-level PT 
program? 
o Yes   
o No   
o Unsure   
 
 
7. What course (s) is this material taught in?  Select all that apply. 
o Anatomy   
o Cardiopulmonary   
o Integumentary   
o Neuromuscular    
o Musculoskeletal    
o Pathophysiology    
o Physiology    
o Other, describe:   ________________________________________________ 
 
 
8. Approximately, how many hours are spent in lecture on the topic of pathophysiology of the lymphatic 
system? 
Please select hours using the slide bar  
 
 
9. Please select the types of edema that are taught at this institution's entry-level PT program.  Select all that 
apply. 
o Combined Insufficiency    
o Dynamic Insufficiency - Edema    
o Lipo-lymphedema (lipedema)    
o Mechanical Insufficiency - Lymphedema    
o Phlebo-lymphodynamic edema (CVI)    
o Phlebo-lymphostatic edema (CVI)    
o Other, describe:   ________________________________________________ 
 
- 36 -  
10. Is the subject matter of examination of the lymphatic system (e.g. circumferential measurements, special 
tests, volumetric measurements, integument, etc.) taught at this institution's entry-level PT program? 
o Yes    
o No    
o Unsure    
 
11. What course (s) is this material taught in?  Select all that apply. 
o Anatomy    
o Cardiopulmonary    
o Integumentary    
o Neuromuscular    
o Musculoskeletal    
o Pathophysiology    
o Physiology    
o Other, describe:   ________________________________________________ 
 
12. The coursework on examination of lymphatic system (e.g. circumferential measurements, special tests, 
volumetric measurements, integument, etc.) includes: 
o Overview of material - lecture    
o Application of the techniques - lab    
o Other, describe:   ________________________________________________ 
 
13. Approximately, how many lab hours are utilized to teach about examination for the lymphatic system (e.g. 
circumferential measurements, special tests, volumetric measurements, integument, etc.)? 




14. Approximately, how many lecture hours are utilized to teach about examination for the lymphatic system 
(e.g. circumferential measurement, special tests, volumetric measurements, integument, etc.)? 




15. Is the subject matter of interventions for the lymphatic system taught at this institution's entry-level PT 
program? 
o Yes    
o No    
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16. What course (s) is this material taught in?  Select all that apply. 
o Anatomy    
o Cardiopulmonary    
o Integumentary    
o Neuromuscular    
o Musculoskeletal    
o Pathophysiology    
o Physiology    
o Other, describe:   ________________________________________________ 
 
17. Please select which lymphatic interventions that are taught at this institution's entry-level PT 
program.  Select all that apply. 
o Compression Devices (garments, night-time garment, devices, etc.)    
o Manual lymphatic techniques    
o Multi-layer compression bandaging    
o Sequential pneumatic compression pump    
o Skin care    
o Therapeutic exercises    
o Other, describe:   ________________________________________________ 
 
 
18. Please identify if the coursework on the following interventions include lecture, lab, or both. 
 Lecture  Lab  
Compression Devices (garments, night-time 
garments, devices, etc.)   o  o  
Manual lymphatic techniques   o  o  
Multi-layer compression bandaging   o  o  
Sequential pneumatic compression pump   o  o  
Skin care   o  o  
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19. Approximately, how many lab hours are utilized to teach about the following lymphatic interventions? 
Compression Devices (garments, night-time garments, 
devices, etc.)   
Manual Lymphatic Techniques  
 
Multi-layer compression bandaging  
 
Sequential pneumatic compression pump  
 
Skin care  
 




20. Approximately, how many lecture hours are utilized to teach about the following lymphatic interventions? 
Compression Devices (garments, night-time garments, 
devices, etc.)   
Manual Lymphatic Techniques  
 
Multi-layer compression bandaging  
 
Sequential pneumatic compression pump  
 
Skin care  
 
Therapeutic exercises  
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Disagree  Not Sure  
The didactic 
education about the 
anatomy and 
physiology of the 
lymphatics is entry-
level PT material.   
o  o  o  o  o  o  
The didactic 
education about the 
pathophysiology 
lymphatic system is 
entry-level PT 
material.   
o  o  o  o  o  o  
The skill set training 







integument, etc.) is 
entry-level PT 
material.   
o  o  o  o  o  o  
The skill set training 
in interventions of 
the lymphatic system 
consisting of manual 
lymphatic techniques 
is entry-level PT  
material.   
o  o  o  o  o  o  
The skill set training 
in interventions of 




level PT material.   
o  o  o  o  o  o  
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22. Please indicate if you consider the following didactic content matters as either entry-level material, non-
entry-level material, or not sure for PT programs. 
 
Entry-
Level  Not Sure  Non Entry-Level  
Anatomy of the deep lymphatics (joint 
capsule, periosteum, tendon, muscle)   o  o  o  
Anatomy of the superficial lymphatics   o  o  o  
Comorbidities of lymphedema   o  o  o  
Functional limitation reporting   o  o  o  
Lymphedema classification   o  o  o  
Micro-circulation physiology   o  o  o  
Lipedema   o  o  o  
Pathophysiology of chronic venous 
insufficiency   
o  o  o  
Pathophysiology of lymphedema   o  o  o  
Physiology of the lymphatics   o  o  o  
 
 
23.  Please indicate if you consider the following lymphatic intervention topics as either entry-level or non-
entry-level material for PT programs. 
 Entry-Level  Not Sure  Non Entry-Level  
Complete Decongestive 
Therapy   o  o  o  
Compression garments 
and devices   o  o  o  
Elastic taping   o  o  o  
Manual lymphatic 
techniques   o  o  o  
Multi-layer compression 
bandaging   
o  o  o  
Sequential pneumatic 
compression pump   
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24. Considering the integration of lymphology in the entry-level PT programs, which of the following 
challenges have you observed or are aware of?  Select all that apply. 
o Content is undervalued by faculty    
o Content is undervalued by students    
o I have not observed or aware of any challenges    
o Lack of expertise    
o Lack of resources    
o Lack of time    
o Material is beyond entry-level knowledge    
o Material does not integrate into current curriculum    
o Other, describe:   ________________________________________________ 
 
25. Which of the following strategies have you observed or are aware of being adapted to integrate the subject 
matter of lymphatics into the entry-level PT programs?  Select all that apply.   
o Consulted with credentialed therapist (s) about the subject matter    
o Credentialed liaison/adjunct instructor to teach the subject    
o Designated a faculty member to teach on the subject matter in all courses where the subject is taught    
o I have not observed or aware of any strategies being adapted    
o Offered elective courses pertaining to lymphatics    
o Offered supervised clinical education experiences with either lymphedema clinics or clinics that have a 
certified lymphedema therapist    
o Provided training for faculty member    
o Other, describe:   ________________________________________________ 
 
 
26. How would you grade the content adequacy of the lymphology curriculum in the entry-level PT programs 
in the United States? 
 
 








27. Identify the geographical region that the institution you teach at is located. 
o Midwest    
o Northeast    
o South    
o West    
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28. Which category best describes this institution? 
o Private Institution    
o Public institution    
 
29. What is your age in years? 
o 18 - 24    
o 25 - 30    
o 31 - 40    
o 41 - 50    
o 51 - 60    
o 61 or older    
 
30. What is your gender orientation? 
o Female    
o Male    
o Prefer not to answer    
o Transgender    
 
 
31. Do you currently provide physical therapy clinical care for a patient population? 
o Yes  (23)  
o No  (24)  
 
32. Identify which patient population (s) you provide physical therapy for.  Select all that apply 
o Cardiopulmonary    
o Geriatrics    
o Integumentary    
o Neuromusculoskeletal    
o Oncology    
o Orthopedics    
o Pediatrics    
o Sports Medicine    
o Women's Health  (18)  
o Other, describe:  (17) ________________________________________________ 
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33.  Please select any of the following areas that you have acquired specialty certifications?  Select all that 
apply. 
o Cardiovascular and Pulmonary    
o Clinical Electrophysiology    
o Geriatrics    
o Lymphedema    
o Neurology    
o Oncology    
o Orthopedics    
o Pediatrics    
o Sports Medicine    
o Women's Health    
o Wound Care    
o None of the above    
o Other, describe:   ________________________________________________ 
 
34. What position(s) do you hold within the academic institution that you are employed?  Select all that apply. 
o Adjunct/Liaison Member    
o Assistant Professor    
o Associate Professor    
o Clinical Professor    
o Curriculum Coordinator of the PT program    
o Director of the PT program    
o Professor    
o Other, describe:   ________________________________________________ 
 
35. What is your academic employment status? 
o Full Time    
o Part Time    
o Occasional    
o No formal appointment    
 
 
36. How many years have you been a faculty member at your current institution employment? 
Please select years with slide bar  
 
 
37. What primary practice patterns do you teach?  Select all that apply. 
o Cardiovascular/Pulmonary    
o Geriatrics    
o Integumentary    
o Musculoskeletal    
o Neuromuscular    
o Pediatrics    
o Women's Health    
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ABSTRACT 
 
Background:  Manual lymphatic drainage techniques (MLdT) have received interest for their 
efficacy in orthopedic rehabilitation and sports medicine.  Strength of the body of evidence for 
using MLdT on conditions affecting the musculoskeletal system is not established.  Purpose:  
To determine whether MLdT in addition to conventional rehabilitation on conditions affecting 
the musculoskeletal system, can decrease edema, and improve ROM, patient-reported outcomes, 
and healthcare utilization.  Methods:  Studies published between 2007 and 2018, with similar 
outcome measurements, were grouped for analysis.  Strength of the body of evidence was 
determined by using the Cochrane GRADE guidelines, and the American College of Chest 
Physicians guidelines.  Findings:  There is moderate support for the use of MLdT for conditions 
affecting the musculoskeletal system as effective interventions to reduce pain, and improve 
patient-reported outcomes pertaining to functional activities and quality of life (QOL).  MLdT 
are moderately effective treatment methods associated with lower healthcare utilization, edema 
reduction, and improving ROM.  Conclusions:  Moderate evidence was observed supporting the 
efficacy of MLdT in combination with conventional rehabilitation interventions for the treatment 
of conditions affecting the musculoskeletal system.  Future research is needed to provide 
stronger evidence to support the use of MLdT for patients with conditions affecting the 
musculoskeletal system, and to determine which interventions concurrent with MLdT produce 
best outcomes. 
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INTRODUCTION 
Inflammatory responses secondary to orthopedic disorders involve the lymphatic system 
with clinical presentations including non-infectious lymphangitis, lymphangiospasms, and 
lymphadenitis.1  Subsequently, an altered cellular environment may lead to the proliferation of 
hyaluronan, fibrinogen, and irregular collagen that advance fibrosis and scar tissue.2,3  
Unmanaged edema promotes less favorable states of repaired tissue that is prone to subsequent 
injury, or is less functional than the uninjured tissue state.2  Therapists in orthopedic practice are 
routinely required to select edema management interventions, which requires sound clinical 
reasoning.  
Many modalities have been utilized within the rehabilitation field to address edema and 
pain resulting from orthopedic disorders, including but not limited to ice, elevation, compression, 
electrical stimulation, ultrasound, and massage.4–10  The effectiveness of these modalities in 
reducing edema remains inconclusive.  Additionally, their physiologic effect on the lymphatic 
system have not been fully explicated.5,6,9,11  Manual lymphatic drainage techniques (MLdT) can 
decrease edema and are one of the four components of complete decongestive therapy, which is 
considered the “gold standard” treatment for lymphedema.12–14  MLdT are gentle and rhythmic 
soft tissue techniques that stimulate the lymphatic structures without promoting erythema or 
inflammation 1,15,16 ,while supporting the absorption of excess fluid, protein, and waste products.  
The abolishment of an inflammatory reaction and associated edema is not expected from MLdT 
because this requires multifaceted treatment interventions.  Although preliminary studies provide 
evidence to the effects of MLdT,15–17 the mechanism for these effects are still under 
investigation.  From a physiological perspective, the gentle pressure and stretching components 
of MLdT stimulate the intrinsic and extrinsic lymph pumps, which increases lymph velocity via 
the contraction of smooth muscles within the lymph collector vessel.18  Manual lymphatic 
drainage techniques have demonstrated an effect on improving the contractility of the lymphatics 
as visualized by indocyanine green, near-infrared fluorescence imaging.19   
In addition to edema reduction, MLdT are recognized for decreasing pain by stimulating 
a general parasympathetic response for the patient, resulting in general relaxation.17,20,21  The 
absorption of nociceptive chemical stimulants, such as lactic acid, cytokines, and inflammatory 
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effect.1,22,23  The rhythmic, intermittent, and gentle pressures of MLdT stimulate the large 
diameter, non-nociceptive nerve fibers and decrease pain.24  
Manual lymphatic drainage techniques have received interest in orthopedic rehabilitation 
and sports medicine.25,26  A 2009 systematic review concluded that manual lymphatic drainage 
techniques were effective when combined with conventional musculoskeletal therapies, in sports 
medicine and rehabilitation.  The authors concluded that MLdT are particularly useful in 
reducing edema and enzyme serum levels associated with acute skeletal muscle cell damage.26  
Another review also confirmed the effectiveness of MLdT for patients with musculoskeletal 
edema in orthopedic injuries.25  Although these previous reviews have provided some evidence 
of the benefits of MLdT pertaining to reducing musculoskeletal edema from acute orthopedic 
and sports-related injuries; the body of evidence on the effects of MLdT on range of motion 
(ROM), patient-reported outcomes pertaining to pain, functional activities and quality of life 
(QOL), and health care utilization (HU) have yet to be explored.  
OBJECTIVES 
The primary objective of this systematic review was to examine if the addition of MLdT 
to conventional rehabilitation interventions in people with conditions affecting the 
musculoskeletal system were effective in decreasing edema, and improving ROM and patient-
reported outcomes.  A secondary objective was to examine outcomes specifically related to 
edema, pain, ROM, functional outcomes, QOL, and HU between interventions with and without 
MLdT.  
SEARCH STRATEGY 
This systematic review used the Preferred Reporting Items for Systematic Reviews and 
Meta-analysis (PRISMA) format.27  An extensive literature probe was conducted from 09/07/17 
through 04/07/18 using the following electronic databases: PEDro (via University of Sydney), 
CINAHL (via EBSCO), PubMed (via U.S. National Library of Medicine), Cochrane Library (via 
Wiley Online Library), Scopus (via Elsevier), Physical Therapy & Sports Medicine Collection 
(via GALE CENGAGE Learning), and Google Scholar.  Key search terms included lymph, 
lymphatic, mobilization, drainage, manual, orthopedic, musculoskeletal, edema, oedema, knee, 
foot, ankle, hip, back, neck, shoulder, elbow, wrist, and hand.  Filters included [NOT] 
lymphedema, [NOT] cancer, human subjects, clinical trials, case reports, retracted publications, 
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ELIGIBILITY CRITERIA  
Screening of titles and abstracts were conducted by the principal investigator and co-
investigator, using study selection-criterions, designed by the authors for guidance.  Occasions in 
which there were discrepancies, a third reviewer also completed the screening for inclusion.  
Criteria for initial inclusion included those articles written in English, with a publication date 
range of 01/01/2007 through 05/15/2018.  Due to a dearth of peer-reviewed journal articles on 
MLdT and conditions affecting the musculoskeletal system, the primary search included 
randomized trials, non-randomized controlled cohort studies, case-series, and case-control 
studies.  The population of interest were human subjects aged five years or older with a 
confirmed condition affecting the neuromusculoskeletal system, not limited to a specific body 
region.  The working definition for conditions affecting the musculoskeletal system was a result 
of searching for inclusionary terms under this broad heading.28–31  Inclusionary terms for 
conditions affecting the musculoskeletal system are listed in Appendix III.A.  These broadly-
based definitions, enabled searching for relevant literature to expand multiple methods of MLdT, 
as well as, multiple conditions that are commonly seen within orthopedic rehabilitation practices. 
The intervention inclusion criteria included, manual interventions from frequently 
reported MLdT, including Vodder technique, manual lymph drainage, Chikly technique, lymph 
drainage therapy, Artzberger technique, manual edema mobilization (MEM), or Leduc 
technique.32–36  Techniques that stimulated the lymphatics from a light touch, rhythmic, skin 
tractioning method, not directly associated with a specific tenet, were also included in the study 
selection.  MLdT may have been used as a stand-alone treatment or concomitant with other 
modalities, other than those in the exclusion criteria.   
Studies that were anecdotal, descriptive, expert opinions, or qualitative designs were 
excluded.  Conditions, such as cancer, lymphedema, lympho-lipedema, and chronic venous 
insufficiency were excluded.   
DATA EXTRACTION 
Data extraction from the included studies was conducted independently by the principal 
investigator and the co-investigator, using a template adapted from the Cochrane Handbook for 
Systematic Reviews of Intervention – A.6.1 characteristics of included studies for systematic 
reviews.37  Discrepancies were resolved with a third reviewer.  The characteristics of interest 
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musculoskeletal system, aims of the study, intervention group, control group, outcomes, key 
findings, and conclusions.  The information on other conventional interventions were added to 
the characteristics template.  The level of evidence was determined using the 2011 Oxford 
Centre for Evidence-based Medicine (OCEBM).38  The PEDro scale, was used to determine the 
internal validity of the randomized controlled trial (RCT) studies.39–41  The PEDro scale 
operational criteria are outlined in Appendix III.B.  The PEDro scores for each study were given 
individually by the authors, and discrepancies resolved by a third author.  Upon scores 
finalization, studies were given a descriptive terminology quality rating, ranging from poor to 
excellent as previously developed by Foley, et al.42  The studies were grouped, based on similar 
outcomes data, for the synthesis of the body of evidence.  The strength and quality of the body of 
evidence was determined by using the Grading of Recommendations, Assessment, Development, 
and Evaluation (GRADE) guidelines.43–46  Using GRADE methodology levels of evidence 
(Appendix III.C), outcomes from the studies were assessed based on their limitations, 
heterogeneity, directness, and publication bias.  Using operational definitions and guidelines 
from the American College of Chest Physicians (ACCP)46,47 the level of evidence was further 
evaluated. (Appendix III.D).  
RESULTS 
The initial literature search resulted in retrieving 112 published articles.  Duplicates were 
removed. Screening of the remaining 97 articles based on the title and abstract, resulted in the 
removal of 82 articles.  A total of 15 articles met the inclusion criteria and were included for a 
full text review.  A total of five articles24,48–51 met eligibility criteria, and were included in the 
analyses (Figure III.1).  The kappa value for interrater agreement for manuscript selection was 
considered substantial52 at 0.77.  
Insert figure III.1 here 
Various tenets of MLdT were described in the literature, as well as various outcomes and 
their measures.  All studies included in the analyses had RCT research design. Inadequate 
blinding of subjects, and of intervention therapists were noted in all the studies, as well as a lack 
of intention-to-treat analysis.  Four out of five studies had a “good” rating of methodological 
quality (internal validity) according to the PEDro scale (Table III.1), and categorical ratings.42  
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A low scoring RCT study50 was included, as it offered information pertaining to the auxiliary 
intervention of compression. 
Three of the included studies focused on the effects of MLdT in acute orthopedic 
disorders, specifically postoperative knee arthroplasty and transtibial amputation.48,50,51  The 
study by Knygsand-Roenhoej and Maribo focused on subacute edema resulting from distal 
radius fracture.49  The remaining study focused on the effect of MLdT in a chronic condition.24  
Homogeneous outcomes of the studies included edema, ROM, patient-reported outcomes on 
pain, function, and QOL, and HU.  A summary of the key findings is presented in Table III.2, 
and a summary of qualitative assessments is shown in Table III.3. 
BENEFITS OF MLdT ON EDEMA 
 Various edema measurement methods were employed in the studies, including 
Volumeter, bioimpedance, and circumferential measurements.  Minimal clinically important 
difference (MCID) of edema measurements in breast cancer related lymphedema patients have 
been analyzed. In this population, MCID values for circumferential measurement range from 
0.37 to 0.71 centimeter, and percent volume change range from 1.5% to 3.5%.53  MCID values 
have not been established for edema in conditions affecting the musculoskeletal system.  
Pichonnaz et al.,51 and Ebert et al.,48 reported a lack of significant changes in edema following 
MLdT.  An increase in edema from the second to the seventh day during the MLdT treatment 
period has been reported.51  Edema increased by 1.9% in the group receiving 30 minutes of 
MLdT in addition to conventional treatment, compared to 4.1% in the control group receiving 30 
minutes of relaxation training in addition to conventional treatment.51  Topuz et al. found 
statistically significant reduction (p < 0.05) in circumferential measurements in patients who 
received complete decongestive physiotherapy (CDP).50  In their study, multilayer short-stretch 
compression therapy was used in addition to MLdT.50  In comparison with traditional edema 
management techniques (TEM) (i.e. elevation, compression, and functional training), non-
statistically significant reduction in edema following three (p = 0.31) and six weeks (p = 0.31) of 
MLdT was reported.49  However, edema reduction was achieved with significantly fewer edema 
treatment sessions (p = 0.03) with MLdT (14.1 sessions) compared to TEM techniques (19.2 
sessions).49  In summary, studies providing MLdT alone or adding MLdT to a conventional 
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BENEFITS OF MLdT ON RANGE OF MOTION 
 Both MLdT and TEM improved active ROM (p < 0.01) for thumb opposition and 
fingertip to palm distance, but the difference between groups was not significant at six weeks (p 
= 0.32) and nine weeks (p = 0.23) follow-up.49  Studies of patients with TKA have demonstrated 
improvements in ROM following MLdT.48,51  In the study by Ebert et al.,48 a significant increase 
in knee flexion active ROM was observed in the group receiving MLdT (p = 0.031) compared to 
controls who did not receive MLdT.  Similarly, Pichonnaz et al. found that knee flexion 
contracture was more than 2° less prevalent in the MLdT group compared to the control group at 
3 months post TKA, although the difference between groups did not reach statistical significance 
(p = 0.07).51  In summary, three out of seven included studies measured ROM and all reported 
significant improvements in ROM with adding MLdT to the treatment. 
BENEFITS OF MLdT ON PATIENT-REPORTED OUTCOMES 
Pain 
 In the studies included for the review, pain was measured using a standard Visual Analog 
Scale (VAS), or a numeric pain scale.  Pain scales have been analyzed for MCID with various 
patient populations and disorders, and therefore should be considered context-specific, and 
interpreted appropriately to avoid any misguidance.54  MCID improvements in pain, represented 
on a ten centimeter (100 mm) visual analog scale have also been noted to range widely from 8 
mm to 40 mm.54  Diagnosis may also influence the MCID; noted when comparing TKA pain 
levels measuring a 22.6 mm MCID;55 whereas, in systemic sclerosis MCID was represented by 
32.02 mm.56  In this review, comparing the effect on pain levels post-distal radius fracture, 
during rest and activity, both MLT and TEM techniques decreased pain levels, but showed no 
statistically significant overall mean differences between groups (rest = 0.40, p = 0.30; activity = 
0.22, p = 0.42).49  Similarly studies in patients post-TKA did not find differences between MLdT 
and TEM.48,51  Pichonnaz et al.51 noted a significant decrease in pain immediately after the 
application of 4 out of 5 MLdT treatment sessions, but it was not statistically significant between 
groups 3 months postoperative at rest (9.0 mm, p = 0.52) and during gait activities (16.7 mm, p = 
0.06), and the reduction in pain did not meet or exceed the MCID for pain levels.55  Ekici et al.24 
noted significant and progressive decreases in fibromyalgia pain levels with both MLdT and 
massage groups, but no significant difference in pain levels between groups at the end of 5 
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first treatment till the end of the study.  In summary, 4 out of 5 studies measured pain levels and 
all reported effectiveness in reducing pain with providing MLdT alone or adding MLdT to a 
conventional treatment, however, not all improvements were statistically significant in 
comparison to controls. 
Other Self-Reported Outcomes 
Various self-reported outcome measurement tools on functional activities and QOL were 
utilized across the studies.  Using an investigator designed questionnaire, Knygsand-Roenhoej 
and Maribo49 found statistically significant improvements in activities of daily living that were 
seen after three weeks of MEM (p = 0.03) compared to TEM techniques, but the improvements 
plateaued at the sixth and ninth weeks follow-up.  Tying shoelaces, eating with a knife and fork, 
peeling potatoes, and cutting a slice of bread were among the activities included in the 
questionnaire.49  The study of patients post-TKA by Ebert et al.48 reported improvements in QOL 
as measured by the Knee Injury and Osteoarthritis Outcome Score questionnaire, with significant 
time effect (p < 0.001), but without significant group or interaction effects.  In comparison, 
another study of patients post-KA observed that MLdT had no significant effect on self-reported 
knee function as measured by Knee Society Score questionnaire (p = 0.90), and the Western 
Ontario and McMaster Universities Osteoarthritis Index (p = 0.50).51  Patients with fibromyalgia 
treated with MLdT demonstrated significant improvements in the total score of Fibromyalgia 
Impact Questionnaire (p = 0.01),  and scores in areas of feeling more rested in the morning (p = 
0.006), and less anxiety (p = 0.060), compared to those treated with connective tissue massage.24  
In summary, 4 out of 5 included studies reported on self-reported outcomes, in which 2 reported 
effectiveness in improving either functional activities or QOL, when providing MLdT alone or 
adding MLT to a conventional treatment.  Not all improvements were statistically significant in 
comparison to controls. 
BENEFITS OF MLdT ON HEALTHCARE UTILIZATION 
 Two studies addressed the efficacy of MLdT from a framework of HU.  Healthcare 
Utilization can be associated with appropriate or inappropriate treatment, frequent or infrequent 
visits, and of high or low cost.  In comparison with TEM, significantly fewer sessions for edema 
treatment were required with MEM (p = 0.03), in order to decrease subacute arm/hand edema.49  
In geriatric patients post transtibial amputation, the application of complete decongestive 
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resulted in a significantly shorter transition period to a permanent prostheses (p < 0.05); 
compared to single use, multi-application compression bandages.50  In summary, a decrease in 
medication costs for migraine patients, a decrease in total number of visits for individuals with 
hand/arm edema, and a decrease in the cost of supplies for individuals using permanent 
prostheses have been reported.  Therefore, MLdT may lower HU in selected patient conditions. 
DISCUSSION 
Summary of Evidence 
 Moderate evidence supports the use of MLdT for decreasing edema in acute, subacute, 
and chronic healing phases of conditions affecting the musculoskeletal system.  While studies 
pertaining to acute edema evidenced a lack of volume reduction with MLdT, one study51 
reported less increase in edema compared to the control group.  Reduction in girth50 suggested 
that acute edema may benefit from MLdT, when the addition of auxiliary multilayer short-stretch 
compression bandaging and exercises is incorporated.  Compression was one key treatment 
which appeared to influence the outcomes of one study;49 all subjects in the control group 
utilized compression by means of Coban® and Isotoner® gloves, whereas, the MEM 
intervention group used a “low-stretch bandage system if needed.”49  
Moderate evidence suggests the use of MLdT for improving ROM after TKA.  This 
evidence seems to be antithetical with the lack of significant edema reduction noted in two 
studies.48,51  One author51 suggested that their improved ROM observations may be attributed to 
the slight decrease in edema, mechanical effects of MLdT during popliteal maneuvers, 
prevention of fibrosis through protein reabsorption, or simply through relaxation. 
Moderate evidence promotes the use of MLdT for decreasing pain and improving 
outcomes pertaining to functional activities and QOL.  While MLdT do not present with 
superiority in decreasing pain levels compared to other forms of manual therapy techniques, 
there seems to be preliminary evidence that these techniques may afford a quicker and more 
stable analgesic effect.51  Similar to the effects on pain level outcomes, MLdT are not superior in 
improving self-reported functional or QOL outcomes compared to other treatment measures. 
Moderate evidence supports the use of MLdT for improving HU.  Patient advocacy 
requires rehabilitation therapists to be responsible with the delivery of evidence-based practice.  
In these preliminary studies, MLdT promoted the use of less medication and supplies, and fewer 
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Limitations and Strengths 
 While the available body of literature pertaining to orthopedics and MLdT continues to 
build, there are limited high quality evidence studies encompassing the broad spectrum of 
conditions affecting the musculoskeletal system, which poses the inevitable random error of 
significant heterogeneity of included studies.  The diversity of study populations, outcome 
measures, and study designs may lead the intended audience to question the applicability of the 
summary of the evidence provided. In addition, the low number of participants included in the 
studies render results that are not necessarily generalizable.  However, the notable heterogeneity 
embodies the orthopedic practice of rehabilitation specialists, which establishes this systematic 
review true and applicable to orthopedic practice diversity.  Another limitation that arises from a 
dearth of literature, is the uncertainty of gathering all related studies.  Finally, there may have 
been studies with non-significant or inconclusive data, which have not been published, that 
would have influenced the overall results. 
CONCLUSIONS 
There was moderate support for using MLdT for conditions affecting the musculoskeletal 
system as effective interventions to reduce pain, and improve function and/or QOL.  This review 
also affirms that MLdT are effective treatment methods associated with lower HU.  Pertaining to 
ROM improvement and edema reduction, the results of this study suggest that MLdT with 
auxiliary therapies may be effective, and certainly not ineffective or harmful.  However, due to 
moderate methodological quality of the included studies, the evidence-based practice of MLdT 
should only proceed with clinical expertise and the patient values in perspective.  While the 
studies represented in this review demonstrated heterogeneity, their differences are an 
appropriate generalizable outcome for orthopedic therapy practices.  Since the first similar 
systematic review by Vairo et al26 there has been an increase number of randomized clinical 
trials pertaining to MLdT.  However, the need for further RCTs and cohort studies are warranted, 
to understand the attributes, benefits, and limitations of MLdT.  Standardized measurements are 
imperative to these future studies, and researchers are advised to consider homogenous 
methodology with previous studies.  In addition, research on MCID for edema pertaining to 
conditions affecting the musculoskeletal system would make significant clinical and comparative 
lymphedema research contributions.  Future research is needed to provide stronger evidence to 
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provide evidence as to which auxiliary interventions concurrent with MLdT produce best 
outcomes. 
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* One study was a protocol with embedded MLT text.  One study was dismissed due to its case 
series design.  Three studies focused on the physiological effects of MLT not related to an 
orthopedic disorder.  One study had English abstract but foreign manuscript.  Two studies did 
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Knygsand-Roenhoej K, et al. (2011) 2 RCT 6/10 Good 
Pichonnaz C, et al. (2011) 2 RCT 7/10 Good 
Ebert D, et al. (2013) 2 RCT 7/10 Good 
Ekici G, et al. (2009) 2 RCT 7/10 Good 
Topuz S, et al. (2012) 2 RCT 4/10 Fair 
OCEBM = Oxford Centre of Evidence Based Medicine, RCT = Randomized Clinical Trial, PEDro = 
Physiotherapy Evidence Database 
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Table III.2. Summary of Key Findings. 





29 patients, 72% Females with 
average age 64, 5-8 weeks after 
unilateral distal radius fracture, 
treated with plaster cast, internal 
or external fixation, and with a 
diagnosis of subacute edema. 
n = 14; 3x/wk for 4 weeks and 
then 2x/wk for 2 weeks 
consisting of   Modified 
MEM, HEP, low stretch 
bandage if needed, Isotoner 
glove daily. 





56 patients diagnosed status post 
TKA, 65% women with a mean 
age of 71. 
n = 29; 5 thirty minutes 
sessions of MLD 
(Strossenreuther method) per 
working day from 2nd day to 
7th day post operatively. 
Postoperative hospital-
based rehabilitation 
protocol = ROM, 
strengthening, CPM, gait 
training, and cryotherapy. 
Ebert, et al. 
(2013) 
 
43 patients/53 knees (72% males) 
with a mean age of 70 years, 
diagnosed status post TKA. 
n = 24, 30 minutes of MLD 
and remedial postoperative 
orthopedic massage 
techniques, on postoperative 
days 2, 3, and 4. 
Postoperative hospital-
based rehabilitation 
protocol = ROM, 
strengthening, CPM, gait 
training, and cryotherapy. 
Ekici, et al. 
(2009) 
 
53 women with a mean age of 38 
years, diagnosed with 
fibromyalgia. 
n = 26 females; 5x/wk for 3 
weeks consisting of 45 
minutes of MLD therapy. 
None 
Topuz, et al. 
(2012) 
 
11 patients, mean age 67 years, 
diagnosed postoperative transtibial 
amputee. 




isometrics, and isotonics.  
The CDP was instructed 
to conduct diaphragmatic 
breathing. 
Complete Decongestive Physiotherapy (CDP), Continuous Passive Motion (CPM), Fibromyalgia Impact 
Questionnaire (FIQ), Health Related Quality of Life (HRQoL), Home Exercise Program (HEP), Manual Edema 
Mobilization (MEM), Manual Lymph Drainage (MLD), Quality of Life (QOL), Range of Motion (ROM), Total 
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Table III.2 Continued.  Summary of Key Findings. 





Measured at 1st, 3rd, 6th, 9th, 
and 26th week post inclusion.  
Edema, active ROM, pain, and 
ADL, number of treatment 
sessions.  
In the modified MEM group, 
improvement was observed in ADL 
after the 3 weeks measurement (p = 
0.03).  Fewer edema treatment 
sessions were needed (p = 0.03) in the 
modified MEM group.  
Neither modified MEM 
treatment nor traditional 
edema treatment were superior 
to each other.  Modified MEM 
resulted in fewer required 
sessions to decrease subacute 




(2016)   
Measured at enrollment, 2nd 
day, 7th day, and 3 months 
postoperative TKA.  Truncated 
Cone Volumetric measures via 
tape, bioimpedance, VAS, Knee 
Society Score, Osteoarthritis 
Index, Gait analysis, active and 
passive knee ROM. 
Passive knee flexion contracture at the 
3 months measurement was 
statistically significant for being lower 
and less frequent in the MLD group 
compared to the control group.  Pain 
level decrease on the VAS 
immediately after the MLD treatment 
was statistically significant for 80% of 
the MLD sessions. 
MLD applied in the short-term 
after TKA did not reduce 
swelling.  MLD reduced pain 
after the treatment session and 
reduced the extent of knee 
flexion contracture and its 
frequency 3 months post 
operatively. 
Ebert,  
et al.  
(2013) 
Measured at enrollment, days 2, 
3, 4 and 6 weeks post 
operatively.  Active and passive 
knee ROM, Truncated Cone 
Volumetric measures via tape, 
VAS, and Knee Injury and 
Osteoarthritis Outcome Score.    
Increased active knee flexion at day 4 
post-surgery (p =0.014, 95% CI, effect 
size =0.79,1.68-16.67) and at 6 weeks 
postoperatively (p =0.012, 95% CI, 
effect size =0.87,2.32-16.78). 
MLD applied in the short term 
after TKA improves active 
knee flexion up to 6 weeks 
postoperatively. 
Ekici,  
et al.  
(2009)  
Measured at baseline and at end 
of treatment (3 weeks). VAS, 
pain pressure threshold 
algometry, HRQoL, FIQ. 
Improvements regarding pain 
intensity, pain pressure threshold, and 
HRQoL (p <0.05).  The MLD group 
improvements with the FIQ total score 
(p = 0.010).  Subsets of the FIQ 
(morning tiredness FIQ-7 and anxiety 
FIQ-9) particularly demonstrated 
improvements (p = 0.006) 
MLD Therapy was found to 
be more effective than 
Connective Tissue Massage 
according to subsets of the 
FIQ (morning tiredness and 
anxiety) and total FIQ scores. 
Topuz,  
et al.  
(2012) 
Circumferential measurements 
at 5 locations of the involved 
lower extremity, Days of 
hospital stay, and days to 
transition into permanent 
prosthesis. 
The transition into permanent 
prosthesis was shorter in the CDP 
group (p < 0.05). Circumferential 
measurements were more obvious in 
the CDP group (p < 0.05).  
CDP is effective in reducing 
post amputation stump edema 
in geriatric amputees.  The 
reduction of edema was more 
obvious in the CDP group.  
CDP is effective in shortening 
the transitional period into 
permanent prostheses. 
Complete Decongestive Physiotherapy (CDP), Continuous Passive Motion (CPM), Fibromyalgia Impact Questionnaire 
(FIQ), Health Related Quality of Life (HRQoL), Home Exercise Program (HEP), Manual Edema Mobilization (MEM), 
Manual Lymph Drainage (MLD), Quality of Life (QOL), Range of Motion (ROM), Total Knee Arthroplasty (TKA), 
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Table III.3.  Summary of Qualitative Assessments.à 








Ebert et al. 2013; 
Knygsand-Roenhoej and 
Maribo 2011; Pichonnaz 






Ebert et al. 2013; Ekici 
et al. 2009; Knygsand-
Roenhoej and Maribo 







Ebert et al. 2013; 
Knygsand-Roenhoej and 
Maribo 2011; Pichonnaz 









Ebert et al. 2013; Ekici 
et al. 2009; Knygsand-
Roenhoej and Maribo 













à  Due to limited number of events, small sample size, and studies with non-normal distribution, effect 
sizes were not pooled. 
¨ No serious risk of bias.  PEDro internal validity scale ranged 6-8, and a “good”40 rating. 
º Topuz, et al. utilized different compression strategies between groups, which may have influenced a 
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Table III.3 Continued.  Summary of Qualitative Assessments.à 
Outcomes Inconsistency Indirectness Publication Bias Imprecision 
Edema (-1)¨¨ (- 0)¨¨¨ (- 0) ¨¨¨¨ (- 0) Ë 
Pain (-1)¨¨ (- 0)¨¨¨ (- 0) ¨¨¨¨ (- 0) 
Range of Motion (-1)¨¨ (- 0)¨¨¨ (- 0) ¨¨¨¨ (- 0) 
QOL and Other 
Self-Reported 
Outcomes 
(-1)¨¨ (- 0)¨¨¨ (- 0) ¨¨¨¨ (- 0) 
Healthcare 
Utilization (-1)¨¨ (- 0)¨¨¨  (- 0) ¨¨¨¨ (- 0) Ë 
à  Due to studies with small sample sizes and studies with non-normal distribution, effect sizes were 
not pooled. 
¨¨ Due to heterogeneity of studies and small populations resulted in inconsistent effect sizes. 
¨¨¨ Conclusions of the studies directly applied to the PICO.   
¨¨¨¨ Not observed and unlikely. No conflicts of interest reported. 
Ë Topuz, et al. (2012) had small number of events and moderate confidence intervals, but did not 
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Table III.3 Continued.  Summary of Qualitative Assessments.à 
Outcomes Dose-Response Association 
Residual 





Edema (+ 0) (+ 0) (+ 0) » ✪✪✪❍ Moderate Moderate 
Pain (+ 0) (+0) (+ 0)  ✪✪✪❍ Moderate Moderate 
Range of Motion (+ 0) (+ 0) (+ 0)              ✪✪✪❍ 
Moderate 
Moderate 
QOL and Other 
Self-Reported 
Outcomes 
(+ 0) (+ 0) (+ 1) Å ✪✪✪✪ High Moderate 
Healthcare 




à  Due to studies with small sample sizes and studies with non-normal distribution, effect sizes were 
not pooled. 
» Topuz, et al. (2012) had large and/or very large effect sizes for outcomes. 
Å Ekici, et al. (2009) contributed a large effect size. 
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Appendix III.A. Inclusionary Terms and Examples of Key Word Combinations. 
Inclusionary Terms 
Conditions affecting the musculoskeletal system may consist of many conditions including, but not 
limited to, fractures, tendinitis, tendinosis, bursitis, sprains, strains, tears, degenerative conditions, post 
orthopedic surgical conditions, arthritis, bursitis, elbow pain and conditions, fibromyalgia, foot pain 
and conditions, fractures, hip pain and conditions, low back pain and conditions, hand pain and 
conditions, knee pain and conditions, neck pain and conditions, osteoporosis, shoulder pain and 
conditions, and soft tissue injuries.28-31 
Key Search Terms and Strategy 








Manual Lymph Drainage 













PubMed Search Strategy Examples: 
1. lymphatic AND drainage AND hand NOT lymphedema 
2. lymphatic AND drainage AND knee NOT lymphedema 
3. manual lymph drainage AND ankle NOT lymphedema 
4. manual lymph drainage NOT lymphedema NOT cancer 
5. lymphatic drainage AND orthopedic NOT cancer NOT lymphedema 
Google Scholar Search Strategy Examples: 
1. "manual lymph drainage" knee edema -lymphedema 
2. "manual edema mobilization" hand edema -lymphedema 
3. "manual lymph drainage" -cancer -lymphedema 
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Appendix III.B.  Operational Criteria of the PEDro Scale. 
1. Eligibility criteria were specified; 
2. Random allocation of subjects into groups (in a crossover study, subjects were randomly 
allocated an order in which treatments were received); 
3. Allocation was concealed; 
4. Groups were similar at baseline regarding the most important prognostic indicators; 
5. There was blinding of all subjects; 
6. There was blinding of all therapists who administered the therapy; 
7. There was blinding of all assessors who measured at least one key outcome; 
8. Measures of at least one key outcome were obtained from > 85% of the subjects initial 
allocated to groups; 
9. All subjects for whom outcome measures were available received the treatment or control 
condition as allocated or if not the case, then data for at least one key outcome was 
analyzed by “intention to treat” 
10. The between-group statistical comparisons are reported for at least one key outcome; and 
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Appendix III.C.  Operational Definitions of GRADE’s Four Levels of Evidence 
 
1. High Level of Quality (✪✪✪✪): Authors are very confident that the true effect lied close 
to that of the estimate of the effect. 
 
2. Moderate Level of Quality (✪✪✪❍): Authors are moderately confident in the effect:  
The true effect is likely to be close to the estimate of the effect but there is a possibility 
that it is substantially different. 
 
3. Low Level of Quality (✪✪❍❍): Authors confidence in the effect estimate is limited.  
The true effect may be substantially different from the estimate of the effect. 
 
4. Very Low Level of Quality (✪❍❍❍): Authors have very little confidence in the effect 
estimate: The true effect is likely to be substantially different from the estimate of the 
effect. 
 
Five categories which may downgrade the quality of evidence: 
1. Risk of Bias: -1 if serious, -2 if very serious 
2. Inconsistency: -1 if serious, -2 if very serious 
3. Indirectness: -1 if serious, -2 if very serious 
4. Imprecision: -1 if serious, -2 if very serious 
5. Publication Bias: -1 if likely, -2 if very likely 
Three categories which may upgrade the quality of evidence: 
1. Large Effect: +1 if large, +2 if very large 
2. Dose Response: +1 if evidence of a gradient 
3. All plausible residual confounding: +1 would reduce a demonstrated effect, or would 
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Appendix III.D.  Operational Definitions of ACCP. 
 
1. High Level of Quality: Reports from RCTs without significant limitations or overriding 
evidence from observational studies. 
 
2. Moderate Level of Quality: Reports from RCTs with consequential limitations 
(inconsistent results, methodological flows, indirect, or imprecise) or from observational 
studies with exceptionally strong evidence. 
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ABSTRACT 
 
Background: Breast cancer survivors (BCS) with breast cancer related lymphedema (BCRL) 
have demonstrated neuromusculoskeletal restrictions, sensorimotor impairments, postural 
instability, and balance deficits.  To date, there have not been studies which investigate outcome 
measures (OMs) used by certified lymphedema therapists (CLTs) on BCS with BCRL.  
Objectives: The purpose of this study was to examine 1) OMs used by CLTs on BCS with 
BCRL and their differences between professions; 2) unique characteristic predictors for use of 
OMs; and 3) facilitators and barriers which influence CLTs use of OMs and their differences 
between professions.  Methods:  Cross-sectional online survey research design.  Electronic 
surveys were distributed to certified lymphedema therapists from various institutions.  Data from 
70 physical therapists (PTs) and 41 occupational therapists (OTs) were analyzed from 130 
completed surveys.  Descriptive statistics, Chi-square test of independence, and independent 
samples t-test were used to examine respondent demographic and practice characteristics, and 
group differences multiple variables, while binary logistic regression examined unique predictors 
to the use of OMs.  Results:  Sixteen OMs used most often assessed joint function, flexibility, 
strength, pain, volume, sensation, tissue consistency, body composition, health related quality of 
life, and upper quadrant function.  There were differences between PTs and OTs in use of OMs 
but no trends in associations with specializations or schooling.  Lymphology Association of 
North America certification, practice setting, and profession (PT and OT) predicted the use of 
some OMs.  Use of OMs were valued by OTs and PTs but not equally.  Conclusions:  This 
study has identified individual OMs used on BCS with BCRL in clinical practice among 
interdisciplinary CLT practitioners.  The number of OMs used to assess body functions and 
structures exceed those OMs for activities and participation which may be influenced by CLT 
profession, LANA certification, and level of highest degree.  CLTs agree on the benefits of and 
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INTRODUCTION 
Breast cancer related lymphedema (BCRL) that develops in breast cancer survivors 
(BCS) is a consequence of cancer intervention procedures, and characterized as an excessive 
accumulation of protein rich fluid in the interstitial environment of the ipsilateral upper-
quadrant.1  The incidence of BCRL is approximately 30-42% of those who undergo axillary 
lymphadenectomy, or irradiation interventions status post modified radical mastectomy.1,2  
BCRL is a progressive chronic disease that presents with variable morbidity affecting body 
functions and body structures, and restrictions and limitations in activities and participation.  The 
comorbidities include various musculoskeletal changes limiting range of motion and strength, 
difficulty reaching, increased fatigue and volume, sensory impairments, pain, integument 
changes, low self-esteem, and quality of life.1,3–7  In addition, BCS with BCRL have also 
demonstrated impairments of proprioception and sensorimotor functions realized as significant 
decrease in postural stability and balance.8,9   
Outcome Measures 
 Standardized outcome measures (OMs) are an essential component of evidence-based 
practice (EBP) and are often incorporated in the examination of a disorder and the outcome 
assessment of interventions for related impairments of body functions and structures, and 
limitations of activities and participation.10,11  The results of these OMs provide a foundation for 
clinical reasoning in the diagnosis, prognosis, and establishment of intervention and/or 
management of a health condition.12  The use of OMs in the clinical setting can justify the 
efficacy of a plan of care for chronic conditions such as in BCRL.  OMs are a key component to 
patient-centered care, value-based health services, and current reimbursement models, especially 
in complex long-term conditions.13    
Generally, physical therapists (PT) hold positive attitudes about EBP and believe that 
OMs enhance patient-provider and provider-payer communication, enhance examination 
thoroughness, and improve directing and focusing a plan of care.11,14  Similarly, nurses (RN) and 
athletic trainers (ATC) have positive beliefs about EBP.15,16  While various healthcare 
professionals have positive believes about EBP and that OMs are considered useful for 
enhancing levels of communication and thoroughness of a plan of care, their use may be limited 
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74 - 85%16,17 of clinically practicing ATCs do not use patient-reported OMs.  In contrast, use of 
OMs within specialty groups may demonstrate favorable trends.  A study investigating therapists 
who were specialized in hand therapy reported that 92% used patient-reported OMs.18    
Barriers and Facilitators To Using Outcome Measures 
 Knowledge of and the competence to use of OMs are routinely reported as  significant 
barriers for the use of OMs across healthcare disciplines.15,19,20  Other significant barriers 
reported across disciplines include lack of time to implement, scoring and interpreting OMs, 
difficulty in patient comprehension, low perceived value of the measurement, lack of suitability 
of the instrument, lack of appropriate psychometric properties of the instrument, diminished 
attitude toward EBP and OMs, and lack of advocacy from management and peers.14–16,19–23  
Common facilitators of OMs juxtapose the barriers.  What is clearly evident in the literature is 
that education is needed to inform clinicians of OMs and enhance their competence and 
confidence in their use, which will facilitate clinical use of OMs, valuing EBP, promotion within 
the work setting, and cooperative initiatives in research.15,19,20,24  
Current Evidence for Outcome Measures on Breast Cancer Survivors and Lymphedema 
 In 2010, the American Physical Therapy Association (APTA) Oncology Section formed 
the Breast Cancer – Evaluation Database to Guide Effectiveness (EDGE) Task Force, 
commissioned to identifying best tests/outcome measures that were reliable, valid, and had good 
clinical utility for individuals treated for breast cancer.25  The Breast Cancer EDGE Task Force 
used domains of the World Health Organization’s (WHO) International Classification of 
Functioning, Disability, and Health (ICF) model to categorize outcomes and identify valid 
clinical measurement tools.  Studies related to lymphedema focused on upper extremity 
assessment26 and quality of life27 OMs of secondary lymphedema in BCS.  A clinical practice 
guideline was developed by the Oncology Section of the APTA and published in 2017.28  This 
guideline focused on the diagnosis of upper-quadrant lymphedema secondary to breast cancer.  
Table IV.1 lists the OMs recommended by the Breast Cancer EDGE Task Force rated B 
(moderate recommendation) or A (Strong recommendation) for clinical use on BCS.  In 2013, 
the Dutch Society of Dermatology organized a task force to create guidelines for lymphedema 
supporting a continuum of assessments and intervention modalities.29  Due to effectiveness and 
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and from the chronic care model.31  The Dutch Lymphedema Guideline recommendations of 
OMs (Table IV.1) were made based on an interdisciplinary approach to lymphedema and broad 
subdomains of measures under the ICF domains of body functions and structures, and activities 
and participation.     
Recommended OMs on BCS, lymphedema, and BCS with BCRL have been established 
by the Breast Cancer EDGE Task Force and the Dutch Society of Dermatology.  Beyond these 
documents, there are additional OMs for these populations evidenced in the research literature.  
There have not been studies investigating the use of OMs, whether or not recommended, by 
certified lymphedema therapists (CLTs) on BCS who have BCRL.  Adding to that fact is that 
there is a multidisciplinary group of professionals that are CLTs including, PTs, occupational 
therapists (OTs), massage therapists (MTs), nurses (RNs), and physicians (MDs).32  The use of 
OMs across a number of healthcare disciplines14,16,33 has been limited over the last decade.  
Furthermore, there is limited evidence on differences in the use of OMs between PTs, OTs, RNs, 
and MDs.33,34  Past studies have reported a greater use OMs by PTs compared to OTs,34 and 
MDs and RNs compared to PTs and OTs.33  Facilitators and barriers to the use of OMs on BCS 
with BCRL have not been explored in the diverse healthcare professionals (e.g. PTs, OTs, MTs, 
MDs, and RNs) that are CLTs.  The purpose of this study was to examine 1) OMs used by CLTs 
on BCS with BCRL and their differences between professions; 2) unique characteristic 
predictors for use of OMs; and 3) facilitators and barriers which influence CLTs use of OMs and 
their differences between professions. 
METHODS 
Design and Subjects 
A cross-sectional online survey design was implemented, gathering responses from CLTs from 
various post-professional lymphedema continuing education programs and related professional 
associations in the United States.  The distinct inclusion criterion of the CLT population was 
determined due to their use of OMs in BCRL practice, their expertise and extensive lymphedema 
training, and for the convenience sampling from continuing education programs and the 
professional associations that relate to BCS and BCRL.  CLTs who did not see patients with 
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Instrument 
 An online survey (Appendix IV.A) format was constructed through Qualtrics software, 
Version June, 2020 of Qualtrics, copyright© 2020 Qualtrics.  The survey was divided into three 
domains to gather; 1) demographics and practice characteristics of respondents (22 questions), 2) 
levels of use of standardized and clinically relevant OMs with subdomains of joint function, 
flexibility, strength, volume, pain, sensation, tissue consistency, body composition, patient-
reported functions and health-related quality of life (HRQOL), patient-reported upper quadrant 
function, patient-reported fatigue, mobility and balance, and upper extremity activity and motor 
control (92 questions), and 3) levels of agreement on facilitators and barriers to using OMs (38 
questions).  Survey development used a modified version of the validated surveys from Jette et 
al.11,14 which investigated evidence-based practice and OMs used in physical therapy.  In 
addition, survey development also followed a survey from a thesis35 with various modifications. 
Modifications of these surveys were made to 1) improve face validity by focusing questions 
toward BCRL and multi-disciplinary CLTs; 2) incorporate standardized and clinically relevant 
OMs; and 3) incorporate facilitators and barriers to the use of BCRL OMs.  Facilitators and 
barriers to the use of OMs were categorized from a modified format outlined by Braun et al.,36 
which includes; 1)  beliefs of the therapist, 2) knowledge and competence, 3) healthcare practice, 
4) business structures, and 5) healthcare equality.   
 Face validity of the survey was attested by the primary investigator and three 
collaborative colleagues via assessing its design based on similar studies. Consultation with two 
colleagues, with experience in survey research design, about survey formatting, grammar, and 
precision of questions prompted survey questionnaire modifications.  The questionnaire was then 
pilot tested by six certified lymphedema therapists.  An agreement between a minimum of two37 
CLTs with BCRL experience on the survey instrument was considered sufficient to confer the 
content validity of the survey instrument.  Content validity was determined by calculating the 
item-level content validity index (I-CVI) which measures the content validity of the individual 
items, and the average I-CVI for the content validity of the overall tool.38  Six content experts 
were asked to rate whether each domain and subdomain item had clarity and was relevant based 
upon its breadth to capture CLT’s clinical practice use, barriers, and facilitators of OMs.  The I-
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1.00), and facilitators and barriers domain (I-CVI = 1.00).  The average I-CVI for the survey tool 
was 0.99.  These experts were also invited to provide recommendations to the survey which 
resulted in minor grammar modifications to the final survey. 
Procedure 
 The study received exempt status by the Health Sciences and Behavioral Sciences 
Institutional Review Board of the University of Michigan – Flint and from A.T. Still University-
Arizona Institutional Review Board.  Approximately 7,000 emails with survey links were e-
mailed to CLT graduates from the post-professional education institutions and related 
professional associations.  After giving consent, participants completed the online survey 
questionnaire administered through Qualtrics®.  The survey was available for 53 days, but due to 
low response rate, a follow-up email was sent 16 days after the initial invitation and another 
institution was included 25 days after the outset for further dissemination of the survey.   
Data Analysis  
Data were analyzed using IBM® SPSS® version 26 (Armonk, NY).  The total sample of 
respondents (n = 130) included PT, OT, MT, and RN.  The completion rate was 98%, with 3 
surveys incomplete at 99%, 85%, and 70% completion.  Due to sparsity of respondents from MT 
and RN professions, the sample was collapsed for analysis (n = 111) and included groups most 
represented, including 1) OT CLTs (n = 41) and 2) PT CLTs (n = 70).  These groups were 
examined to understand their 1) demographic (Table IV.2) and 2) practice characteristics (Table 
IV.3) differences.  Characteristics included continuous, ordinal, and categorical data.  A Shapiro-
Wilk test showed a departure from normality for PT and OT CLTs for 1) years as CLT, 2) 
percent of practice devoted to lymphedema interventions, 3) number of BCRL clients in eight 
hours work day, 4) minutes allocated for initial evaluation, 5) minutes allocated for re-
evaluation, 6) hours per week providing lymphedema interventions, and 7) percent of patients 
seen in specific age groups.  Descriptive statistics were presented as means + standard deviations 
(SD), counts (n), and frequencies (%).  Frequencies for multiple response variables (i.e. 
respondents could choose more than one choice) are reported as count and percent of cases.  
Independent samples t-test were used to analyze group differences for parametric data.  
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Whitney U test.  Fisher’s exact test was used when more than 20% of cells had expected counts 
less than five.  Alpha level was set at 0.05 for all analysis. 
   The primary dependent categorical variables were OMs and were separated in two 
categories; 1) OMs used by CLTs to measure ICF domains of body functions and body structures 
with levels of 1.1) joint function, 1.2) flexibility, 1.3) strength, 1.4) volume, 1.5) pain, 1.6) tissue 
consistency, 1.7) body composition, and 1.8) sensation (Table IV.4); and 2) OMs used by CLTs 
to measure ICF domains of activities and participation and restrictions with levels of 2.1) patient-
reported function and HRQOL, 2.2) patient-reported upper quadrant function, 2.3) patient-
reported fatigue, 2.4) mobility and balance, and 2.5) Upper extremity activity and motor control 
(Table IV.5).  Categories 1.1-1.7 and 2.3-2.4 were chosen based on their prominence in the 
BCRL literature including the APTA Oncology Section Breast Cancer EDGE Task Force 
recommendations, APTA Oncology Section Clinical Practice Guidelines for diagnosing BCRL, 
and the Dutch Lymphedema Guidelines.  Categories 2.1 and 2.2 was parsed from the Breast 
Cancer EDGE Task Force category of Measures of Patient Reported Function and Quality of 
Life (Table IV.1) for a more robust analysis of upper quadrant function and health-related quality 
of life and for the inclusion of additional measures.  Categories 1.8 and 2.5 were chosen based on 
their inclusion in the Guide to Physical Therapist Practice Focus on Tests and Measures39 and 
their ability to gather upper extremity sensation, function, and motor performance in an objective 
format.  The survey included 92 OMs that respondents ticked a Likert scale for level of use, 
which consisted of frequently used (i.e. used for initial examinations and reassessments), 
occasionally used (i.e. used for initial examinations), seldom used (i.e. intermittent use as 
warranted), and do not use.  To simplify for analysis, this scale was dichotomized into Used to 
some degree of frequency (frequently, occasionally, and seldom used) and Not Used with 
frequencies reported as count and percent of responses (Table IV.4 and IV.5).  For ease of 
reporting, the OMs were grouped by quartile cut points (Table IV.6) which divided the range of 
their use into equal probabilities.  Chi-square test of independence was used to show group 
differences in the use of OMs between OTs and PTs, and when more than 20% of cells had 
expected counts less than five, the Fisher’s exact test was implemented (Table IV.4 and IV.5). 
We used binary logistic regression to examine if respondent demographic and practice 
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retrieved from Tables IV.4 and IV.5.  Characteristics of interest were selected based on how 
commonly they are reported in the literature associated with the use of OMs and evidence-based 
practice, which included 1) age of therapist,40 2) highest degree earned,14,21 3) years in practice,41 
4) practice specialization (dichotomized),14,21 5) years as CLT,41 6) Lymphology Association of 
North America (LANA) certification,14,21 7) practice setting (dichotomized),14 8) minutes 
allocated for initial evaluation,14,21 and 9) profession.42,43  Profession and highest degree were 
correlated (rs = 0.22, p = 0.02) as well as therapist age and years of practice (r = .90, p < 0.001), 
which resulted in a moderate risk of multicollinearity (variance inflation factor > 5).  Age of 
therapist was subsequently removed from the analysis resulting in a decreased risk of 
multicollinearity in the logistic models (Table IV.7).  While other characteristics were 
considered, their cell sizes were inadequate to run logistic regression with meaningful output for 
inference.   
The secondary dependent variable was facilitators and barriers for use of OMs and were 
categorized into five domains; 1) beliefs of the therapist, 2) knowledge and competence, 3) 
healthcare practice, 4) business structures, and 5) healthcare equality (Table IV.5) based off a 
previous study.36  Statements regarding facilitators and barriers for use of OMs were scaled 
ordinally with 1) strongly agree, 2) somewhat agree, 3) neither agree or disagree, 4) somewhat 
disagree, and 5) strongly disagree.  For the analysis, the ordinal scale was collapsed into three 
categories; 1) somewhat to strongly agree, 2) neither agree or disagree, and 3) somewhat to 
strongly disagree.  The frequencies for each ordinal level were reported as count and percent of 
responses for both groups in Table IV.8.  Chi-square analysis was used to examine differences 
between groups for all facilitators and barriers and Fisher’s exact test was used when more than 




As presented more completely in Tables IV.2 and IV.3, of those CLT respondents (n = 
111) who use OMs on BCS with BCRL, 98% (n = 109) of the respondents were female and 2% 
(n = 2) were male, with an average age of 48 + 10.6 years which was not significantly different 
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located mainly in Midwest US (30.6%, n = 34), followed by Southeast US (22.5%, n = 25) and 
Northeast US (21.6%, n = 24), where they practiced mostly in an outpatient clinic (n = 104, 
93.7%) in either a suburban (42.3%, n = 47) or urban (36.9%, n = 41) community.  The number 
of years in professional practice between PTs and OTs were not significantly different (t(102) = -
0.67, p = 0.50), and averaged 22.7 + 11.6 years.  Forty-eight (68.5%) of PTs pursued National 
CLT certification through LANA, while only 56% (n = 23) of OTs pursued this credentialing.  
Respondents similarly reported a mean of 64.2% + 29.2 of their practice devoted to lymphedema 
management.  The allocation of intervention and management for BCRL was similar for PTs and 
OTs with an average of 3.5 + 3 BCS with BCRL seen in eight hours work day.  Further 
respondent and practice characteristics and their related group differences are evidenced in 
Tables IV.2 and IV.3. 
Use of outcome measures 
Measures to assess ICF domains of body function and structures 
 A number of OMs were identified as being used at some level of frequency by CLTs to 
measure ICF domains of body functions and structures (Table IV.4).  The use of circumferential 
measurements and calculated volume as the singular OM used at some level of frequency by 
CLTs for volume measures (99.1%, n = 110).  In contrast, the bioimpedance spectroscopy OM 
for measuring volume was used at some level of frequency by only 20.7% of respondents.  OMs 
used most often (i.e. 75.1 – 100% of respondents) (Table IV.4 and IV.6) were 1) goniometry for 
AROM to measure joint function (99.1%, n = 110) with no significant difference between OT 
and PT groups (p = 0.37), 2) Stiff glenohumeral joint to measure flexibility (93.7%, n = 104) 
with PTs using this measure more often (p = 0.01),  3) MMT to measure strength (98.2%, n = 
109) with no difference (p = 1.00) between professions, 4) Light touch brushing to measure 
sensation (95.5%, n = 106) with no difference between groups (p = 0.36), 5) numeric pain scale 
(94.6%, n = 105) to measure pain with no difference between PTs and OTs (p = 1.00), 6) Pitting 
edema test to measure tissue consistency (98.2%, n = 109) with no difference between groups (p 
= 0.13), and 7) body weight to measure body composition (91.0%, n = 101) with no significant 
difference in use between professions (p = 0.09).  Tonometer (7.2%, n = 8), Myoton (8.1%, n = 
9) and SkinFibrometer (5.4%, n = 6), which are able to quantifiably measure tissue consistency 
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Measures to assess ICF domains of activities and participation 
 There were a number of OMs identified as being used at some level of frequency by 
CLTs to measure ICF domains of activities and participation (Table IV.5).  The LLIS for patient-
reported HRQOL and the QuickDASH for patient-reported upper quadrant (UQ) function were 
the patient-reported OMs used most often (i.e. fourth quartile of responses) by CLTs (82.9%, n = 
92 and 85.6%, n = 95, respectively).  OTs used the LLIS more often than PTs (c2 (1, n = 111) = 
4.40, p = 0.04).  Other OMs that are used to measure activities and participation (Table IV.5) 
include 1) DASH (73.0%, n = 81) for patient-reported UQ function with no significant difference 
between groups (c2 (1, n = 111) = 1.86, p = 0.19), 2) Visual analog scale (55.0%, n = 61) for 
patient-reported fatigue with PTs using it more often that OTs (c2 (1, n = 111) = 4.78, p = 0.03), 
and 3) Timed up and Go (73%, n = 81) for mobility and balance, which PTs use more often that 
OTs (c2 (1, n = 111) = 12.30, p < 0.01).  Six out of thirteen patient-reported OMs for fatigue 
(Table IV.6) were used least often with probability distributions of use ranging from 2.7% (n = 
3) to 10.8% (n = 12).  All OMs listed under the category of upper extremity and motor control 
were used least often (Table IV.6), which included 1) 9 Item Arm Motor Ability Test (4.5%, n = 
5), 2) Ruler Drop Test/ReacStick (4.5%, n = 5), 3) Finger Tapper (5.4%, n = 6), 4) Action 
Research Arm Test (8.1%, n = 9), 5) Box and Block Test (12.6%, n = 14), and 6) Purdue Peg 
Board (23.4%, n = 26). 
Characteristics influencing use of outcome measures 
There were unique respondent and practice characteristics of CLTs that predicted the use 
of OMs.  The significant findings applied to only a few OMs and they are presented in Table 
IV.10.  The results present that CLTs who are OTs are eleven times more likely to use the pinch 
dynamometer OM to assess strength and three times more likely to use the monofilament OM to 
assess sensation.  CLTs that are not LANA certified are nearly four times more likely to use the 
sharp-dull discrimination OM for sensation and the DASH OM for patient-reported upper 
quadrant function, and are three times more likely to measure fatigue with the visual analog scale 
OM.  Those CLTs with their highest professional degree being Master’s of Science or Art are 
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Facilitators and barriers to use of outcome measures 
Facilitators and barriers to the use of OMs were investigated for both PTs and OTs (Table 
IV.8) and those that met a 75% frequency threshold at either ends of the scale are highlighted 
here.  Most CLTs agreed that the use of OMs helps direct the plan of care (90.1%, n= 100), 
improves quality of care (76.6%, n = 85), helps in the clinical reasoning for choice of 
interventions (77.5%, n = 86), and are necessary for the practice of BCRL interventions and 
management (94.6%, n = 105).  They also largely agreed that use of OMs improve 
communication with their BCS clients with BCRL (80.2%, n = 89) and with other healthcare 
stakeholders (76.6%, n = 85).  Eighty percent of CLT respondents (n = 88) were consistently 
incorporating clinical practice guidelines (CPG) and systematic reviews in their diagnosis and 
interventions on BCRL, and they mostly agreed (78.2%, n = 86) that they had the ability to 
access current research pertaining to BCRL through professional journals.  CLTs largely agreed 
that use of OMs was part of their personal practice model (81.8%, n = 90), were important for 
assisting in the identification of comorbidities (87.3%, n = 96), and helped determine the efficacy 
of their intervention on BCRL (72%, n = 80).  Respondents also mostly agreed that executing 
OMs at regular intervals and for patient discharge were important (86.3%, n = 95 and 80%, n = 
88, respectively).  CLT respondents mostly disagreed that clients with BCRL requested that they 
use OMs (82.7%, n = 91).  Table IV.9 listed the significant differences between professions for 
the facilitators and barriers.  Compared to OTs (2.4%, n = 1), PTs (18.6%, n = 13) disagreed that 
OMs improve quality of care toward clients with BCRL.  A similar scenario is noted with 18.8% 
(n = 13) of PTs disagreeing that OMS are necessary to determine intervention efficacy for clients 
with BCRL, compared to 2.4% (n = 1) of OTs.  PTs were relatively uncertain if OMS increase 
the efficiency of evaluations, with 40% (n = 28) of the profession both agreeing and disagreeing.  
However, a majority (68.3%, n = 38) of OTs felt that OMs increased the efficiency of 
evaluations.  Twenty percent of PTs (n = 14) neither agreed or disagreed that OMs improved 
communication with other healthcare stakeholders, compared to 2.4% of OTs (n = 1).  A 
majority of OTs (92.7%, n = 38) agreed that the use of OMs helps in the clinical reasoning for 
choice of interventions on clients with BCRL, whereas only 68.6% (n = 48) of PT agreed and 
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DISCUSSION  
Participants 
The participants made up an equitable sample of PT and OT CLTs presumed present in 
the population.  The demographics and practice characteristics in this sample are comparative to 
a 2010 national (n = 415) and a 2018 international survey (n = 950) that investigated practice 
environments, patient characteristics, and educational frameworks of CLTs.44,45  Similarities 
included; 1) female sex (98% vs 95%), 2) average age (48 vs 46), 3) percentage of PTs in PT/OT 
sample (63% vs 59%), and 4) percent practicing in outpatient facilities (93% vs 88%).  This 
sample deviated from the 2018 survey with 64% (n = 71) of respondents being LANA certified 
(compared to 33%) and a professional work history of 22.5 years (range 1 – 45) (compared to 
10.7 years).  A majority of CLTs practiced in the Midwestern, Northeastern, and Southeastern 
regions of the US, while respondents from the Western, and Southwestern regions were few, 
which is similar to a 2020 study on CLT’s practice patterns.46  The distributions of this BCRL 
focused sample is comparable to the generalized lymphedema studies since 2009 and appears to 
be representative of the CLT population at large.  These similar distributions suggest persistent 
gaps in this specialized field.  In both BCRL and generalized lymphedema CLT populations 
there remains a limited number of male practitioners and younger practitioners.  In addition, 
most CLTs practice in outpatient settings have been relatively unchanged since 2009 which is a 
concern for persons with lymphedema that are home bound or in a skilled nursing facility.  In 
this study, rural community settings were least represented, which aligns with typical access to 
cancer care in rural regions of the US and influences patient outcomes,47 bringing attention to the 
need for lymphedema management services in the underserved rural community settings.   
OMs CLTs use that measure body functions and structures 
There were a number of OMs used at some level of frequency to assess body functions 
and structures.  Current CPGs that focus on the diagnosis and interventions of BCRL28,48 
recommend using circumferential measurements for calculated volume which aligns with what is 
currently being used by CLTs as noted in this study.  However, this OM may not be appropriate 
for subclinical/stage 0 BCRL, with the recommendation to use bioimpedance analysis,28 of 
which the bioimpedance spectroscopy was an OM used least often (20.7%).  Additional OMs 
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AROM, 3) stiffness of the glenohumeral joint for flexibility, and 4) MMT which have all been 
analyzed via systematic review by the Breast Cancer EDGE Task Force of the Oncology Section 
of the American Physical Therapy Association.25  Of these, MMT was not recommended for use 
due to insufficient information on individuals with or post cancer.  Body weight and BMI were 
used by CLTs and their use was recommended by the Dutch Society of Dermatology.29  Pitting 
edema test via palpation was used to measure tissue consistency and has been vetted by 
systematic analysis, but was not recommended for use due to absence of diagnostic accuracy.28  
Ultrasonography was recommended in the BCRL CPG to asses underlying tissue changes, but 
only for Stage III BCRL,28 but was used by only 6.3% of respondents.  Other tissue consistency 
OMs that were used least often (i.e. first quartile, 0-25%) include the SkinFibrometer which is a 
valid and reliable (Intrarater ICC 0.88, 95% CI 0.82 – 0.84) quantitative measure of skin 
stiffness,49,50 tonometer (e.g. Durometer), and the Myoton which is a reliable quantitative 
measures (Intrarater ICC 0.89 (95% CI 0.74-1.00), Interrater ICC 0.74 (95% CI 0.45-1.00).50,51  
This is a significant concern as it demonstrates minimal use of available OMs with appropriate 
psychometrics and good clinical utility to assess tissue consistency as it is a component for 
staging lymphedema according to the International Society of Lymphology (ISL) staging 
system.52  Other measures frequently used but not formally analyzed by systematic review for 
BCRL include light touch brushing and tissue texture assessment via palpation.  Unfortunately, a 
few of the OMs (e.g. dynamic motion of scapula, stiffness of glenohumeral joint, tissue texture-
palpation, pitting edema test-palpation, pectoralis major and minor length, and manual muscle 
test) used by CLTs for body functions and structures may present with psychometric limitations 
for clinical settings involved in care for BCS and BCRL.  This limitation severely limits the 
objective findings needed to demonstrate effective progress and efficacy of interventions, 
especially in areas such as tissue consistency, of which the ISL lymphedema staging are based 
on.  Without valid and reliable objective measures for basics such as sensation, strength, and 
tissue consistency there are limitations in transfer of care, identification of comorbidities, and 
guidance for clinical reasoning on interventions.  For instance, a CLT will need to specifically 
address deficits in sensation and strength in the home management program and improvements 
will need to be noted with valid and reliable OMs to foster clinical reasoning to adjust a plan of 
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versus reduction in fibrosis remains elusive and is detrimental for continuum of care.  Subjective 
OMs with poor psychometrics also limit the knowledge translation from research trials into the 
clinical practice. 
OMs that CLTs use to measure activities and participation 
Few OMs for measuring activities and participation were identified as being used most 
often.  We had hypothesized that the number of impairment-based OMs would be used most 
often compared to OMs that assess activity and participation and our results concur.  
Surprisingly, CLTs are not frequently measuring upper extremity activity and motor control with 
objective and quantifiable OMs, as all measures assessed were found to reside in the first quartile 
of probability distributions (i.e. used least often).  Respondents use the LLIS and/or QuickDASH 
most often (i.e. fourth quartile of responses) to measure activities and participation.  The 
QuickDASH has been recommended by the Breast Cancer EDGE Task Force and has been 
determined to be a valid and reliable measure for breast cancer survivors53 but not specifically 
for BCRL.  The LLIS is a validated patient-reported HRQOL OM but recent studies using 
COSMIN have not recommended its use on BCRL.54,55  The Lymphoedema Quality of Life 
(LYMQOL) questionnaire was reported as being used by a three (2.7%) of the respondents but 
was not included in the list of OMs on the survey.  This measure was not recommended by the 
Breast Cancer EDGE Task Force and other sources due to poor psychometrics and/or poor 
clinical utility.54–56  The Focus On Therapeutic Outcomes (FOTO) tool was reported as being 
used in the categories of 1) pain, 2) HRQOL, 3) upper quadrant function, 4) fatigue, 5) mobility 
and balance, and 6) upper extremity activity and motor control.  FOTO is a web-based tool that 
uses patient-reported OMs to measure the functional status of patients.  FOTO has a category for 
lymphedema which includes upper and lower extremity OMs and also includes the Fear 
Avoidance Belief – Physical Activity and patient satisfaction self-report questionnaires.  Other 
patient-reported OMs, such as the patient specific functional scale and FACIT fatigue scale can 
be selected for the patient to complete as part of FOTO; however, the list of additional patient-
reported OMs is generated by developer, NetHealth®, and may not be extensive for the needs of 
the patient or clinical practice.  Perhaps more concerning is that the Centers for Medicare and 
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individually for measuring performance….”57  This study has identified OMs that are 
performance-based and patient-reported in the ICF domain of activities and participation.  
Performance-based and patient-reported OMs 
The importance of using both performance-based and patient-reported OMs cannot be 
overstated.  In a 2011 study comparing the two types of OMs on physiologic, psychosocial, and 
health factors influencing rehabilitation care, Bean et al. suggested that their findings revealed 
both performance-based and patient-reported OMs did not provide equivalent information about 
a patient’s functional status and that their use should be chosen based upon the unique settings 
and situations of care.58  These sentiments are expressed by other authors who have investigated 
these two types of OMs; reporting low to moderate correlations between them (r = 0.29 – 0.59, rs 
= 0.45 – 0.74).59,60  In the case of BCRL, it may be prudent to use performance-based OMs for 
UE motor control activities if the interventions being evaluated for efficacy emphasized those 
limitations, while using a patient-reported OM may be more appropriate if the interventions 
being evaluated for efficacy are geared toward independence of BCRL management, activities of 
daily living, skin care, psychosocial factors, and fatigue.   
Group differences and unique predictors to the use of OMs 
Nearly half of the OMs in the third and fourth quartiles demonstrated significant 
differences in usage between PTs and OTs.  This may result in the inability to compare outcomes 
with standardized OMs and can interfere with transition and continuum of care if standardized 
OMs are not routinely used by CLTs, especially when inter-referral patterns exist.  
Specializations14,21 may offer plausible explanation for these differences; however, this 
characteristic does not lend to a consistent explanation.  For instance, there were significant 
group differences in the use of volumeter, pinch dynamometer, monofilament, and two-point 
discrimination with OTs using it most often, which may be attributed to the fact that significantly 
(p < 0.01) more OTs identified as being credentialed hand therapists (19.5%, n = 8) compared to 
PTs (0.0%, n = 0).  This trend is also seen with least often used upper extremity activity and 
motor control OMs (e.g. 9 Hole Peg Test, Perdue Peg Board, and Box and Block Test).  
However, using Chi-square and Fisher’s Exact test to examine associations between 
specializations and the use of OMs revealed that the hand therapy specialization is only 
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0.01).  There may be other reasons for group differences that were not investigated in this study 
such as business practice and professional role identification within a practice.  The mobility and 
balance OMs were most often used by PTs despite that the OTs identified as having specialties in 
geriatrics (14.6%, n = 6) and acute care (19.5%, n = 8) more than PTs ((c2 (1, n = 111) = 10.83, p 
< 0.01), (c2 (1, n = 111) = 5.10, p = 0.03) respectively), and significant group difference were not 
observed for the neurology specialty (p = 0.29).  In fact, those respondents who identified as 
being credentialed in geriatrics and/or neurology used the 9 Hole Peg Test (p = 0.01 and p < 0.01 
respectively), Box and Block Test (p = 0.03 and p < 0.01 respectively), Purdue Peg Board Test 
(p = 0.03 and p < 0.01 respectively), and the Volumeter (p = 0.02 and p = 0.02 respectively).  So, 
while associations exist between credentialed specializations and use of OMs, commonplace 
trends related to profession are not fully evident.  The binary logistic regression explored this 
further by looking at additional factors and covariates that may actually predict the use of the 
OMs.  Significant predictors for the use of OMs included profession (e.g. OT and PT), LANA 
certification, and highest degree earned (e.g. Certification, Bachelors, Masters, Clinical 
Doctorate, Academic Doctorate).  Profession,42,43 specialization,14,21 and highest degree 
earned,14,21 have been previously reported as being associated with use of OMs and our results 
concur to a limited extent.  Of interest was that despite the difference in use of OMs between PTs 
and OTs, profession did not consistently present as a predictor for the same OMs that showed 
differences (Tables IV.4 and IV.5) between profession.  The unique contribution of profession 
and the other predictors to the most often used OMs may also be considered as contributors to 
the facilitators and barriers to the use of OMs and will need further exploration.   
Facilitators and barriers to the use of OMs 
Our study demonstrates a diverse distribution for most facilitators and barriers, which 
will require further future statistical examination and most likely would benefit from a mixed 
methods research study, combining components of quantitative and qualitative research 
strategies, especially in categories of healthcare equality, business structures, and knowledge and 
competence.  Understanding how the predictor variables in this study are associated with the 
facilitators and barriers is of interest for future examination.  Examining the differences of 
opinions on facilitators and barriers between OT and PT CLTs has revealed some shortcomings 
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the use of OMs do not improve quality of care or determine intervention efficacy.  In contrast to 
OTs, more PTs do not agree that the use of OMs increase the efficiency of evaluations and are 
uncertain if their use improves communication with other healthcare stakeholders.  Compared to 
OTs, more PTs disagree that the use of OMs helps in the clinical reasoning for choice of 
interventions on clients with BCRL.  While these professional differences exist, overall the 
respondents value the use of OMs and find them necessary for the interventions and management 
of BCRL which is similar to other studies on EBP and OMs.11,14,42  The CLTs reported that they 
are incorporating CPG and systematic reviews related to BCRL diagnosis and interventions into 
their clinical practice.  However, the use of MMT and LLIS as two OMs used most often for 
evaluations and reevaluations seem to suggest otherwise.  While many respondents reported that 
OMs assisted in the identification of comorbidities, some of the impairment OMs were clinician 
rated.  Furthermore, OMs for patient-reported fatigue, mobility and balance, and UE activity and 
motor control were not frequently used.  These factors can limit a specialist’s ability to identify 
the comorbidities of BCRL, such as proliferative fibrosis and adiposity, and deficits in strength, 
motor control, and balance.  Ninety-five percent of respondents used AROM, MMT, 
circumference, sensation, and tissue consistency OMs most often on BCRL.  However, these 
measures alone limit a specialist’s comprehensive understanding of the chronic condition and 
related comorbidities, bringing into consideration the lack of whole-body assessment and 
interventions.  A concern exists about the barriers related to knowledge and competence.  Lack 
of knowledge of OMs has been investigated as being a barrier to their use.15,21,40,42,43,61  While 
most CLT respondents in our study reported that they had sufficient skills (70%, n = 78) to use 
and interpret the results (64%, n = 71) of OMs for clients with BCRL, only 46% (n = 51) 
reported that they had sufficient knowledge about OMs for BCRL and a majority (67%, n =74) 
reported that they had difficulty knowing the best OM to choose due to numerous options.  A 
majority (68%, n = 75) of respondents agreed that they did not receive sufficient training in their 
professional education on OMs for clients with BCRL.  Whereas, an equal proportion of 
respondents reported that they did (45%, n = 50) or did not (44%, n = 49) receive sufficient 
training in their post-professional CLT courses on OMs for clients with BCRL. This is 
concerning for pre and post-professional educators and researchers.  Extensive choices of OMs 
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Educators, both pre- and postprofessional play a significant role in exposing PTs and OTs to the 
knowledge and skills related to these OMs.   
Education on OMs for BCS with BCRL 
Previous studies suggest that therapists practicing with a specialty tend to use OMs,14,18,21 
and perhaps the best placement for education on OMs for BCRL outside of entry-level OM skill 
sets should be included in the training for CLTs.  LANA provides guidelines promoting 
“standards for the certification of healthcare professionals who help individuals with 
lymphedema and/or related disorders manage their lymphedema and to promote lymphedema 
awareness and the science of lymphology.”62  According to the Policy and Procedures Manual, 
LANA has defined curriculum content that is foundational and required of continuing education 
programs.62  This foundational content includes the theoretical instruction and practical lab work 
for all components of Complete Decongestive Therapy (CDT).62  The manual lacks specific 
language pertaining to curriculum on OMs for the assessments used on individuals with 
lymphedema.  However, in the LANA Candidate Information Booklet, the examination content 
outline delineates topics requiring OMs such as 1) differentiating edema etiologies, and 2) 
conducting examination (e.g. weight, limb appearance, ROM, strength, posture, gait, sensation, 
volume, tissue texture, and skin integrity).32  Identifying OMs with good psychometric properties 
for the examination on BCS with BCRL, including the associated comorbidities, benefits the 
CLT regardless of their professional background (e.g. PT, OT, MT, RN, or physician). 
Consensus-based core outcome set 
Implementing a consensus-based set of outcomes, also known as a core outcome set 
(COS), on BCS with BCRL is a worthy endeavor for all allied stakeholders to capture baseline 
measures and BCRL comorbidities across the ICF domains.  A COS can be an essential 
component of EBP which can be used in clinical trials, assist in the examination of a disorder 
and related comorbidities, and for the purpose of outcome assessment of interventions.10,11  The 
use of a COS can reduce selective reporting on conditions, inconsistency in clinical use, and 
variability of reporting across interdisciplinary medical fields that represent  CLTs who treat 
BCRL.63,64  COSs can lead to improved systematic reviews and meta-analyses by facilitating 
robust effect sizes.  The development of a COS is comprehensive; however, the groundwork has 
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with good psychometrics and clinical utility.  Furthering the cause for a COS for BCS with 
BCRL will require various stakeholders to expand and then refine the list of outcome domains 
identified by the Breast Cancer EDGE Task Force studies, and then process through the Core 
Outcome Measures in Effectiveness Trials (COMET) guidelines.63  Not only is a COS a feasible 
endeavor, but identifying the OMs to measure the COS is certainly within reach, as well as 
providing guidance as to “when” to measure are also attainable.  To that end, this study has 
identified fifteen OMs which PT and OT CLTs tend to use most often.  Most of these trending 
OMs have been recommended by the Breast Cancer EDGE Task Force, however, there are a few 
that are either not recommended or need further review for BCRL usage recommendations.  
LIMITATIONS 
   The number of practicing CLTs in the United States is not documented and CLT 
graduates from the participating institutions ranged from 340 to 3200.  An a priori survey sample 
size of 174 was expected, however, this sample size was abandoned due to the convenience 
sampling method, which prevented management of the emails being distributed, resulted in cross 
over emails from the various institutions, and returned a limited response.  In addition, the 
sample size for the analysis (n = 111) included a sample of OTs and PTs from the total sample (n 
= 130). These factors limit our ability to generalize the findings to the CLT population consisting 
of PT, OT, MT, and RN despite that the sample appears to be unbiased to the true population that 
other national and international studies have reported on.  There is concern that the lack of other 
professions, practice settings, geographical locations, and the male sex may have limited our 
understanding of the use of OMs and the predictive contribution that these characteristics 
provide.  In addition, the density of CLTs that practice in outpatient clinics may have limited 
insights into use of OMs in other settings (e.g. home healthcare, long-term care).  Further 
research will need to seek input from respondents that have these characteristics.  Due to small 
cell counts some data analyses were not feasible.  This may be a result of the multiple response 
option for some survey questions but is also reflective of the sample size.  Further research may 
address this via mixed methodology.   
CONCLUSIONS 
 This study adds to current knowledge by identifying OMs with good psychometrics, as 
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CLTs to measure body functions and body structures, and activities and participation.  OMs used 
most often that assess body functions and structures exceed those OMs for activities and 
participation.  Recommended OMs from the Breast Cancer EDGE Task Force, CPG from the 
Oncology Section of the APTA, and the Dutch Lymphedema Guideline that assess ICF domains 
that were identified as used most often (Table IV.6) in this study include; 1) goniometry PROM 
and 2) goniometry AROM for joint function, 3) stiffness of the glenohumeral joint for flexibility, 
4) hand grip dynamometer for strength, 5) circumference for volume, 6) numeric pain scale for 
pain, 7) pitting edema test for tissue consistency, 8) body weight and 9) BMI for body 
composition, and 10) QuickDash for patient-reported upper quadrant function.  This study also 
adds to current knowledge by identifying a multidisciplinary CLT consensus on other OMs used 
most often (Table IV.6) which include 1) MMT for strength, 2) light touch brushing for 
sensation, 3) tissue texture assessment for tissue consistency, 4) visual analog scale for pain, and 
5) LLIS for patient-reported HRQOL.  This study also identifies OMs being used by CLTs on 
BCS with BCRL that need further investigation for their use, including 1) dynamic motion of the 
scapula, 2) pectoralis major length, 3) MMT, 4) pinch dynamometer, 5) light touch brushing, 6) 
monofilament, 7) sharp-dull discrimination, 8) two-point discrimination, 9) tissue texture 
assessment, 10) LLIS, 11) Berg Balance Scale, 12) functional reach, and 13) five times sit to 
stand.  The use of OMs may be influenced by CLT profession, specialization, and level of 
highest degree.  The differences between PT and OT CLTs use of OMs are sporadic.  Whereas 
PT CLTs seem to use mobility and balance and flexibility OMs more that OTs, OT CLTs use 
sensation and HRQOL OMs more than PTs.  These differences cannot be solely attributed to 
additional credentialed specializations.  However, profession, LANA certification, and highest 
degree earned lend to the prediction of use for some OMs.  In general, CLTs agree on the 
benefits of and to the use of OMs, however, PT CLTs may value the use of OMs less than OTs.  
CLTs also experience barriers to their use related to knowledge and competence of OMs.  These 
barriers foster the need for further guidance in selective OMs for BCS with BCRL and the 
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Table IV.1. Oncology Section Breast Cancer EDGE Task Force,27-29 Upper-Quadrant Lymphedema 
Guideline,30 and Dutch Lymphedema Guideline Recommended Outcome Measures.31 
ICF* Domains of Body Functions 
















Measures of Joint Function 
Goniometry – passive range of 
motion 4   X X 
Goniometry – active range of 
motion 3   X X 
Inclinometer – passive range of 
motion 3     
Inclinometer – active range of 
motion 3     
Measures of Flexibility 
Muscle Length – pectoralis minor 3     
Muscle Length – pectoralis minor 
via Borstad scapular index 3     
Stiffness of glenohumeral joint 3     
Measures of Strength 
Hand grip strength 3   X AI 
Hand-held dynamometry 3   X AI 
Measures of Volume 
Bioelectrical Impedance 
Spectroscopy 4 B    
Circumference 4 B X X X 
Perometer   X X X 
Water Displacement (Volumeter) 4 B X X X 
Measures of Pain 
Brief Pain Inventory 4     
Brief Pain Inventory – Short Form 4     
McGill Pain Questionnaire 4     
McGill Pain Questionnaire – Short 
Form 4     
Numeric Pain Rating Scale 4     
Pain Disability Index 4     
Visual Analog Scale – Pain 4   X X 
Measures of Tissue Consistency 
Pitting Test   X X X 
Ultrasonography  B    
Measures of Body Composition 
Body Weight, Body Mass Index   X X X 
*ICF = International Classification of Functioning, Disability, and Health; EDGE Rating Scale: 4 = Highly 
Recommended, 3 = Recommended; Clinical Practice Guideline Rating Scale: A = Strong Recommendation, B = 
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Table IV.1 cont. Oncology Section Breast Cancer EDGE Task Force,27-29 Upper-Quadrant 
Lymphedema Guideline,30 and Dutch Lymphedema Guideline Recommended Outcome Measures.31 













Measures of Patient Reported Function and QOL 
BREAST-Q 4    
EORTC Quality of Life Questionnaire-Breast 4    
Functional Assessment of Cancer Therapy-
Breast  4    
Functional Assessment of Cancer Therapy-
Breast + 4   4    
Functional Assessment of Cancer Therapy/ 
Gynecologic Oncology Group-Neurotoxicity(v4) 4    
Lymph — ICF Arm  X X  
Upper Limb Lymphedema Measure — 27  X X  
Disability of Arm, Shoulder, and Hand 
Questionnaire  4  AI AI 
Penn Shoulder Score  4    
QuickDASH 3    
Shoulder Pain and Disability Index  4    
Shoulder Rating Questionnaire  4    
Measures of Fatigue 
Bi-Dimensional Fatigue Scale /Chalder/ Fatigue 
Questionnaire 3    
Brief Fatigue Inventory  4    
Diagnostic Interview for Cancer-Related Fatigue  3    
FACT-B 4    
Fatigue Symptom Inventory  3    
Functional Assessment of Chronic Illness 
Therapy – Fatigue 3    
MOS-SF36/Rand/Vitality 3    
Multidimensional Fatigue Symptom Inventory  4    
Piper Fatigue Scale Revised  3    
Profile of Mood States Fatigue/Vigor and 
Fatigue/Inertia Subscales 3    
Visual Analog Scale 3  AI AI 
Wu Cancer Fatigue Scale 3    
Measures of Mobility and Balance 
6-Minute Walk Test 3    
Fullerton Advanced Balance Scale 3    
Gait Analysis   AI AI 
Timed Up and Go  3    
*ICF = International Classification of Functioning, Disability, and Health; EDGE Rating Scale: 4 = Highly 
Recommended, 3 = Recommended; Clinical Practice Guideline Rating Scale: A = Strong Recommendation, B = 
Moderate Recommendation; AI = As Indicated 
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Table IV.2.  Demographic Characteristics.   





Occupation                              n (%) 41 (37%) 70 (63%)  
Age (years) (n = 111) 48 + 11.2 48 + 10.3 t = -0.27, p = 0.79 
Sex                                            n (%) 
Female 
Male 
 40 (97.6%) 
 1 (2.4%) 
 69 (98.6%) 
 1 (1.4%) 
p = 1.00# 
Ethnicity                                  n (%) 
Asian 
Black or African American 
Other 
Prefer not to answer 
White 
 4 (9.8%) 
 1 (2.4%) 
 0 (0%) 
 1 (2.4%) 
 35 (85.4%) 
 1 (1.4%) 
 1 (1.4%) 
 3 (4.3%) 
 0 (0%) 
 65 (92.9%) 
p = 0.06# 
Highest Degree Earned          n (%) 
Bachelor of Arts or Science 
 Master of Arts or Science 
Clinical Doctorate 
 12 (29.3%) 
 21 (51.2%) 
 8 (19.5%) 
 17 (24.3%) 
 18 (25.7%) 
 35 (50%) 
c2 = 11.24,  
p < 0.01* 
Years in Practice (n = 104) 22 + 12.5 23 + 11.2 t = -0.67, p = 0.50 
Practice Specialization^         n (%) 
Acute care 













Have a Specialization 
Not Specialized 
 8 (19.5%) 
 1 (2.4%) 
 6 (14.6%) 
 8 (19.5%) 
 5 (12.2%) 
 5 (12.2%) 
 0 (0%) 
 11 (26.8%) 
 5 (12.2%) 
 1 (2.4%) 
 1 (2.4%) 
 15 (36.6%) 
 4 (9.8%) 
 
 26 (63.4%) 
 15 (36.6%) 
 4 (5.7%) 
 1 (1.4%) 
 0 (0%) 
 0 (0%) 
 7 (10%) 
 4 (5.7%) 
 1 (1.4%) 
 14 (20%) 
 9 (12.9%) 
 1 (1.4%) 
 3 (4.3%) 
 41 (58.6%) 
 9 (12.9%) 
 
 29 (41.4%) 
 41 (58.6%) 
c2 = 5.10, p = 0.03* 
p = 1.00# 
c2 = 10.83, p <0.01* 
c2 = 14.72, p <0.01* 
p = 0.76# 
p = 0.29# 
p = 1.00# 
c2 = 0.69, p = 0.48 
c2 = 0.01, p = 1.00 
p = 1.00# 
p = 1.00# 
c2 = 5.00, p = 0.03* 
p = 0.76# 
 
c2 = 5.00,  
p = 0.03* 
* = Significant, +Mann-Whitney U test, # = Fisher’s Exact test, ^ = Multiple response variable; n (% of 
cases).  CLT = Certified Lymphedema Therapist, ACOLS = Academy of Lymphatic Studies, ILWTI = 
International Lymphedema and Wound Training Institute, LLCC = LDT Lymphedema Complex 
Decongestive Therapy Certification, UWM = University of Wisconsin Milwaukee 












Table IV.2. continued 





CLT Institution Attended^     n (%) 
ACOLS 
Casley-Smith 
Dr. Vodder School International 
ILWTI 
Klose Training Lymphedema Cert. 
Norton School of Lymphatic Therapy 
Pacific Therapy Education, Inc. 
Upledger – Chikly LLCC 
UWM Lymphedema Therapist Cert. 
Other School 
 19 (46.3%) 
 2 (4.9%) 
 0 (0%) 
 0 (0%) 
 9 (22%) 
 6 (14.6%) 
 1 (2.4%) 
 0 (0%) 
 9 (22%) 
 1 (2.4%) 
 26 (37.1%) 
 1 (1.4%) 
 2 (2.9%) 
 2 (2.9%) 
 18 (25.7%) 
 18 (25.7%) 
 1 (1.4%) 
 2 (2.9%) 
 1 (1.4%) 
 7 (10%) 
 
p = 0.42# 
p = 0.55# 
p = 0.53# 
p = 0.53# 
c2 = 0.19, p = 0.82 
c2 = 1.87, p = 0.23 
p = 1.00# 
p = 0.53# 
c2 = 13.29, p < 0.01 
p = 0.25# 
Years as CLT (n = 111) 11 + 7.6 11 + 10.0 U = 1310, p = 0.73+ 
LANA Certified                       n (%)  23 (56.1%)  48 (68.5%) c2 = 1.75, p = 1.86 
 
* = Significant, +Mann-Whitney U test, ^ = Multiple response variable; n (% of cases), CLT = 
Certified Lymphedema Therapist, ACOLS = Academy of Lymphatic Studies, ILWTI = International 
Lymphedema and Wound Training Institute, LLCC = LDT Lymphedema Complex Decongestive 
Therapy Certification, UWM = University of Wisconsin Milwaukee 












Table IV.3. Practice Characteristics. 





Type of Practice Setting          n (%) 
Acute & Subacute Care 
 Outpatient Clinic 
 4 (9.8%) 
 37 (90.2%) 
 3 (4.3%) 
 67 (95.7%) 
 
p = 0.42# 







Neither US or Canada 
 17 (41.4%) 
 5 (12.2%) 
 11 (26.8%) 
 4 (9.8%) 
 4 (9.8%) 
 0 (0%) 
 17 (24.3%) 
 19 (27.2%) 
 14 (20%) 
 7 (10%) 
 12 (17.1%) 
 1 (1.4%) 
p = 0.20# 




 15 (36.6%) 
 12 (29.3%) 
 14 (34.1%) 
 8 (11.4%) 
 35 (50%) 
 27 (38.6%) 
c2 = 10.66, p < 0.01* 
% of practice devoted to 
lymphedema treatment 66 + 31.7 63.1 + 27.8 U = 1283, p = 0.35
+ 
Number of BCRL clients in eight 
hours work day 3 + 2.0 4 + 3.4 U = 1683, p = 0.07
+ 
Minutes allocated for initial 
evaluation 61 + 24.6 59 + 13.2 U = 1278, p = 0.29
+ 
Minutes allocated for re-evaluation 54 + 20.6 55 + 11.2 U = 1411, p = 0.87+ 
Hours per week providing 
lymphedema treatment 14 + 13.2 15 + 10.7 U = 1550, p = 0.39
+  
% of patients in age group 
< 21 years 
21 – 40 years 
41 – 60 years 
61 – 75 years 
> 75 years 
0.25 + 1.1 
14.4 + 13.2 
39.0 + 19.5 
32.8 + 16.0 
13.9 + 12.4 
0.96 + 6.0 
14.6 + 10.3 
41.6 + 15.0 
30.6 + 14.8 
12.5 + 12.0 
U = 1487, p = 0.48+ 
U = 1539, p = 0.52+ 
U = 1649, p = 0.19+ 
U = 1329, p = 0.51+ 
U = 1319, p = 0.47+ 
* = Significant, # = Fisher’s exact test, +Mann-Whitney U test, PT = Physical Therapists, OT = Occupational 
Therapists, BCRL = Breast Cancer Related Lymphedema, CVI = Chronic Venous Insufficiency, LE = 
Lymphedema 













Table IV.3. continued 





Treat Other Conditions      n (%) 




Head and Neck LE 
Lipedema 
Neurological 








 16 (39%) 
 40 (97.6%) 
 4 (9.8%) 
 30 (73.2%) 
 31 (75.6%) 
 21 (51.2%) 
 28 (68.3%) 
 36 (87.8%) 
 25 (61%) 
 31 (75.6%) 
 33 (80.5%) 
 36 (87.8%) 
 0 (0%) 
 3 (7.3%) 
 29 (41.4%) 
 59 (84.3%) 
 4 (5.7%) 
 62 (88.6%) 
 59 (84.3%) 
 37 (52.9%) 
 54 (77.1%) 
 46 (65.7%) 
 34 (48.6%) 
 43 (61.4%) 
 57 (81.4%) 
 3 (4.3%) 
 2 (2.9%) 
 3 (4.3%) 
c2 = 0.06, p = 0.80 
p = 0.05#* 
p = 0.46# 
c2 = 4.32, p = 0.04* 
c2 = 1.27, p = 0.26 
c2 = 0.03, p = 0.87 
c2 = 1.05, p = 0.31 
c2 = 6.54, p = 0.01* 
c2 = 1.60, p = 0.21 
c2 = 2.34, p = 0.13 
c2 = 0.02, p = 0.90 
c2 = 7.25, p = 0.01* 
p = 0.53# 
p = 0.67# 
* = Significant, # = Fisher’s Exact test. PT = Physical Therapists, OT = Occupational 
Therapists, BCRL = Breast Cancer Related Lymphedema, CVI = Chronic Venous 
Insufficiency, LE = Lymphedema.  ^ = Multiple response variable; n (% of cases) 
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Table IV.4. Group Differences in Use of Outcome Measures in the 3rd and 4th Quartiles that Measure ICF 
Domains of Body Functions and Body Structures. 
Domain 
 












Dynamic Motion of Scapula 
Use at some frequency 
Do not use 
Goniometer PROM 
Use at some frequency 
Do not use 
Goniometer AROM 
Use at some frequency 
Do not use                                     
 23 (56.1%) 
 18 (43.9%)¨ 
 
 37 (90.2%) 
 4 (9.8%) 
 
 40 (97.6%) 
1 (2.4%)
 53 (75.7%)¨ 
 17 (24.3%) 
 
 69 (98.6%) 
 1 (1.4%) 
 
 70 (100%) 
0 (0%) 
 76 (68.5%) 
 35 (31.5%) 
 
 106 (95.5%) 
 5 (4.5%) 
 
 110 (99.1%) 
 1 (0.9%) 
c2 = 4.61, p = 0.04* 
 
 
p = 0.06# 
 
p = 0.37# 
 
Flexibility 
Pectoralis Major Length 
Use at some frequency 
Do not use 
Pectoralis Minor Length 
Use at some frequency 
Do not use 
Stiff Glenohumeral Joint 
Use at some frequency 
Do not use  
 
 20 (48.8%) 
 21 (51.2%)¨ 
 
 18 (43.9%) 
 23 (56.1%)¨ 
 
 35 (85.4%) 
 6 (14.6%)¨ 
 
 61 (87.1%)¨ 
 9 (12.9%) 
 
 59 (84.3%)¨ 
 11 (15.7%) 
 
 69 (98.6%)¨ 
 1 (1.4%) 
 
 81 (73%) 
 30 (27%) 
 
 77 (69.4%) 
 34 (30.6%) 
 
 104 (93.7%) 
 7 (6.3%) 
 
c2 = 19.29, p < 0.01* 
 
 
c2 = 19.84, p < 0.01* 
 
 
p < 0.01*# 
 
Strength 
Hand Grip Dynamometer 
Use at some frequency 
Do not use 
Hand Held Dynamometry 
Use at some frequency 
Do not use 
Manual Muscle Test 
Use at some frequency 
Do not use 
Pinch Dynamometer 
Use at some frequency 
Do not use 
 
 38 (92.7%) 
 3 (7.3%) 
 
 26 (63.4%) 
 15 (36.6%) 
 
 40 (97.6%) 
 1 (2.4%) 
 
 38 (92.7%)¨ 
 3 (7.3%) 
 
 60 (85.7%) 
 10 (14.3%) 
 
 46 (65.7%) 
 24 (34.3%) 
 
 69 (98.6%) 
 1 (1.4%) 
 
 35 (50%) 
 35 (50%)¨ 
 
 98 (88.3%) 
 13 (11.7%) 
 
 72 (64.9%) 
 39 (35.1%) 
 
 109 (98.2%) 
 2 (1.8%) 
 
 73 (65.8%) 
 38 (34.2%) 
 
p = 0.37# 
 
 
c2 = 0.06, p = 0.84 
 
 
p = 1.00# 
 
 
c2 = 20.92, p < 0.01* 
 
Volume and/or TWC 
Circumferential Measurements/ 
Calculated Volume 
Use at some frequency 
Do not use 
 40 (97.6%) 
 1 (2.4%) 
 70 (100%) 
 0 (0%) 
 110 (99.1%) 
 1 (0.9%) 
p = 0.37 
 
* = Significant, # = Fisher’s Exact test, ¨standardized residuals and % were used to demonstrate strength of the 
group to the Chi-square value, CLT = Certified Lymphedema Therapist, IFC = International Classification of 
Functioning, Disability and Health, PT = Physical Therapists, OT = Occupational Therapists, TWC = Tissue 
Water Content. 
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Table IV.4. continued. 
Domain 
 












Numeric Pain Scale 
Use at some frequency 
Do not use 
Visual Analog Scale 
Use at some frequency 
Do not use 
 39 (95.1%) 
 2 (4.9%) 
 
 32 (78%) 
 9 (22%) 
 66 (94.3%) 
 4 (5.7%) 
 
 60 (85.7%) 
 10 (14.3%) 
 105 (94.6%) 
 6 (5.4%) 
 
 92 (82.9%) 
 19 (17.1%) 
p = 1.00# 
 
 
c2 = 1.07, p = 0.43 
 
Sensation 
Light Touch Brushing 
Use at some frequency 
Do not use 
Monofilament 
Use at some frequency 
Do not use 
Sharp-Dull Discrimination 
Use at some frequency 
Do not use 
Two-Point Discrimination 
Use at some frequency 
Do not use 
 
 38 (92.7%) 
 3 (7.3%) 
 
 31 (75.6%)¨ 
 10 (24.4%) 
 
 34 (82.9%) 
 7 (17.1%) 
 
 32 (78%)¨ 
 9 (22%) 
 
 68 (97.1%) 
 2 (2.9%) 
 
 38 (54.3%) 
 32 (45.7%)¨ 
 
 46 (65.7%) 
 24 (34.3%) 
 
 39 (55.7%) 
 31 (44.3%)¨ 
 
 106 (95.5%) 
 5 (4.5%) 
 
 69 (62.2%) 
 42 (37.8%) 
 
 80 (72.1%) 
 31 (27.9%) 
 
71 (64%) 
 40 (36%) 
 
p = 0.36# 
 
 
c2 = 4.99, p = 0.03* 
 
 
c2 = 3.81, p = 0.08 
 
 
c2 = 5.60, p = 0.02* 
 
Tissue Consistency 
Pitting Edema Test – Palpation 
Use at some frequency 
Do not use 
Tissue Texture – Palpation 
Use at some frequency 
Do not use 
 39 (95.1%) 
 2 (4.9%) 
 
 39 (95.1%) 
 2 (4.9%) 
 70 (100%) 
 0 (0%) 
 
 69 (98.6%) 
 1 (1.4%) 
 109 (98.2%) 




p = 0.13# 
 
 




Use at some frequency 
Do not use 
Body Mass Index 
Use at some frequency 
Do not use 
 40 (97.6%) 
 1 (2.4%) 
 
 37 (90.2%) 
 4 (9.8%) 
 61 (87.1%) 
 9 (12.9%) 
 
 58 (82.9%) 
 12 (17.1%) 
 101 (91%) 
 10 (9%) 
 
 95 (85.6%) 
 16 (14.4%) 
p = 0.09# 
 
 
c2 = 1.14, p = 0.40 
 
* = Significant, # = Fisher’s Exact test, ¨standardized residuals and % were used to demonstrate strength of the 
group to the Chi-square value, PT = Physical Therapists, OT = Occupational Therapists 
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Table IV.5. Group Differences in Use of Outcome Measures in the 3rd and 4th Quartiles that Measure ICF 
Domains of Activities and Participation. 
Domain 
 












Lymphedema Life Impact Scale 
Use at some frequency 
Do not use 
 
 38 (92.7%)¨ 
 3 (7.3%) 
 54 (77.1%) 
 16 (22.9%)¨ 
 92 (82.9%) 
 19 (17.1%) 





Use at some frequency 
Do not use 
QuickDASH 
Use at some frequency 
Do not use 
 
 33 (80.5%) 
 8 (19.5%) 
 
 38 (92.7%) 
 3 (7.3%) 
 
 48 (68.6%) 
 22 (31.4%) 
 
 57 (81.4%) 
 13 (18.6%) 
 
 81 (73%) 
 30 (27%) 
 
 95 (85.6%) 
 16 (14.4%) 
 
c2 = 1.86, p = 0.19 
 
 
c2 = 2.66, p = 0.16 
 
Patient-Reported Fatigue  
Visual Analog Scale 
Use at some frequency 
Do not use 
 
 17 (41.5%) 
 24 (58.5%)¨ 
 
 44 (62.9%)¨ 
 26 (37.1%) 
 
 61 (55%) 
 50 (45%) 
 
c2 = 4.78, p = 0.03* 
 
Mobility and Balance 
Berg Balance Scale 
Use at some frequency 
Do not use 
Functional Reach 
Use at some frequency 
Do not use 
Timed Up and Go 
Use at some frequency 
Do not use 
5x Sit to Stand 
Use at some frequency 
Do not use 
6 Minute Walk Test 
Use at some frequency 
Do not use 
 21 (51.2%) 
 20 (48.8%)¨ 
 
 20 (48.8%) 
 21 (51.2%) 
 
 22 (53.7%) 
 19 (46.3%)¨ 
 
 11 (26.8%) 
 30 (73.2%)¨ 
 
 12 (29.3%) 
 29 (70.7%)¨ 
 54 (77.1%)¨ 
 16 (22.9%) 
 
 39 (55.7%) 
 31 (44.3%) 
 
 59 (84.3%)¨ 
 11 (15.7%) 
 
 50 (71.4%)¨ 
 20 (28.6%) 
 
 44 (62.9%)¨ 
 26 (37.1%) 
 75 (67.6%) 
 36 (32.4%) 
 
 59 (53.2%) 
 52 (46.8%) 
 
 81 (73%) 
 30 (27%) 
 
 61 (55%) 
 50 (45%) 
 
 56 (50.5%) 
 55 (49.5%) 
c2 = 7.93, p < 0.01* 
 
 
c2 = 0.50, p = 0.56 
 
 
c2 = 12.30, p < 0.01* 
 
 
c2 = 20.78, p < 0.01* 
 
 
c2 = 11.67, p < 0.01* 
 
UE Activity & Motor Control NA NA NA NA 
* = Significant, # = Fisher’ s Exact test, ¨standardized residuals and % were used to demonstrate strength of the 
group to the Chi-square value, NA = OMs did not meet 50% threshold, CLT = Certified Lymphedema Therapist, 
ICF = International Classification of Functioning, Disability and Health, PT = Physical Therapists, OT = 
Occupational Therapists, HRQOL = Health Related Quality of Life, UQ = Upper Quadrant, DASH = Disability 
of Arm, Shoulder, and Hand  
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Table IV.6. Outcome Measures Divided in Quartile Probability Distributions.* 
Outcome Measure Frequently 
Used n (%) 
Occasionally 
Used n (%) 
Seldom 
Used n (%) 
Do Not Use 
N (%) 75.1% – 100% 
Circumferential Measurements 106 (95.5%) 2 (1.8%) 2 (1.8%) 1 (0.9%) 
Tissue Texture – Palpation 105 (94.6%) 2 (1.8%) 1 (0.9%) 3 (2.7%) 
Pitting Edema Test – Palpation 104 (93.7%) 4 (3.6%) 1 (0.9%) 2 (1.8%) 
Numeric Pain Scale 104 (93.7%) 0 (0.0%) 1 (0.9%) 6 (5.4%) 
Goniometer AROM 100 (90.1%) 7 (6.3%) 3 (2.7%) 1 (0.9%) 
Manual Muscle Test 88 (79.3%) 19 (17.1%) 2 (1.8%) 2 (1.8%) 
Stiff Glenohumeral Joint 73 (65.8%) 23 (20.7%) 8 (7.2%) 7 (6.3%) 
Goniometer PROM 69 (62.2%) 22 (19.8%) 15 (13.5%) 5 (4.5%) 
Light Touch Brushing 67 (60.4%) 25 (22.5%) 14 (12.6%) 5 (4.5%) 
QuickDASH 67 (60.4%) 13 (11.7%) 15 (13.5%) 16 (14.4%) 
Body Weight 65 (58.6%) 24 (21.6%) 12 (10.8%) 10 (9.0%) 
Lymphedema Life Impact Scale 65 (58.6%) 17 (15.3%) 10 (9.0%) 19 (17.1%) 
Visual Analog Scale - Pain 65 (58.6%) 13 (11.7%) 14 (12.6%) 19 (17.1%) 
Body Mass Index 61 (55.0%) 20 (18.0%) 14 (12.6%) 16 (14.4%) 
Hand Grip Dynamometer 38 (34.2%) 31 (28.0%) 29 (26.1%) 13 (11.7%) 
50.1% - 75%     
Pectoralis Major Length 52 (46.9%) 16 (14.4%) 13 (11.7%) 30 (27.0%) 
DASH 47 (42.4%) 19 (17.1%) 15 (13.5%) 30 (27.0%) 
Pectoralis Minor Length 44 (39.7%) 20 (18.0%) 13 (11.7%) 34 (30.6%) 
Visual Analog Scale - Fatigue 35 (31.5%) 12 (12.6%) 12 (10.9%) 50 (45.0%) 
Dynamic Motion of Scapula 34 (30.7%) 20 (18.0%) 22 (19.8%) 35 (31.5%) 
Timed Up and Go 31 (28.0%) 35 (31.5%) 15 (13.5%) 30 (27.0%) 
Five Times Sit to Stand 28 (25.3%) 15 (13.5%) 18 (16.2%) 50 (45.0%) 
Hand Held Dynamometry 23 (20.7%) 24 (21.6%) 25 (22.5%) 39 (35.2%) 
Berg Balance Scale 22 (19.8%) 34 (30.6%) 19 (17.1%) 36 (32.5%) 
Pinch Dynamometer 19 (17.1%) 19 (17.1%) 35 (31.5%) 38 (34.3%) 
Six Minute Walk Test 18 (16.2%) 22 (19.8%) 16 (14.4%) 55 (50.0%) 
Sharp-Dull Discrimination 17 (15.3%) 33 (29.8%) 30 (27.0%) 31 (27.9%) 
Functional Reach 13 (11.7%) 22 (19.8%) 24 (21.6%) 52 (46.9%) 
Two-Point Discrimination 9 (8.2%) 26 (23.4%) 36 (32.4%) 40 (36.0%) 
Monofilament 9 (8.2%) 26 (23.4%) 34 (30.6%) 42 (37.8%) 
25.1% - 50%     
Upper Extremity Functional Index 19 (17.1%) 11 (9.9%) 13 (11.7%) 68 (61.3%) 
Pain Disability Index 17 (15.3%) 10 (9.0%) 19 (17.1%) 64 (58.6%) 
Brief Fatigue Inventory 14 (12.6%) 13 (11.7%) 9 (8.1%) 75 (67.6%) 
Brief Pain Inventory 14 (12.6%) 6 (5.4%) 19 (17.1%) 72 (64.9%) 
Shoulder Pain and Disability Index 12 (10.8%) 13 (11.7%) 20 (18.0%) 66 (59.5%) 
Nine Hole Peg Test 12 (10.8%) 7 (6.3%) 15 (13.5%) 77 (69.4%) 
Two Minute Walk Test 11 (9.9%) 21 (18.9%) 18 (16.2%) 16 (55.0%) 
Breast Cancer Questionnaire 11 (9.9%) 9 (8.1%) 9 (8.1%) 82 (73.9%) 
*Listed in quantiles of 0-25%, 25.1-50%, 50.1%-75%, 75.1%-100%.  Each quartile is listed in 
descending order based on Frequently Used.  AROM = Active Range of Motion, PROM = Passive Range 
of Motion, DASH = Disabilities of the Arm, Shoulder, and Hand.  Bolded text denotes OMs 
systematically assessed by Breast Cancer Edge Task Force and/or Dutch Lymphedema Guidelines. 
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Table IV.6. continued.* 
Outcome Measure Frequently Used n (%) 
Occasionally 
Used n (%) 
Seldom 
Used n (%) 
Do Not Use 
N (%) 
25.1% - 50%     
One-Repetition Maximum 10 (9.0%) 11 (9.9%) 31 (27.9%) 59 (53.2%) 
Brief Pain Inventory – Short Form 10 (9.0%) 10 (9.0%) 18 (16.2%) 73 (65.8%) 
Functional Independence Measure 10 (9.0%) 10 (9.0%) 14 (12.6%) 77 (69.4%) 
FACT-B 7 (6.3%) 7 (6.3%) 13 (12.6%) 75 (74.8%) 
McGill Pain Questionnaire – Short 
Form 5 (4.5%) 4 (3.6%) 19 (17.1%) 83 (74.8%) 
Activities-Specific Balance Confidence 
Scale 4 (3.6%) 14 (12.6%) 13 (11.7%) 80 (72.1%) 
Inclinometer AROM 4 (3.6%) 9 (8.1%) 19 (17.1%) 79 (71.2%) 
Vibration/Tuning Fork 3 (2.7%) 11 (9.9%) 32 (28.8%) 65 (58.6%) 
Inclinometer PROM 3 (2.7%) 5 (4.5%) 22 (19.8%) 81 (73.0%) 
0% - 25%     
Bioelectrical Impedance Spectroscopy 
– Volume 14 (12.6%) 2 (1.8%) 7 (6.3%) 88 (79.3%) 
Bioelectrical Impedance Analysis – 
Body Composition 12 (10.8%) 3 (2.7%) 3 (2.7%) 93 (83.8%) 
Lymphoedema Functioning Disability 
and Health Questionnaire 10 (9.0%) 9 (8.1%) 5 (4.5%) 87 (78.4%) 
Barthel Index 8 (7.2%) 7 (6.3%) 12 (10.8%) 84 (75.7%) 
Upper Limb Lymphedema Measure 6 (5.4%) 7 (6.3%) 5 (4.5%) 93 (83.8%) 
Functional Assessment of Cancer 
Therapy – Breast +4 6 (5.4%) 4 (3.6%) 11 (9.9%) 90 (81.1%) 
Penn Shoulder Score 6 (5.4%) 1 (0.9%) 5 (4.5%) 99 (89.2%) 
Pectoralis Minor Length – Borstad 5 (4.5%) 6 (5.4%) 13 (11.7%) 87 (78.4%) 
Perometry 4 (3.6%) 1 (0.9%) 5 (4.5%) 101 (91.0%) 
Purdue Pegboard 3 (2.7%) 12 (10.8%) 11 (9.9%) 85 (76.6%) 
Shoulder Disability Questionnaire 3 (2.7%) 8 (7.2%) 12 (10.8%) 88 (79.3%) 
Functional Assessment of Cancer 
Therapy Breast 3 (2.7%) 8 (7.2%) 10 (9.0%) 90 (81.1%) 
Balance Evaluation Systems Test 3 (2.7%) 5 (4.5%) 8 (7.2%) 95 (85.6%) 
McGill Pain Questionnaire 3 (2.7%) 4 (3.6%) 18 (16.2%) 86 (77.5%) 
Breast – Q 3 (2.7%) 3 (2.7%) 9 (8.1%) 96 (86.5%) 
Diagnostic Interview for Cancer 
Related Fatigue 3 (2.7%) 2 (1.8%) 3 (2.7%) 103 (92.8%) 
Fullerton Advanced Balance Scale 2 (1.8%) 5 (4.5%) 8 (7.2%) 96 (86.5%) 
Box and Block Test 2 (1.8%) 3 (2.7%) 9 (8.1%) 97 (87.4%) 
FACT/Gynecologic Oncology Group 
Neurotoxicity (v4) 2 (1.8%) 3 (2.7%) 8 (7.2%) 98 (88.3%) 
Short Performance Physical Battery 1 (0.9%) 5 (4.5%) 6 (5.4%) 99 (89.2%) 
Ultrasonography 1 (0.9%) 2 (1.8%) 4 (3.6%) 104 (93.7%) 
*Listed in quantiles of 0-25%, 25.1-50%, 50.1%-75%, 75.1%-100%.  Each quartile is listed in descending 
order based on Frequently Used.  FACT = Functional Assessment of Cancer Therapy, AROM = Active 
Range of Motion, PROM = Passive Range of Motion. 



















Table IV.6. continued.* 
Outcome Measure Frequently Used n (%) 
Occasionally 
Used n (%) 
Seldom 
Used n (%) 
Do Not Use 
N (%) 
0% - 25%     
EORTC Quality of Life 
Questionnaire – Breast 1 (0.9%) 2 (1.8%) 7 (6.3%) 101 (91.0%) 
Myoton – Tissue Consistency 1 (0.9%) 2 (1.8%) 6 (5.4%) 102 (91.9%) 
Shoulder Rating Questionnaire 1 (0.9%) 2 (1.8%) 6 (5.4%) 102 (91.9%) 
Functional Assessment of Chronic 
Illness Therapy – Fatigue 1 (0.9%) 2 (1.8%) 5 (4.5%) 103 (92.8%) 
Tissue Dielectric Constant 1 (0.9%) 1 (0.9%) 4 (3.6%) 105 (94.6%) 
Ruler Drop Test/ReacStick 1 (0.9%) 0 (0.0%) 7 (6.3%) 103 (92.8%) 
Wu Cancer Fatigue 1 (0.9%) 0 (0.0%) 4 (3.6%) 106 (95.5%) 
Multidimensional Fatigue Symptom 
Inventory 1 (0.9%) 0 (0.0%) 3 (2.7%) 107 (96.4%) 
Water Displacement/Volumeter 0 (0.0%) 10 (9.0%) 13 (11.7%) 88 (79.3%) 
Fatigue Symptom Inventory 0 (0.0%) 7 (6.3%) 5 (4.5%) 99 (89.2%) 
Functional Living Index – Cancer 0 (0.0%) 5 (4.5%) 8 (7.2%) 98 (88.3%) 
Skin Fibrometer 0 (0.0%) 2 (1.8%) 4 (3.6%) 105 (94.6%) 
Finger Tapper Test 0 (0.0%) 2 (1.8%) 4 (3.6%) 105 (94.6%) 
MOS-SF36/Rand/Vitality 0 (0.0%) 2 (1.8%) 3 (2.7%) 106 (95.5%) 
Action Research Arm Test 0 (0.0%) 1 (0.9%) 8 (7.2%) 102 (91.9%) 
Tonometry 0 (0.0%) 1 (0.9%) 7 (6.3%) 103 (92.8%) 
Profile of Mood States 
Fatigue/Vigor and Fatigue/Inertia 
Subscales 0 (0.0%) 1 (0.9%) 4 (3.6%) 106 (95.5%) 
Piper Fatigue Scale Revised 0 (0.0%) 0 (0.0%) 5 (4.5%) 106 (95.5%) 
Short Form Wolf Motor Function 
Test 0 (0.0%) 0 (0.0%) 5 (4.5%) 106 (95.5%) 
Nine Item Arm Motor Ability Test 0 (0.0%) 0 (0.0%) 5 (4.5%) 106 (95.5%) 
3D Imaging 0 (0.0%) 0 (0.0%) 4 (3.6%) 107 (96.4%) 
Myoton – Body Composition 0 (0.0%) 0 (0.0%) 4 (3.6%) 107 (96.4%) 
Bi-Dimensional Fatigue Scale 0 (0.0%) 0 (0.0%) 4 (3.6%) 107 (96.4%) 
Chalder Fatigue Questionnaire 0 (0.0%) 0 (0.0%) 3 (2.7%) 108 (97.3%) 
*Listed in quantiles of 0-25%, 25.1-50%, 50.1%-75%, 75.1%-100%.  Each quartile is listed in 
descending order based on Frequently Used.  EORTC = European Organization for Research and 
Treatment of Cancer 









Table IV.7. Multicollinearity of Independent Variables. 
Variable Tolerance* VIF# 
Profession 0.85 1.17 
Highest Degree 0.74 1.36 
Years in Practice 0.55 1.81 
Practice Specialization 0.88 1.14 
LANA Certified 0.82 1.21 
Years as CLT 0.58 1.73 
Practice Setting 0.95 1.06 
Initial Evaluation Minutes 0.88 1.13 
*= values less than 0.1 should be investigated.  # = Variance 
Inflation Factor: values above 10 are an indication of 
multicollinearity.  For weaker models, values > 2.5 is of 
concern.   
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Table IV.8. Facilitators and Barriers to Use of Outcome Measures. 
Category Agree  Neither Agree or Disagree  Disagree  
Beliefs of the Therapist n (%) n (%) n (%) 
The use of OMs is necessary for the practice of BCRL treatment 
and management. (n = 111) 105 (94.6%) 2 (1.8%) 4 (3.6%) 
The use of OMs for clients with BCRL places unreasonable 
demand on the practitioner. (n = 110) 32 (29.1%) 23 (20.9%) 55 (50.0%) 
The use of OMs improves quality of care toward clients with 
BCRL. (n =111) 85 (76.6%) 12 (10.8%) 14 (12.6%) 
The use of OMs helps direct the plan of care for clients with 
BCRL. (n = 111) 100 (90.1%) 7 (6.3%) 4 (3.6%) 
The use of outcome measures helps in the clinical reasoning for 
choice of interventions on clients with BCRL. (n = 111) 86 (77.5%) 10 (9.0%) 15 (13.5%) 
The use of OMs improves communication with clients who have 
BCRL. (n = 111) 89 (80.2%) 18 (16.2%) 4 (3.6%) 
The use of OMs improves communication with other healthcare 
stakeholders. (n = 111) 85 (76.6%) 15 (13.5%) 11 (9.9%) 
The use of OMs increases the efficiency of evaluations with 
clients who have BCRL. (n = 111) 56 (50.5%) 20 (18.0%) 35 (31.5%) 
OMs help to motivate and encourage clients with BCRL in the 
treatment and management of their condition. (n = 111) 66 (59.5%) 28 (25.2%) 17 (15.3%) 
Knowledge and Competence    
I have sufficient knowledge about OMs for clients with BCRL. 
(n = 111) 51 (46.0%) 17 (15.3%) 43 (38.7%) 
I have sufficient skills to use OMs for clients with BCRL. 
(n = 111) 78 (70.3%) 13 (11.7%) 20 (18.0%) 
The interpretation of the results obtained by OMs are easily 
interpreted for clinical reasoning pertaining to BCRL. (n = 110) 71 (64.5%) 19 (17.3%) 20 (18.2%) 
I have the ability to access current research pertaining to BCRL 
through professional journals. (n =110) 86 (78.2%) 4 (3.6%) 20 (18.2%) 
With so many OMs, I do not know the best option to choose to use 
on my clients with BCRL. (n = 110) 74 (67.3%) 17 (15.4%) 19 (17.3%) 
I consistently incorporate CPG and systematic reviews related to 
BCRL diagnosis and interventions (n = 110) 88 (80.0%) 17 (15.5%) 5 (4.5%) 
I received sufficient training in using various OMs on clients with 
BCRL (n = 110) 40 (36.4%) 23 (20.9%) 47 (42.7%) 
I received sufficient training about OM for clients with BCRL in 
my professional training (n = 110) 25 (22.7%) 10 (9.1%) 75 (68.2%) 
I received sufficient training about OM for clients with BCRL in 
my post-professional CLT course(s) (n = 110) 50 (45.5%) 11 (10.0%) 49 (44.5%) 
Healthcare Practice    
OMs are important for assisting in the identification of 
comorbidities in clients with BCRL. (n = 110) 96 (87.3%) 10 (9.1%) 4 (3.6%) 
The use of OMs is necessary to determine treatment efficacy for 
clients with BCRL. (n = 110) 80 (72.7%) 16 (14.5%) 14 (12.8%) 
The use of OMs is part of my personal practice model. (n = 110) 90 (81.8%) 12 (10.9%) 8 (7.3%) 
Clients with BCRL request that I use OMs. (n = 110) 7 (6.4%) 12 (10.9%) 91 (82.7%) 




- 112 - 
 
 
Table IV.8. continued. 
Category Agree  Neither Agree or Disagree  Disagree  
Healthcare Practice n (%) n (%) n (%) 
It is important to execute OMs for patient discharge. (n = 110) 88 (80.0%) 6 (5.5%) 16 (14.5%) 
It is important to execute OMs at regular intervals for patient 
progress summaries. (n = 110) 95 (86.3%) 8 (7.3%) 7 (6.4%) 
Clients with BCRL that I see ARE NOT suitable for OMs. (n = 
110) 9 (8.2%) 16 (14.5%) 85 (77.3%) 
Business Structures    
Management at my work place supports the use of OMs on clients 
with BCRL. (n = 110) 77 (70.0%) 19 (17.3%) 14 (12.7%) 
I have sufficient time to conduct a battery of OMs on clients with 
BCRL. (n = 110) 29 (26.4%) 12 (10.9%) 69 (62.7%) 
I have sufficient time to analyze results of OMs for clients with 
BCRL. (n = 110) 30 (27.3%) 12 (10.9%) 68 (61.8%) 
I have sufficient time to complete documentation of OMs for 
clients with BCRL. (n = 110) 26 (23.6%) 13 (11.9%) 71 (64.5%) 
Using OMs on clients with BCRL is encouraged at my workplace. 
(n = 110) 73 (66.3%) 20 (18.2%) 17 (15.5%) 
I have colleague support in using outcome OMs on clients with 
BCRL. (n =110) 55 (50.0%) 32 (29.1%) 23 (20.9%) 
At my workplace, I have access to the tools I need to conduct 
OMs to address the comorbidities in clients with BCRL. (n = 110) 57 (51.8%) 14 (12.7%) 39 (35.5%) 
EMRs for documentation facilitates the use of OMs on clients 
with BCRL. (n = 110) 61 (55.5%) 17 (15.5%) 32 (29.0%) 
Paper records for documentation facilitates the use of OMs on 
clients with BCRL. (n = 110) 48 (43.6%) 36 (32.8%) 26 (23.6%) 
Healthcare Equality    
Clients with BCRL have difficulty understanding the written 
instructions of the patient reported OMs. (n = 110) 45 (41%) 27 (24.5%) 38 (34.5%) 
Clients with BCRL have difficulty understanding the verbal 
instructions of OMs. (n = 110) 32 (29.1%) 23 (20.9%) 55 (50.0%) 
The patient-reported OMs for clients with BCRL are NOT gender 
inclusive. (n = 110) 35 (31.8%) 50 (45.5%) 25 (22.7%) 
The patient-reported OMs for clients with BCRL are NOT 
culturally/ethnically inclusive. (n =110) 33 (30.0%) 50 (45.5%) 27 (24.5%) 
OMs = Outcome Measures, BCRL = Breast Cancer Related Lymphedema, EMRs = Electronic Medical Records 





























Table IV.9. Group Differences for Facilitators and Barriers to Use of Outcome Measures. 
Beliefs of the Therapist 
OT (n = 41) 
n (%) 




Statement                                   Likert Scale                                  
 36 (87.8%) 
 4 (9.8%) 
 1 (2.4%) 
 49 (70%) 
 8 (11.4%) 
 13 (18.6%) 
c2 = 6.47, p = 0.04* 
The use of OMs improves quality of care 
toward clients with BCRL.  
Agree 
Neither Agree or Disagree 
Disagree 
The use of OMs helps in the clinical reasoning 
for choice of interventions on clients with 
BCRL. 
Agree 
Neither Agree or Disagree 
Disagree 
 38 (92.7%) 
 0 (0.0%) 
 3 (7.3%) 
 48 (68.6%) 
 10 (14.3%) 
 12 (17.1%) 
c2 = 9.65, p = 0.01* 
The use of OMs improves communication with 
other healthcare stakeholders. 
Agree 
Neither Agree or Disagree 
Disagree 
 36 (87.8%) 
 1 (2.4%) 
 4 (9.8%) 
 49 (70%) 
 14 (20%) 
 7 (10%) 
c2 = 6.97, p = 0.03* 
The use of OMs increases the efficiency of 
evaluations with clients who have BCRL. 
Agree 
Neither Agree or Disagree 
Disagree 
 28 (68.3%) 
 6 (14.6%) 
 7 (17.1%) 
 28 (40%) 
 14 (20%) 
 28 (40%) 
c2 = 8.83, p = 0.01* 
Healthcare Practice 
OT (n = 41) 
n (%) 
PT (n = 70) 
n (%) 
 
Statement                                   Likert Scale                                  
 36 (87.8%) 
 4 (9.8%) 
 1 (2.4%) 
 44 (63.8%) 
 12 (17.4%) 
 13 (18.8%) 
c2 = 8.51, p = 0.01* 
The use of OMs is necessary to determine 
intervention efficacy for clients with BCRL. 
Agree 
Neither Agree or Disagree 
Disagree 
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Table IV.10. Unique Predictors of Use of Outcome Measures. 
Outcome measure    Predictor variable Wald c2 Significance OR, Exp (B) 95% CI 
Pinch dynamometer     
OT profession 10.49 p < 0.01 11.36 2.61 – 49.45 
Monofilament     
OT profession 4.45 p = 0.04 3.01 1.08 – 8.39 
Sharp-dull discrimination     
 Not LANA certified 4.74 p = 0.03 3.65 1.14 – 11.69 
DASH     
Not LANA certified 5.77 p = 0.02 4.37 1.31 – 14.59 
VAS - Fatigue     
Not LANA certified 4.80 p = 0.03 3.23 1.13 – 9.24 
Functional reach     
Highest degree – Master’s 5.71 p = 0.02 3.65 1.26 – 10.53 
OR = odds ratio, CI = confidence interval, OT = occupational therapist, DASH = Disability of the 
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Appendix IV.A. Survey on Use of Outcome Measures by Certified Lymphedema Therapists on 
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Q1 Consent to Participate in a Research Study - Online Survey   (HUM00188013)      
Ph.D. in PT student, David Doubblestein, PT, OCS, CLT-LANA, LLCC, Cert. MDT of the University of Michigan-
Flint, Department of Physical Therapy, invites you to be a part of a research study to investigate the use of outcome 
measures by certified lymphedema therapists (CLT) on breast cancer survivors (BCS) with breast cancer related 
lymphedema (BCRL).  As a CLT, you are invited to participate in this study by completing the web-based 
survey.  The study’s aim is to examine: 1) the use of outcome measures used by CLT on BCS with BCRL and their 
associated factors; and 2) facilitators and barriers with influence CLT use of outcome measures and their associated 
factors.  The survey will take approximately 25 minutes to complete.  The researchers were careful in using 
language in the questions when developing the survey to facilitate the ease of understanding and responding.  While 
you may not receive any direct benefit for your participation in this survey, we hope that this study will contribute to 
the improvement of the field of lymphology via the assessment, planning, and providing lymphedema 
therapeutics.  Researchers will not be able to link your survey responses to you.  The survey software has been set so 
that no identifying information is captured alongside your survey responses.  Participation in this study is completely 
voluntary.  When completing the survey, you will need to be located in the United States.  Those who complete the 
survey may choose to be entered into a randomized prize drawing for a $25 dollars gift card, of which there are 
60.  To be entered into the drawing, you will need to provide your name, postal address, and email address.  This 
data will not be linked to the survey and will be destroyed within 30 days from the closure of the survey.  There will 
be four $25.00 gift cards given for a total of 15 drawings occurring on 15 separate days.  Participants who choose to 
participate will be pooled into 15 equally distributed groups. Individuals cannot be entered into a pool for a prize 
more than once.  Odds of winning a gift card is based on the total number of individuals who complete the survey 
and choose to participate in the drawing.  Survey respondents are eligible to win a maximum of one prize.  Prize 
drawings are conducted within 30 days of the conclusion of the survey on 05/07/21.  Prize winners will be notified 
by email.  Should you decide to participate now, you may change your mind and stop at any time by simply exiting 
the survey.  We expect to publish the results of this study, but will not include any information that would identify 
you.     
If you have questions about this survey, you can contact 
 Principal Investigator:  David Doubblestein, PT 
 Email: ddoubble@umich.edu  
 Phone: 231-629-7109 
 Faculty Advisor: Cathy Larson, PT, PhD 
 Email: clarson@umich.edu  
 Phone: 810-762-3373  
 Faculty Advisor: Amy Yorke, PT, PhD 
 Email: amyorke@umich.edu 
 Phone: 810-762-3373     As part of their review, the University of Michigan Institutional Review Board Health 
Sciences and Behavioral Sciences has determined that this study is no more than minimal risk and exempt 
from on-going IRB oversight.      
Informed Consent:   
 By clicking on "Yes, I agree to participate," you are consenting to participate in this research survey.   
  If you do not wish to participate, select "No, I do not wish to participate" to exit the survey.      
o Yes, I agree to participate  (1)  
o No, I do not wish to participate  (2)  
 
Skip To: End of Survey If Consent to Participate in a Research Study - Online Survey Use of Outcome Measures by 
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Q2  Do you see clients with breast cancer related lymphedema? 
o Yes  (1)  
o No  (2)  
 
Skip To: End of Block If  Do you see clients with breast cancer related lymphedema? = No 
 








Q5 What is your gender?  
o Female  (9)  
o Male  (10)  
o Transgender  (11)  









- 118 - 
Q6 Please identify your ethnicity. 
o American Indian or Alaska Native  (13)  
o Asian  (14)  
o Black or African American  (12)  
o Native Hawaiian or Pacific Islander  (15)  
o White  (11)  
o Other  (16)  
o Prefer not to answer  (17)  
 
 
Q7 What is your profession? 
o Certified Athletic Trainer  (1)  
o Chiropractor  (2)  
o Massage Therapist  (3)  
o Nurse  (4)  
o Occupational Therapist  (5)  
o Occupational Therapist Assistant  (6)  
o Physical Therapist  (7)  
o Physical Therapist Assistant  (8)  
o Physician  (9)  
o Physician Assistant  (10)  
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Q8 What is your highest earned degree?  Select all that apply. 
o Academic Doctorate (e.g. PhD, D.Sc.)  (6)  
o Clinical Doctorate (e.g. MD, DPT, DC, ATD, OTD, DNP)  (5)  
o Master of Arts or Science (e.g. MSPT, MAT, MOT, MSN)  (4)  
o Bachelor of Arts or Science (e.g. BScPT, BScOT, BScAT, BScMT, BScN)  (3)  
o Associate of Arts (e.g. PTA, COTA)  (2)  
o Certification/Credentialing (CMT, CBT, CMBT, LMT, RMT)  (1)  
 
 
Q9 Which of the following best describes the geographical region of your clinical practice? 
o Midwest United States (OH, IN, MI, IL, MO, IA, WI, MN, ND, SD, NE, KS)  (1)  
o Northeast United States (MD, PA, NY, VT, ME, NH, MA, RI, CT, NJ, DE)  (2)  
o Southwest United States (AZ, NM, TX, OK)  (3)  
o Southeast United States (AR, LA, MS, AL, FL, GA, SC, NC, VA, WV, KY, TN, DE)  (5)  
o West United States (CO, UT, WY, MT, ID, WA, OR, NV, CA, AK, HI)  (4)  
o Canada  (6)  
o Neither United States or Canada  (7)  
 
 
Q10 Which of the following best describes the community setting of your clinical practice? 
o Urban  (1)  
o Suburban  (2)  
o Rural  (3)  
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Q13 From which school did you receive your training and credentials as a certified lymphedema therapist 
(CLT)?  Select all that apply. 
o Academy of Lymphatic Studies  (1)  
o Brennan School of Innovative Lymphatic Studies  (2)  
o Casley Smith International  (3)  
o Chikly Health Institute - LLCC  (4)  
o Dr. Vodder School International  (5)  
o International Lymphedema & Wound Training Institute  (7)  
o Klose Training Lymphedema Certification  (8)  
o Norton School of Lymphatic Therapy  (6)  
o Pacific Therapy Education, Inc.  (10)  
o UWM Lymphedema Therapist Certification  (12)  
o Other school that offers minimum of 135 hours of CLT training and certification (please name and identify 
if not within U.S.):  (11) ________________________________________________ 
 
 
Q14 Are you a nationally certified lymphedema therapist through the Lymphology Association of North America 
(CLT-LANA)? 
o Yes  (1)  
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Q15 What other broad scope of practice specializations are you credentialed in?  (select all that apply) 
o Acute Care  (13)  
o Clinical Electrophysiology  (1)  
o Cardiovascular and Pulmonary  (2)  
o Family Medicine  (15)  
o Geriatric  (3)  
o Hand Therapy  (4)  
o Internal Medicine  (14)  
o Manual Therapy  (5)  
o Neurology  (6)  
o Obstetrics & Gynecology  (18)  
o Oncology  (7)  
o Orthopaedic  (8)  
o Pediatric  (9)  
o Plastic Surgery  (16)  
o Sports  (10)  
o Vascular Medicine  (17)  
o Other (please describe):  (11) ________________________________________________ 
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Q16 Which of the following BEST describes the facility at which you conduct MOST of your Breast Cancer Related 
Lymphedema patient/client care?  (please select only one)  
o Acute Care Hospital  (1)  
o Acute Rehabilitation  (2)  
o Extended Care Facility  (3)  
o Facility-Based Outpatient Clinic  (4)  
o Home Health Care  (5)  
o Privately Owned Outpatient Clinic  (6)  
o Subacute Rehabilitation  (7)  
o University  (8)  
o Other (please describe):  (9) ________________________________________________ 
 
 
Q17 How would you characterize the age of the patient population with breast cancer related lymphedema you 
manage?  Please put a number in ALL of the boxes (could be 0%). 
o Percentage < 21 years of age  (12) ________________________________________________ 
o Percentage 21 - 40 years of age  (13) ________________________________________________ 
o Percentage 41 - 60 years of age  (14) ________________________________________________ 
o Percentage 61 - 75 years of age  (15) ________________________________________________ 
o Percentage > 75 years of age  (16) ________________________________________________ 
 
 
Q18 Approximately what percentage of your practice is devoted to the treatment of lymphedema? 
 Not Applicable 
 
 0 10 20 30 40 50 60 70 80 90 100 
 










- 123 - 
 
Q19 On average, how many Breast Cancer Related Lymphedema clients do you see in an eight hours work day?  If 
working less than 8 hours, please sum to 8 hours work day. 
 Not Applicable 
 
 0 3 6 9 12 15 18 21 24 27 30 
 





Q20 On average, how many hours per week do you provide interventions on clients with breast cancer related 
lymphedema? 
 Not Applicable 
 
 0 8 16 24 32 40 48 56 64 72 80 
 





Q21 On average, how many minutes are allocated for an initial evaluation on clients with breast cancer related 
lymphedema?  
 Not Applicable 
 
 0 9 18 27 36 45 54 63 72 81 90 
 





Q22 On average, how many minutes are allocated for a follow-up appointment on clients with breast cancer related 
lymphedema?  
 Not Applicable 
 
 0 9 18 27 36 45 54 63 72 81 90 
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Q23 Do you treat lymphedema that has manifested with any of the following conditions? (please select all that 
apply) 
o Arthritis  (1)  
o Chronic Venous Insufficiency  (2)  
o Filariasis Infection  (3)  
o Head and Neck Cancer  (4)  
o Lipedema  (5)  
o Neurological Conditions  (6)  
o Reproductive Organ Cancers  (7)  
o Orthopedic Conditions  (8)  
o Post-Operative General  (9)  
o Post-Operative Orthopedic  (10)  
o Primary Lymphedema  (11)  
o Wounds  (12)  
o Other (please describe):  (13) ________________________________________________ 
o None  (14)  
 
 
Q24 Do you conduct assessments on clients with breast cancer related lymphedema in which you use outcome 
measures (e.g. ROM, strength, volume, fatigue, quality of life)? 
o Yes  (1)  
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Q25 Please proceed with the second section of the survey which focuses on outcome measures used to identify Body 
Structure and Function Impairments.  Please answer to your best ability. 
 
 
Q26 Which of the following outcome measures do you use to measure JOINT FUNCTION on your clients with 
breast cancer related lymphedema?  Please indicate the frequency of use of each assessment. 
Definitions:   
Frequently Used: Used for initial examination and reassessments.   
Occasionally Used: Used for initial examination.   
Seldom Used: Intermittent use as warranted.    




(dichotomous) (1)  
o  o  o  o  
Goniometry - 
passive range of 
motion (2)  o  o  o  o  
Goniometry - active 
range of motion (3)  o  o  o  o  
Inclinometer - 
passive range of 
motion (4)  o  o  o  o  
Inclinometer - 
active range of 
motion (5)  o  o  o  o  
Others (please 




Display This Question: 
If Which of the following outcome measures do you use to measure JOINT FUNCTION on your clients with... 
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Q27 You have selected that you do not use outcome measure(s) for JOINT FUNCTION from the previous 
question.  From the choices below, please identify barriers in utilizing those outcome measure(s).  Select all that 
apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (6)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (9)  
o My workplace does not support the use of the measure  (10)  
o Too confusing for the patient to understand  (11)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  
o Other (please describe):  (12) ________________________________________________ 
 
 
Q28 Which of the following outcome measures do you use to measure FLEXIBILITY on your clients with breast 
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Definitions:   
Frequently Used: Used for initial examination and reassessments.   
Occasionally Used: Used for initial examination.   
Seldom Used: Intermittent use as warranted.    
 Frequently Used (1) Occasionally Used (2) Seldom Used (3) Do Not Use (4) 
Pectoralis major 
length (7)  o  o  o  o  
Pectoralis minor 
muscle length (1)  o  o  o  o  
Pectoralis minor 
muscle length - 
Borstad scapular 
index (2)  
o  o  o  o  
Stiffness of 
glenohumeral joint 
(3)  o  o  o  o  
Others (please 




Display This Question: 
If Which of the following outcome measures do you use to measure FLEXIBILITY on your clients with br... = 
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Q29 You have selected that you do not use outcome measure(s) for FLEXIBILITY from the previous 
question.  From the choices below, please identify barriers in utilizing those outcome measure(s).  Select all that 
apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (8)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (9)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  
o Other (please describe):  (12) ________________________________________________ 
 
 
Q30 Which of the following outcome measures do you use to measure STRENGTH on your clients with breast 
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Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments. 
Occasionally Used: Used for initial examination. 
Seldom Used: Intermittent use as warranted. 
 Frequently Used (1) Occasionally Used (2) Seldom Used (3) Do Not Use (4) 
Hand Grip 
Dynamometry (1)  o  o  o  o  
Hand Held 
Dynamometry (2)  o  o  o  o  
Manual Muscle 
Testing (MMT) (3)  o  o  o  o  
One Repetition 
Maximum (4)  o  o  o  o  
Pinch 
Dynamometry (Tip, 
Lateral, 3 Jaw 
Chuck) (5)  
o  o  o  o  
Others (please 




Display This Question: 
If Which of the following outcome measures do you use to measure STRENGTH on your clients with breas... = 
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Q31 You have selected that you do not use outcome measure(s) for STRENGTH from the previous question.  From 
the choices below, please identify barriers in utilizing those outcome measure(s).  Select all that apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (9)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (10)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  




Q32 Which of the following outcome measures do you use to measure VOLUME and/or TISSUE WATER 
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Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments. 
Occasionally Used: Used for initial examination. 
Seldom Used: Intermittent use as warranted.   
 Frequently Used (1) 
Occasionally Used 
(2) Seldom Used (3) Do Not Use (4) 
Bioelectrical Impedance 
Spectroscopy (BIS) (1)  o  o  o  o  
Circumferential 
Measurements - 
Calculated Volume (2)  o  o  o  o  
Perometry (3)  o  o  o  o  
Tissue Dielectric 
Constant (TDC) (9)  o  o  o  o  
Water 
displacement/Volumeter 
(4)  o  o  o  o  
3D Imaging (5)  o  o  o  o  
Others (please 




Display This Question: 
If Which of the following outcome measures do you use to measure VOLUME and/or TISSUE WATER 
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Q33 You have selected that you do not use outcome measure(s) for VOLUME and/or TISSUE WATER CONTENT 
from the previous question.  From the choices below, please identify barriers in utilizing those outcome 
measure(s).  Select all that apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (9)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (10)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  
o Other (please describe):  (12) ________________________________________________ 
 
 
Q34 Which of the following outcome measures do you use to measure PAIN on your clients with breast cancer 
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Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments. 
Occasionally Used: Used for initial examination. 
Seldom Used: Intermittent use as warranted. 
 Frequently Used (1) Occasionally Used (2) Seldom Used (3) Do Not Use (4) 
Brief Pain Inventory 
(1)  o  o  o  o  
Brief Pain Inventory 
- Short Form (2)  o  o  o  o  
McGill Pain 
Questionnaire (3)  o  o  o  o  
McGill Pain 
Questionnaire - 
Short Form (4)  o  o  o  o  
Numeric Pain 
Rating Scale (5)  o  o  o  o  
Pain Disability 
Index (6)  o  o  o  o  
Visual Analog Scale 
(7)  o  o  o  o  
Others (please 




Display This Question: 
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Q35 You have selected that you do not use outcome measure(s) for PAIN from the previous question.  From the 
choices below, please identify barriers in utilizing those outcome measure(s).  Select all that apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (9)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (10)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  
o Other (please describe):  (12) ________________________________________________ 
 
 
Q36 Which of the following outcome measures do you use to measure SENSATION on your clients with breast 
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Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments. 
Occasionally Used: Used for initial examination. 
Seldom Used: Intermittent use as warranted. 
 Frequently Used (1) Occasionally Used (2) Seldom Used (3) Do Not Use (4) 
Light Touch (e.g. 
cotton ball, finger, 
brush) (1)  o  o  o  o  
Monofilament (2)  o  o  o  o  
Sharp-Dull 
Discrimination (3)  o  o  o  o  
Two-Point 
Discrimination (4)  o  o  o  o  
Vibration/Tuning 
Fork (5)  o  o  o  o  
Others (please 




Display This Question: 
If Which of the following outcome measures do you use to measure SENSATION on your clients with brea... = 
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Q37 You have selected that you do not use outcome measure(s) for SENSATION from the previous question.  From 
the choices below, please identify barriers in utilizing those outcome measure(s).  Select all that apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (9)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (10)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  
o Other (please describe):  (12) ________________________________________________ 
 
 
Q38 Which of the following outcome measures do you use to measure TISSUE CONSISTENCY on your clients 
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Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments. 
Occasionally Used: Used for initial examination. 
Seldom Used: Intermittent use as warranted. 
 Frequently Used (1) Occasionally Used (2) Seldom Used (3) Do Not Use (4) 
Myoton (1)  o  o  o  o  
Pitting Edema Test - 
Palpation (2)  o  o  o  o  
SkinFibrometer (3)  o  o  o  o  
Tissue Texture - 
Palpation (normal, 
soft, spongy, firm) 
(8)  
o  o  o  o  
Tonometry (4)  o  o  o  o  
Ultrasonography (5)  o  o  o  o  
Others (please 




Display This Question: 
If Which of the following outcome measures do you use to measure TISSUE CONSISTENCY on your clients... 
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Q39 You have selected that you do not use outcome measure(s) for TISSUE CONSISTENCY from the previous 
question.  From the choices below, please identify barriers in utilizing those outcome measure(s).  Select all that 
apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (9)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (10)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  
o Other (please describe):  (12) ________________________________________________ 
 
 
Q40 Which of the following outcome measures do you use to measure BODY COMPOSITION on your clients 
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Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments. 
Occasionally Used: Used for initial examination. 
Seldom Used: Intermittent use as warranted. 
 Frequently Used (1) Occasionally Used (2) Seldom Used (3) Do Not Use (4) 
Myoton (1)  o  o  o  o  
Bioelectrical 
Impedance Analysis 
(6)  o  o  o  o  
Body Weight (2)  o  o  o  o  
Body Mass Index 
(3)  o  o  o  o  
Others (please 




Display This Question: 
If Which of the following outcome measures do you use to measure BODY COMPOSITION on your clients wi... 
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Q41 You have selected that you do not use outcome measure(s) for BODY COMPENSATION from the previous 
question.  From the choices below, please identify barriers in utilizing those outcome measure(s).  Select all that 
apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (9)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (10)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  
o Other (please describe):  (12) ________________________________________________ 
 
 
Page Break  
Q42 This third section of the survey focuses on outcome measures used to identify Activities and Participation 
Limitations.  Please answer to your best ability. 
Q43 Which of the following PATIENT-REPORTED outcome measures do you use to measure HEALTH-
RELATED QUALITY OF LIFE on your clients with breast cancer related lymphedema?  Please indicate the 
frequency of use of each assessment.    
 
Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments.   
Occasionally Used: Used for initial examination.   
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 Frequently Used (1) Occasionally Used (2) Seldom Used (3) Do Not Use (4) 
Breast Cancer 
Questionnaire (14)  o  o  o  o  
Breast-Q (1)  o  o  o  o  
EORTC Quality of 
Life Questionnaire - 
Breast (3)  o  o  o  o  
Functional 
Assessment of 
Cancer Therapy - 
Breast (4)  
o  o  o  o  
Functional 
Assessment of 
Cancer Therapy - 
Breast +4 (5)  








o  o  o  o  
Functional Living 
Index - Cancer (13)  o  o  o  o  
Lymphedema Life 






o  o  o  o  
Others (please 
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Display This Question: 
If Which of the following PATIENT-REPORTED outcome measures do you use to measure HEALTH-
RELATED QUA... = Do Not Use 
 
Q44 You have selected that you do not use PATIENT-REPORTED outcome measure(s) for HEALTH-RELATED 
QUALITY OF LIFE from the previous question.  From the choices below, please identify barriers in utilizing those 
outcome measure(s).  Select all that apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (8)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (9)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  
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Q45 Which of the following PATIENT-REPORTED outcome measures do you use to measure UPPER 
QUADRANT FUNCTION on your clients with breast cancer related lymphedema?  Please indicate the frequency 
of use of each assessment.    
Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments.   
Occasionally Used: Used for initial examination 
 
.   
Seldom Used: Intermittent use as warranted.   
 Frequently Used (1) Occasionally Used (2) Seldom Used (3) Do Not Use (4) 
Disability of Arm, 
Shoulder, and Hand 
Questionnaire 
(DASH) (2)  
o  o  o  o  
Penn Shoulder 
Score (PSS) (9)  o  o  o  o  
QuickDASH (10)  o  o  o  o  
Shoulder Disability 
Questionnaire 
(SDQ) (8)  o  o  o  o  
Shoulder Pain and 
Disability Index 
(SPADI) (11)  o  o  o  o  
Shoulder Rating 
Questionnaire 
(SRQ) (12)  o  o  o  o  
Upper Extremity 
Functional Index 





o  o  o  o  
Others (please 
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Display This Question: 
If Which of the following PATIENT-REPORTED outcome measures do you use to measure UPPER 
QUADRANT FUN... = Do Not Use 
 
Q46 You have selected that you do not use PATIENT-REPORTED outcome measure(s) for UPPER QUADRANT 
FUNCTION from the previous question.  From the choices below, please identify barriers in utilizing those outcome 
measure(s).  Select all that apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (8)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (9)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  





Q47 Which of the following PATIENT-REPORTED outcome measures do you use to measure FATIGUE on 
your clients with breast cancer related lymphedema?  Please indicate the frequency of use of each assessment.   
Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments.   
Occasionally Used: Used for initial examination.   
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Do Not Use 
(4) 
Bi-Dimensional Fatigue Scale (1)  o  o  o  o  
Brief Fatigue Inventory (2)  o  o  o  o  
Chalder Fatigue Questionnaire (3)  o  o  o  o  
Diagnostic Interview for Cancer 
Related Fatigue (4)  o  o  o  o  
FACT-B (5)  o  o  o  o  
Fatigue Symptom Inventory (6)  o  o  o  o  
Functional Assessment of Chronic 
Illness Therapy - Fatigue (7)  o  o  o  o  
MOS-SF36/Rand/Vitality (8)  o  o  o  o  
Multidimensional Fatigue Symptom 
Inventory (9)  o  o  o  o  
Piper Fatigue Scale Revised (10)  o  o  o  o  
Profile of Mood States Fatigue/Vigor 
and Fatigue/Inertia Subscales (11)  o  o  o  o  
Visual Analog Scale (12)  o  o  o  o  
Wu Cancer Fatigue Scale (13)  o  o  o  o  
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Display This Question: 
If Which of the following PATIENT-REPORTED outcome measures do you use to measure FATIGUE on your 
cl... = Do Not Use 
 
Q48 You have selected that you do not use PATIENT-REPORTED outcome measure(s) for FATIGUE from the 
previous question.  From the choices below, please identify barriers in utilizing those outcome measure(s).  Select 
all that apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (9)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (10)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  




Q49 Which of the following outcome measures do you use to measure MOBILITY AND BALANCE on your 
clients with breast cancer related lymphedema?  Please indicate the frequency of use of each assessment. 
Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments. 
Occasionally Used: Used for initial examination. 
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Do Not Use 
(4) 
Activities-Specific Balance 
Confidence Scale (1)  o  o  o  o  
Balance Evaluation Systems Test 
(2)  o  o  o  o  
Berg Balance Scale (3)  o  o  o  o  
Barthel Index (4)  o  o  o  o  
Fullerton Advanced Balance 
Scale (5)  o  o  o  o  
Functional Independence 
Measure (6)  o  o  o  o  
Functional Reach (7)  o  o  o  o  
Short Form Wolf Motor Function 
Test (8)  o  o  o  o  
Short Performance Physical 
Battery (9)  o  o  o  o  
Timed Up and Go (10)  o  o  o  o  
2 - Minute Walk Test (11)  o  o  o  o  
5 - Times Sit to Stand (12)  o  o  o  o  
6 - Minute Walk Test (13)  o  o  o  o  
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Display This Question: 
If Which of the following outcome measures do you use to measure MOBILITY AND BALANCE on your 
client... = Do Not Use 
 
Q50 You have selected that you do not use outcome measure(s) for MOBILITY AND BALANCE from the previous 
question.  From the choices below, please identify barriers in utilizing those outcome measure(s).  Select all that 
apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference(e.g. review of systems, predetermined tests and measures)  (9)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (10)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  
o Other (please describe):  (12) ________________________________________________ 
 
 
Q51 Which of the following outcome measures do you use to measure UPPER EXTREMITY ACTIVITY & 
MOTOR CONTROL on your clients with breast cancer related lymphedema?  Please indicate the frequency of use 
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Frequency Definitions:   
Frequently Used: Used for initial examination and reassessments. 
Occasionally Used: Used for initial examination. 
Seldom Used: Intermittent use as warranted.  
 Frequently Used (1) Occasionally Used (2) Seldom Used (3) Do Not Use (4) 
Action Research 
Arm Test (1)  o  o  o  o  
Box and Block Test 
(2)  o  o  o  o  
Finger Tapper Test 
(3)  o  o  o  o  
Purdue Pegboard (4)  o  o  o  o  
Ruler Drop 
Test/ReacStick (5)  o  o  o  o  
9 - Hole Peg Test 
(6)  o  o  o  o  
9 - Item Arm Motor 
Ability Test (7)  o  o  o  o  
Others (please 




Display This Question: 
If Which of the following outcome measures do you use to measure UPPER EXTREMITY ACTIVITY & 
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Q52 You have selected that you do not use outcome measure(s) for UPPER EXTREMITY & ACTIVITY AND 
MOTOR CONTROL from the previous question.  From the choices below, please identify barriers in utilizing those 
outcome measure(s).  Select all that apply. 
o My attitude and/or personal beliefs toward this outcome measure usefulness  (1)  
o My lack of knowledge of this outcome measure  (2)  
o My lack of skill in using this outcome measure  (3)  
o My lack of time to implement this outcome measure  (4)  
o Too difficult for the patient to perform  (5)  
o My examination preference (e.g. review of systems, predetermined tests and measures)  (9)  
o The outcome measure is not available at my workplace (e.g. cost, resources)  (10)  
o My workplace does not support the use of the measure  (11)  
o Too confusing for the patient to understand  (6)  
o The outcome measure is not inclusive (e.g. culturally, ethnically, gender)  (7)  
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Q53 You are almost done!  We appreciate your time.  Lymphedema stakeholders appreciate your input! 
This fourth section of the survey focuses on perceived beliefs, facilitators, and barriers toward the use of outcome 
measures.  For the following items, please select the appropriate choice for your response.  Please answer to your 
best ability.  
 
 
Q54 The use of outcome measures is necessary for the practice of breast cancer related lymphedema treatment 
and management.  
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q55 The use of outcome measures for clients with breast cancer related lymphedema places unreasonable 
demand on a practitioner. 
o Strongly agree  (11)  
o Somewhat agree  (12)  
o Neither agree nor disagree  (13)  
o Somewhat disagree  (14)  
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Q56 The use of outcome measures improves quality of care toward clients with breast cancer related 
lymphedema.  
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q57 The use of outcome measures helps direct the plan of care for clients with breast cancer related 
lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q58 The use of outcome measures helps in the clinical reasoning for choice of interventions on clients with breast 
cancer related lymphedema.  
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q59 The use of outcome measures improves communication with clients who have breast cancer related 
lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q60 The use of outcome measures improves communication with other healthcare stakeholders (physician, 
colleagues, case managers, and insurance).  
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q61 The use of outcome measures increases the efficiency of evaluations with clients who have breast cancer 
related lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q62 Outcome measures help to motivate and encourage clients with breast cancer related lymphedema in the 
treatment and management of their condition. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q63 I have sufficient knowledge about outcome measures for clients with breast cancer related lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q64 I have sufficient skills to use outcome measures for clients with breast cancer related lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q65 The interpretation of the results obtained by outcome measures are easily interpreted for clinical reasoning 
pertaining to breast cancer related lymphedema.  
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q66 I have the ability to access current research pertaining to breast cancer related lymphedema through 
professional journals. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q67 With so many outcome measures, I do not know the best option to choose to use on my clients with breast 
cancer related lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q68 I consistently incorporate clinical practice guidelines and systematic reviews related to breast cancer related 
lymphedema diagnosis and interventions. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q69 I received sufficient training in using various outcome measures on clients with breast cancer related 
lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q70 I received sufficient training about outcome measures for clients with breast cancer related lymphedema in my 
professional training (e.g. PT, OT, PA). 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q71 I received sufficient training about outcome measures for clients with breast cancer related lymphedema in my 
post-professional CLT course(s). 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q72 Outcome measures are important for assisting in the identification of problems (comorbidities) in clients 
with breast cancer related lymphedema (e.g. fall risk, balance deficits, increased fibrosis, restricted motion, 
decreased reaction time, etc.).  
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q73 The use of outcome measures is necessary to determine treatment efficacy for clients with breast cancer 
related lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q74 The use of outcome measures is part of my personal practice model.  
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q75 Clients with breast cancer related lymphedema request that I use outcome measures.  
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q76 It is important to execute outcome measures for patient discharge. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q77 It is important to execute outcome measures at regular intervals for patient progress summaries.  
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q78 Clients with breast cancer related lymphedema that I see ARE NOT suitable for outcome measures. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q79 Management at my work place supports the use of outcome measures on clients with breast cancer related 
lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q80 I have sufficient time to conduct a battery of outcome measures on clients with breast cancer related 
lymphedema (this includes time for self-report questionnaires). 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q81 I have sufficient time to analyze results of outcome measures for clients with breast cancer related 
lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q82 I have sufficient time to complete documentation of outcome measures for clients with breast cancer related 
lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q83 Using outcome measures on clients with breast cancer related lymphedema is encouraged at my workplace. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q84 I have colleague support in utilizing outcome measures on clients with breast cancer related lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q85 At my workplace, I have access to the tools I need to conduct outcome measures to address the 
comorbidities in clients with to breast cancer related lymphedema (e.g. fall risk, balance deficits, increased fibrosis, 
restricted motion, decreased reaction time, etc.). 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q86 Electronic medical records for documentation facilitates the use of outcome measures (this includes patient 
self-report questionnaires) on clients with breast cancer related lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q87 Paper records for documentation facilitates the use of outcome measures (this includes patient self-report 
questionnaires) on clients with breast cancer related lymphedema. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q88 Clients with breast cancer related lymphedema have difficulty understanding the written instructions of the 
patient-reported outcome measures. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q89 Clients with breast cancer related lymphedema have difficulty understanding the verbal instructions of 
outcome measures. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  




Q90 The patient-reported outcome measures for clients with breast cancer related lymphedema are NOT gender 
inclusive. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
o Strongly disagree  (5)  
 
 
Q91 The patient-reported outcome measures for clients with breast cancer related lymphedema are NOT 
culturally/ethnically inclusive. 
o Strongly agree  (1)  
o Somewhat agree  (2)  
o Neither agree nor disagree  (3)  
o Somewhat disagree  (4)  
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Q92 Thank you for participating in this survey!  You may choose to participate in a randomized drawing for a 
$25.00 Amazon gift card.  Please choose one of the following options below.  Again, we appreciate the time you 
spent completing this survey. 
o Please enter me in the randomized drawing for a $25 Amazon gift card.  (1)  
o I choose not to be entered in the drawing and conclude my participation.  (2)  
 
Skip To: End of Survey If Thank you for participating in this survey! You may choose to participate in a randomized 
drawing... = I choose not to be entered in the drawing and conclude my participation. 
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OVERVIEW 
 
Three manuscripts with separate aims and objectives have been united to accomplish the 
purpose of this dissertation, which was to advance a greater understanding of the status of 
lymphology education and practice in physical therapy through a multimodal investigation of 
entry-level knowledge, post-professional knowledge, and MLdT on lymphedema in the physical 
therapy specialty areas of oncology and orthopaedics. 
 To accomplish the multimodal investigation, three separate studies with two 
separate research designs were implemented.  With the premise that lymphology education is 
important to the future of the physical therapy profession, the first study investigated by means 
of survey research design, the status of lymphology education in professional DPT programs.  
The overall consensus was that lymphology education is entry-level material for DPT students 
albeit a high variability in the hours devoted to disseminating this curricular topic.  Adding to 
this foundation, there has been an increase depth of knowledge from recent discoveries about 
fluid homeostasis and the limitations of previous interventions to reduce edema.  This promoted 
a second study using a systematic review to investigate the effects of manual lymphatic drainage 
techniques (MLdT) on conditions affecting the musculoskeletal system.  There was moderate 
support for using MLdT for conditions affecting the musculoskeletal system as effective 
interventions to reduce pain, improve function and/or QOL, and were associated with lower HU.  
This knowledge gave rise to investigating use of OMs that are foundational for the examination 
of individuals with chronic edema, including BCRL, in both physical and occupational therapy 
practice and in research.  Using survey research methodology, the third study examined the use 
of OMs by post-professional CLTs attending to the impairments and limitations identified in 
BCS with BCRL, including an exploration of predictive factors to their use and the barriers and 
facilitators to the use of OMs.  This final chapter presents a synopsis of the cardinal findings 
from the proceeding chapters, including their strengths and weaknesses, and establishes a 
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SUMMARY OF STUDY RESEARCH DESIGNS AND RESULTS 
STUDY ONE 
 
The aims of this study were to 1) describe current, typical lymphology content within 
professional DPT programs; and 2) identify whether lymphology content is perceived as entry-
level material amongst professional DPT faculty who were responsible for teaching lymphology 
content (TL) and professional DPT faculty who did not teach lymphology content (NTL).  A 
cross-sectional web-based survey research design was implemented to gather data on 
lymphology content, hours, and curriculum standings.  The survey was disseminated to 
professional DPT faculty in the US who taught or did not teach lymphology curriculum.  The 
analysis included descriptive data with means and frequencies, Chi-square test assessing 
relationships between faculty status and entry-level lymphology curriculum status, and Spearman 
rank correlation coefficient assessing relationships between teaching hours and entry-level status.  
The cardinal conclusions were that individual lymphology curriculum contents were 
predominantly considered entry-level material (e.g. anatomy, physiology, pathophysiology, 
classifications, comorbidities, functional limitation reporting, compression pumps, bandaging, 
MLdT, and compression garments), however, variability existed across curricula in range of 
hours devoted to didactic (0.4-14.1 hours) and laboratory (0-10 hours) instruction pertaining to 
lymphology.  This study had limitations in methodology due to recruitment of faculty who were 
involved in the lymphology curriculum allowed for more than one per university to respond to 
the survey.  In addition, the a priori survey sample size of 80 representatives, using a 35% 
response rate1–3 from a larger pool of accredited professional DPT programs in the United States, 
was not accomplished (response rate = 24%) which limited geographical representation and 
generalizability.  Regardless of the inclusivity efforts imbedded in the survey instructions and 
email reminders to participate in the study, a significant disproportion of TL to NTL respondents 
occurred.  Future research indicated to improve the methodology of this survey with the aim to 
have a better generalizable understanding of lymphology curricula in professional DPT programs 
and also to explore best educational practices of teaching didactic and laboratory lymphology 
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STUDY TWO 
 
 The aim of the second study was to determine whether MLdT in addition to conventional 
rehabilitation on conditions affecting the musculoskeletal system, can decrease edema, and 
improve ROM, patient-reported outcomes, and healthcare use.  The objective was to complete a 
systematic review of literature to achieve this aim.  Using PRISMA guidelines, eligible studies 
published between 2007 and 2018, with similar outcome measurements, were grouped for 
analysis and then analyzed for methodological quality via PEDro scale.  Strength of the body of 
evidence was determined by using the Cochrane GRADE guidelines and the American College 
of Chest Physicians guidelines.  The cardinal conclusions were that MLdT was associated with 
lower HU and that there was moderate evidence for the use of MLdT on conditions affecting the 
musculoskeletal system to reduce pain and improve patient-reported outcomes for functional 
activities and QOL.  Other results of the study suggest that MLdT in combination with 
conventional rehabilitation were effective in edema reduction and improving ROM.  Due to 
limited studies (n = 5), moderate PEDro scores, and significant heterogeneity of the studies, a 
meta-analysis was not conducted.  Future randomized control trial research is needed to provide 
stronger evidence to support the use of MLdT for patient with conditions affecting the 
musculoskeletal system and provide evidence as to which auxiliary interventions (e.g. 
compression bandage, compression garment, elastic taping, or exercise) concurrent with MLdT 
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STUDY THREE 
 
This study’s aim was to examine 1) OMs used by CLTs on BCS with BCRL and their 
differences between professions; 2) unique characteristic predictors for use of OMs; and 3) 
facilitators and barriers which influence CLTs use of OMs and their differences between 
professions.  A cross-sectional web-based survey research design was implemented to gather 
demographic information of CLTs and information about levels of use and the facilitators and 
barriers to the use of outcome measures that CLTs use on BCS with BCRL.  The survey was 
distributed to CLT graduates from the post-professional education institutions and related 
professional associations.  The analysis included descriptive data with means and frequencies, 
chi-square test of independence, student t-test, and Mann-Whitney U test for group differences, 
and binary logistic regression for odds ratios as a predictive value of participant characteristics to 
the use of outcome measures. The cardinal conclusions were that the OMs used most often by 
CLTs to measure ICF domains of body functions and structures include 1) goniometry for 
PROM and AROM; 2) stiffness of the glenohumeral joint for flexibility; 4) hand grip 
dynamometer and MMT for strength; 5) circumferential measurements for volume; 6) numeric 
pain scale and visual analog scale for pain; 7) body weight and BMI for body composition; 8) 
light touch brushing for sensation; and 9) pitting edema and tissue texture via palpation for tissue 
consistency.  OMs used most often to measure ICF domains of activities and participation 
include 1) LLIS for patient-reported HRQOL, and 2) QuickDASH for patient-reported upper 
quadrant function.  A CLT’s profession, highest degree earned, and specialization may affect 
their use of OMs.  CLTs value the use of OMs and find them necessary for the treatment and 
management of BCRL.  Most CLTs reported that they had sufficient skills to use and interpret 
the results of OMs for clients with BCRL, however, less than half of the CLTs reported that they 
had sufficient knowledge about OMs for BCRL, while over half of CLTs reported that they had 
difficulty knowing the best OM to choose due to numerous options.  More than half of CLTs 
reported that they did not receive sufficient training on BCRL OMs in their professional 
education and an equal proportion of respondents reporting that they did or did not receive 
sufficient training in their post-professional CLT courses.  Limitations of the study include 
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SUMMARY OF RESULTS 
 
This dissertation added to the existing body of knowledge by advancing a greater 
understanding of the status of lymphology education and practice in physical therapy.  It also 
established a list of OMs used by CLTs which can provide a foundation for lymphology 
educational standards in BCRL examination and evaluation. 
Study One was fundamental to the dissertation by reporting what lymphology content 
was currently being taught in professional DPT curriculums.  The most recent survey research on 
lymphedema management content in physical therapy programs was conducted over 20 years 
ago.4  The field of lymphology has expanded into various disciplines (e.g. oncology, orthopedics, 
and wound care) of physical therapy, which necessitated an updated investigation.  Study One 
identified current lymphology content within professional DPT programs, and indicated that 
programs taught mostly on lymphology intervention, followed by anatomy, physiology, 
pathophysiology, and to a lesser extent examination content.  Peripheral circulation examination 
and reexamination (including lymphedema) are considered a minimum required skill set by the 
APTA – BOD.5  CAPTE6 emphasizes the knowledge base of examination, evaluation, and 
diagnosis of the lymphatics.  Respondents in this survey labeled most of the didactic curriculum 
as being entry-level including anatomy (suprafascial and subfascial), physiology, and 
lymphedema pathophysiology (including its comorbidities).  Pathophysiology content focused on 
teaching about mechanical insufficiency of the lymphatic system, whereas dynamic insufficiency 
and combined insufficiency were taught to a lesser extent.  This study also reported that the 
frequency of teaching about compression devices (garments and bandage alternatives) took 
precedence to other interventions (e.g. MLdT).   
Study Two was conceptualized by considering results from Study One including; 1) the 
frequency that MLdT is entry-level education (58.1%, n = 25); and 2) the frequency that 
mechanical insufficiency (86.8%, n = 33) and dynamic insufficiency (73.7%, n = 28) edemas are 
typically taught in professional DPT lymphology curriculums.  Study Two, a systematic review, 
explored MLdT and their effects on conditions affecting the musculoskeletal system, whose 
resulting edema would by definition be considered either a dynamic or mechanical insufficiency 
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use of MLdT for decreasing edema in acute, subacute, and chronic healing phases of conditions 
affecting the musculoskeletal system. While studies pertaining to acute edema evidenced a lack 
of volume reduction with MLdT, one study7 reported less increase in edema compared to the 
control group. Reduction in girth8 suggested that acute edema may benefit from MLdT, when the 
addition of auxiliary multilayer short-stretch compression bandaging and exercises is 
incorporated. Compression was one key treatment which appeared to influence the outcomes of 
one study;9  This summary aligned with another systematic review published in the same year, 
using some of the same RCT, investigating lymphatic treatments after orthopedic surgery and 
injury.10  Study Two contributed further to the available body of evidence by evidencing 
moderate evidence for the use of MLdT for improving ROM after TKA.  One author7 suggested 
that their improved ROM observations may be attributed to the slight decrease in edema, 
mechanical effects of MLdT during popliteal maneuvers, prevention of fibrosis through protein 
reabsorption, or simply through relaxation.  In addition, the use of MLdT was recommended for 
hastened and stable pain relief and improving outcomes pertaining to functional activities and 
QOL.  One contribution to the body of knowledge which Study Two offered was the moderate 
evidence to support the use of MLdT for improving HU.  Patient-centered care and value-based 
reimbursement models advocate for rehabilitation therapists to be responsible with the delivery 
of evidence-based practice to lower HU.  This systematic review in combination with similar 
reviews, suggest that MLdT with and without auxiliary treatment modalities may abe used as an 
evidence-based intervention for the purpose of lowering HU, decreasing edema and pain, and 
increasing functional activities, ROM, and QOL.10,11   
Various OMs were employed in the individual RCT investigated in Study Two.  Edema 
measurement methods that were employed in the studies, included volumeter, bioimpedance, and 
circumferential measurements.  Also, studies used different OMs for Patient-reported OMs on 
functional activities and HRQOL.  In Study One, the respondents (TL and NTL) somewhat 
agreed to strongly agreed that the subject matter of examination of the lymphatic system (81.4%, 
n = 35) was entry-level material.  Ninety percent (n = 34) of TL respondents reported that their 
professional DPT programs taught on examination pertaining to lymphatics.  Examination 
including circumferential measurements, special tests, volumetric measurement, and integument 
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(28.9%, n = 11), and musculoskeletal (21.1%, n = 8) course.  For the purposes of clinical 
reasoning and differential diagnosis, having the skillsets of lymphatic examination, evaluation, 
and diagnosis would align with their importance as indicated  by CAPTE6 and the APTA – 
BOD.5  These underpinnings led to Study Three and the investigation of the use of OMs by post-
professional CLTs on BCS with BCRL and the facilitators and barriers to the use of OMs.  There 
were a number of OMs identified as being used at some level of frequency by CLTs to measure 
body functions and structures and activities and participation.  Those OMs used most often (i.e. 
fourth quartile of responses) included; 1) goniometry for AROM and PROM (99.1%, n = 110 
and 95.5%, n = 106, respectively), 2) stiff glenohumeral joint (93.7%, n = 104), 3) hand grip 
dynamometry and MMT (88.3%, n = 98 and 98.2%, n = 109, respectively), 4) circumferential 
measurements (99.1%, n = 110), 5) numeric pain scale and visual analog scale (94.6%, n = 105 
and 82.9%, n = 92, respectively), 6) light touch brushing (95.5%, n = 106), 7) pitting edema test 
and tissue texture via palpation (98.2%, n = 109 and 97.3%, n = 108, respectively), 9) body 
weight and BMI (91.0%, n = 101 and 85.6%, n = 95), 10) LLIS (82.9%, n = 92), and 11) 
QuickDASH (85.6%, n = 95).  The number of OMs used to assess body functions and structures 
exceeded those OMs that assess activities and participation.  In fact, there were no OMs used by 
the fourth quartile of CLT respondents to measure patient-reported fatigue, mobility and balance, 
and upper extremity (UE) activity and motor control.  At the third quartile of responses, the 
category of activities and participation did not populate a single OM for upper extremity activity 
and motor control.  Profession, specialization, and highest degree earned were unique 
characteristics of CLTs that predicted the use of some OMs. 
Facilitators and barriers to the use of OMs were investigated for both PT and OT CLTs.  
Most CLTs agreed that the use of OMs helps direct the plan of care (90.1%, n= 100), improves 
quality of care (76.6%, n = 85), helps in the clinical reasoning for choice of interventions 
(77.5%, n = 86), and are necessary for the practice of BCRL interventions and management 
(94.6%, n = 105).  They also largely agreed that OMs improves communication with their BCS 
clients with BCRL (80.2%, n = 89) and with other healthcare stakeholders (76.6%, n = 85).  
CLTs largely agreed that use of OMs were part of their personal practice model (81.8%, n = 90), 
and that OMs were important for assisting in the identification of comorbidities (87.3%, n = 96) 
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LIMITATIONS OF THE DISSERTATION 
 
This dissertation focused on the status of lymphology education and practice in 
professional physical therapy.  Although the lymphatic system is a major body system, its 
presence is commonly morphed into either the circulatory system and/or immune system in 
curriculums and even in physiology textbooks.  The average medical school graduate receives 
less than 30 minutes of lymphology education,12 while our results indicate that physical 
therapists receive a variable range of hours devoted to didactic (0.4-14.1 hours) and laboratory 
(0-10 hours) instruction pertaining to lymphology.  These conditions elude to the realization that 
the general population of faculty, specialists, and researchers in lymphology, let alone 
lymphology in the field of physical therapy, is marginal.  This limited population resulted in the 
primary limitation of recruitment of a sample population across all three studies, those being 
faculty that taught lymphology curriculum, articles about MLdT applied to orthopedic 
conditions, and CLTs that use OMs on BCS with BCRL.  The examination of lymphology 
content and use of OM and their facilitators and barriers were conducted via web-based survey 
research design.  Web-based surveys yield less response than other modes of survey delivery, 
and on average, yield an expected 35% response rate, or approximately a third of the surveys 
administered.1–3  Unfortunately, the low response rates across both survey research designs 
limited a population representation and would not allow generalization of the outcomes.  In 
addition, a sizable disproportion of respondents occurred in both studies.  Both surveys studies 
may have incurred survey burden and recall bias, especially considering the length of Study 
Three and the recall of instructional time in Study One and frequency of OM use in Study Three.  
Study Three examined PTs and OTs from the original sample, thereby limiting the 
generalizability of the results to the CLT population as a whole.  The limited articles that were 
retrieved and included in Study Two limited the analysis due to significant heterogeneity (across 
population, intervention, and outcome measures), low number of total participants, and moderate 
internal validity of the studies.  This prevented a meta-analysis to accurately determine the effect 
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FUTURE RESEARCH 
 
The scholarship of teaching and learning lymphology content is the baseline for future 
research endeavors stemming from this dissertation.  Study One begins to foster further research 
with regards to lymphology education in professional DPT programs.  Future studies may 
consider investigating DPT programs that offer specialist certifications and those that offer 
lymphology education without certification.  This study may use a mixed method approach, 
examining not only what lymphology content was being taught in these programs, but also 
assessing the lymphology knowledge of third year DPT students from different approaches.  In 
addition, interviews with individual faculty members may clarify the reasons for the variability 
of hours devoted to lecture and lab, and toward anatomy, physiology, pathophysiology, 
examination and intervention content that was discovered in Study One.  Currently, I am 
participating as co-investigator of a survey research design from LANA that has examined 
content being taught in post-professional lymphedema therapist certification courses.  The survey 
was disseminated to instructors from continuing education institutions of various tenets.  
Descriptive statistics will examine; 1) what is the current, typical lymphology post-professional 
content being taught, and 2) how the content is being taught (e.g. online or traditional).  This 
study will add knowledge to what has been presented in Study Three by investigating what is 
being taught post-professionally with regard to anatomy, physiology, examination, evaluation, 
clinical reasoning, and interventions of lymphatic and vascular disorders.   
Understanding what core outcomes should be of greatest concern for CLTs to understand, 
identify, and measure on BCS with BCRL requires further investigation.  Creating a COS for 
BCS with BCRL is a worthy endeavor for all allied stakeholders to capture baseline measures 
and BCRL comorbidities across the ICF levels.  This is a feasible endeavor and my relationship 
with LANA and the APTA Oncology section will enhance my efforts to unite various 
stakeholders to expand and then refine a list of outcome domains identified by the Breast Cancer 
EDGE Task Force studies, and then process through the COMET guidelines, including the 
possibility of a Delphi study.  The development of a COS is comprehensive; however, Study 
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only is a COS a feasible endeavor, but identifying the OMs to measure the COS is certainly 
within reach, as well as providing guidance as to “when” to measure are also attainable.  
Study Two introduces the need to understand the use of MLdT and auxiliary modalities 
as interventions across disciplines of physical therapy (e.g. orthopedic, neurology, sports 
medicine, oncology, wound management, and pediatrics).  There have been some recent 
randomized-controlled and quasi-experimental research exploring applications of MLdT for 
post-operative TKA subjects.  Unfortunately, most of the studies are examining acute and 
subacute episodes and also examine either MLdT or compression rather than exploring the 
combination in CDT.  This presents bias to the study and is evidence of the disregard to 
lymphology related to acute, subacute, and chronic edema.  There is a need for well-developed 
RCT to explore the efficacy of MLdT and compression in orthopedic physical therapy practice.  
Future research is needed to provide stronger evidence to support the use of MLdT for patients 
with conditions affecting the musculoskeletal system, and provide evidence as to which auxiliary 
interventions concurrent with MLdT produce best outcomes. 
Study Three revealed that OMs related to upper extremity and motor control were not 
used most often.  Linking lymphology, orthopedics, and neurology, I have proposed an original 
cross-sectional comparison study to investigate reaction time and movement time in females with 
breast cancer-related lymphedema.  Upper extremity simple reaction time and movement time 
are vital for the safety and health of an individual to restore balance and protect the body from an 
oncoming object or fall.  Individuals with breast cancer-related lymphedema (BCRL) have 
demonstrated sensorimotor impairments.  To date, there have not been studies that investigate 
upper extremity simple reaction time and movement time in females with BCRL.  Female BCS 
with and without lymphedema will participate in the study, along with healthy female 
participants without history of breast cancer or upper extremity lymphedema.  I have 
hypothesized that female BCS with unilateral BCRL will have slower simple reaction time, 
movement time, and execution time when performing a quick reaching task, compared to healthy 
females, and female BCS without lymphedema.  In addition, increased simple reaction, 
movement, and execution times in unilateral BCRL will be associated with upper extremity 
volumetric measures.  Additional factors will be investigated to screen biological plausibilities 
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approved by A.T. Still University’s Institutional Review Board and recruitment will commence 
in the fall.  Understanding how a chronic edema such as BCRL can affect the 
neuromusculoskeletal system can extend into future research examining similar edemas in 
orthopedics and neurology.  Assuming the significant finding from this study, my pursuits will 
lead to further investigations examining lower extremity lymphedema, chronic edema in lower 
extremities, and then chronic edema in upper extremities.  Broad research topics can be explored 
such as; 1) gait analysis in chronic edema/lymphedema, 2) balance analysis pre-post 
edema/lymphedema, 3) fear of falling among individuals with lower extremity lymphedema, 4) 
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DISSERTATION CONCLUSIONS 
 
 The results of the studies provided in this dissertation give evidence to the status of 
lymphology education and practice in physical therapy. 
Consistent content and format (didactic and laboratory hours) is currently lacking with 
regards to lymphatic system examination skills, and intervention techniques within the 
professional DPT programs.  The variability of hours was significant, with one program’s 
cumulative hourly investment in lymphology content to be two hours, while another school’s 
cumulative hours were forty.  The rehabilitation knowledge and skill sets of physical therapists, 
that are associated with lymphatics, prepares the field of physical therapy to forge new 
rehabilitation dimensions in lymphology.  Therefore, lymphology deserves a more prominent 
place in professional DPT curriculums, and should be disseminated throughout the various 
curricula modules.  Modifications in physical therapy curriculums occur as the global health care 
environment changes, knowledge within the profession evolves, and the higher education system 
advances in purpose, principles, and policies.  There is evidence for opportunities in developing 
optimal and congruous professional entry-level lymphology education in order to provide patient 
centered evidence-based lymphatic examinations and interventions.  
Lymphedema is not the only condition in which knowledgeable physical therapists can 
apply the skilled aptitudes recommended by CAPTE, and the APTA to address edema, effusion, 
inflammation, joint swelling, pain, and neural compression.  Neurological disorders,13 pain,14,15 
headaches,16,17 complex regional pain syndrome,18,19 rheumatoid arthritis,20 fibromyalgia,21 
chronic fatigue syndrome,22 and sports medicine11,23 are all trending areas for MLdT 
interventions.  There was moderate support for using MLdT as effective interventions to reduce 
pain and edema, improve ROM, and promote function and/or QOL.  In addition, MLdT are 
effective treatment methods associated with lower HU.  However, use of MLdT should only 
proceed with clinical expertise and the patient values in perspective.  Future research is needed to 
provide stronger evidence to support the use of MLdT for patients with conditions affecting the 
musculoskeletal system, and provide evidence as to which auxiliary interventions concurrent 
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Quantifiable OMs are an essential component of EBP and are often incorporated in the 
examination of a disorder and the outcome assessment of interventions for related impairments 
of body functions and structures, and limitations of activities and participation.24,25  The results 
of these measures provide a foundation for clinical reasoning in the diagnosis, prognosis, and 
establishment of intervention and/or management of a health condition.26  The number of OMs 
used most often that assess body functions and structures exceed those OMs for activities and 
participation.  Recommended OMs from the Breast Cancer EDGE Task Force and the Dutch 
Lymphedema Guideline that assess ICF domains that were identified as used most often in this 
study include; 1) goniometry PROM and AROM for joint function, 2) stiffness of the 
glenohumeral joint for flexibility, 3) hand grip dynamometer for strength, 4) circumference for 
volume, 5) numeric pain scale for pain, 6) pitting edema test for tissue consistency, 7) body 
weight and BMI for body composition, and 8) QuickDash for patient-reported upper quadrant 
function.  Other OMs used most often were 1) MMT for strength, 2) light touch brushing for 
sensation, 3) tissue texture assessment for tissue consistency, 4) visual analog scale for pain, and 
5) LLIS for patient-reported HRQOL.  Overall, CLTs largely agree on the benefits of and to the 
use of OMs.  However, they experience barriers to their use related to knowledge and 
competence of OMs.  These barriers foster the need for further guidance in a selective core 
outcome set and OMs with proper psychometrics for BCS with BCRL.  Lymphology education 
related to examination and evaluations for clinical reasoning, diagnosis, and assessment of 
interventions may be lacking in the field of physical therapy both pre and post-professionally, 
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Subject: Notice of Exemption for [HUM00188013]
SUBMISSION INFORMATION:
Title: Use of Outcome Measures by Certified Lymphedema Therapists on Breast Cancer Survivors with Breast Cancer Related Lymphedema
Full Study Title (if applicable): Use of Outcome Measures by Certified Lymphedema Therapists on Breast Cancer Survivors with Breast Cancer Related Lymphedema
Study eResearch ID: HUM00188013
Date of this Notification from IRB: 2/19/2021  
Date of IRB Exempt Determination: 2/19/2021 
UM Federalwide Assurance: FWA00004969 (For the current FWA expiration date, please visit the UM HRPP Webpage)  
OHRP IRB Registration Number(s): IRB00000246
 
IRB EXEMPTION STATUS:
The IRB HSBS has reviewed the study referenced above and determined that, as currently described, it is exempt from ongoing IRB review, per the following federal exemption category:
EXEMPTION 2(i) and/or 2(ii) at 45 CFR 46.104(d):
Research that only includes interactions involving educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures, interview procedures, or observation of public behavior (including visual or auditory recording) if at
least one of the following criteria is met:
(i) The information obtained is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained, directly or through identifiers linked to the subjects;
(ii) Any disclosure of the human subjects' responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, educational
advancement, or reputation
Note that the study is considered exempt as long as any changes to the use of human subjects (including their data) remain within the scope of the exemption category above. Any proposed changes that may exceed the scope of this category,
or the approval conditions of any other non-IRB reviewing committees, must be submitted as an amendment through eResearch.
Although an exemption determination eliminates the need for ongoing IRB review and approval, you still have an obligation to understand and abide by generally accepted principles of responsible and ethical conduct of research. Examples of
these principles can be found in the Belmont Report as well as in guidance from professional societies and scientific organizations.
SUBMITTING AMENDMENTS VIA eRESEARCH:
You can access the online forms for amendments in the eResearch workspace for this exempt study, referenced above.
ACCESSING EXEMPT STUDIES IN eRESEARCH:

















NOTICE OF APPROVAL – EXEMPT HUMAN RESEARCH PROTOCOL 
  
25 February 2021 
 
 
  DETERMINATION:  Exempt Protocol #2021-071 (no greater than minimal risk) 
  PRINCIPAL INVESTIGATOR:  David Doubblestein PhD (c)   
  PROTOCOL TITLE:  “Use of Outcome Measures by Certified Lymphedema Therapists on 
Breast Cancer Survivors with Breast Cancer Related Lymphedema” 
 
 
Dear ATSU Investigator: 
 
The ATSU-AZ IRB has reviewed your application cited above.   The purpose of this study is to examine 
1) the use of outcome measures used by CLT on BCS with BCRL and their associated factors; and 2) 
facilitators and barriers with influence CLT use of outcome measures and their associated factors. 
 
Therefore, per Code of Federal Regulations, 45 CFR §46.104(d)(2i), this project is approved as an 
Exempt human research study, which precludes the federal mandate for IRB continued oversight 
beyond this determination. 
 
45 CFR §46.104(d)(2) 
(2) Surveys, Interviews, Observation: Research that only includes interactions involving 
educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures, interview 
procedures, or observation of public behavior (including visual or auditory recording) if at least 
one of the following criteria is met: 
(i) The information obtained is recorded by the investigator in such a manner that the identity 
of the human subjects cannot readily be ascertained, directly or through identifiers linked to the 
subjects;  
 
You may now proceed with your research.  If your project deviates from materials submitted to the 
ATSU-AZ IRB, you must seek amendment approval from the ATSU-AZ IRB prior to any work involving 
human subjects.  Otherwise, no further reporting to the ATSU-AZ IRB is required.  Keep this letter with 




Brigit M. Ciccarello, M.A. 
IRB Coordinator, Designee of the Chair 
ATSU Arizona Institutional Review Board 
MesaIRB@atsu.edu 
INSTITUTIONAL REVIEW BOARD 
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